data_2b9k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2b9k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 121.933 0.873 . . . . 10.0 112.219 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -127.92 162.79 25.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.831 2.452 . . . . 10.0 106.994 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.9 mt -117.06 134.32 54.9 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.446 -2.057 . . . . 10.0 105.446 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -139.78 147.2 24.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -164.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -145.3 126.11 14.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.193 1.397 . . . . 10.0 107.253 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -168.12 153.3 6.57 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.601 1.16 . . . . 10.0 110.377 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.24 -24.72 27.16 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.395 2.063 . . . . 10.0 113.292 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -76.28 -19.26 58.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.99 30.53 23.11 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.565 1.079 . . . . 10.0 114.668 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -52.75 105.71 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 10.0 111.887 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -74.53 105.52 5.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.833 0.853 . . . . 10.0 109.123 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.6 -10.26 56.12 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.862 1.06 . . . . 10.0 113.862 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.06 -72.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.277 2.631 . . . . 10.0 114.884 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.6 p -165.48 161.96 19.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.174 1.39 . . . . 10.0 110.32 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -158.99 175.3 13.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.233 1.413 . . . . 10.0 109.092 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.67 130.76 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 105.685 -1.968 . . . . 10.0 105.685 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -152.2 137.87 17.86 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.03 -1.47 . . . . 10.0 107.03 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.68 50.13 10.88 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.193 1.797 . . . . 10.0 112.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.79 23.24 63.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.104 0.859 . . . . 10.0 113.382 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -130.7 145.07 51.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.672 -1.603 . . . . 10.0 106.672 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.26 151.0 19.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.801 -0.814 . . . . 10.0 108.801 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -138.2 139.24 39.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 tt -155.11 158.18 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.371 1.068 . . . . 10.0 112.015 -168.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.19 156.94 3.76 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.328 1.851 . . . . 10.0 112.545 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -140.45 -61.52 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.533 -1.222 . . . . 10.0 109.569 168.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -154.23 147.28 24.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.045 1.293 . . . . 10.0 111.21 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.28 160.89 41.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.256 -0.903 . . . . 10.0 110.088 162.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.95 162.64 41.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.54 1.536 . . . . 10.0 108.819 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -94.01 123.16 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -93.62 82.1 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.412 -0.959 . . . . 10.0 108.412 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -54.35 -25.67 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.808 1.243 . . . . 10.0 113.452 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m -63.93 -20.17 65.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.436 1.094 . . . . 10.0 112.847 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -126.81 -16.56 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.143 1.377 . . . . 10.0 111.558 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.68 40.11 38.7 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.507 -0.637 . . . . 10.0 111.507 174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.92 166.85 23.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.759 0.779 . . . . 10.0 110.097 172.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -80.28 152.19 29.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.671 -0.862 . . . . 10.0 108.671 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.2 t -137.56 151.4 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.507 -2.035 . . . . 10.0 105.507 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 170.24 38.48 Favored Glycine 0 N--CA 1.45 -0.369 0 O-C-N 121.353 -0.842 . . . . 10.0 113.246 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -116.84 122.0 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 101.653 -3.462 . . . . 10.0 101.653 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.48 44.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 -164.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -127.09 36.78 4.38 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.13 -45.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.722 0.692 . . . . 10.0 111.512 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.1 t90 . . . . . 0 CA--C 1.532 0.257 0 CA-C-N 118.847 0.748 . . . . 10.0 109.309 -174.564 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 122.054 0.93 . . . . 10.0 111.42 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -128.17 161.47 29.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.108 2.563 . . . . 10.0 106.176 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -108.31 130.95 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.456 -2.053 . . . . 10.0 105.456 172.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.16 142.92 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -162.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.56 140.88 16.62 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.818 0.847 . . . . 10.0 109.833 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.49 153.74 5.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.211 1.404 . . . . 10.0 108.497 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.42 -27.44 28.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.207 1.938 . . . . 10.0 112.786 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -69.29 -30.4 68.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.825 0.676 . . . . 10.0 112.825 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.84 46.83 93.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.377 -0.689 . . . . 10.0 111.377 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -73.29 70.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.065 1.346 . . . . 10.0 111.152 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -52.61 121.28 6.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.737 1.215 . . . . 10.0 109.77 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -9.12 18.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.621 0.971 . . . . 10.0 113.621 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.34 -65.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.348 2.659 . . . . 10.0 114.986 -170.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 p -165.26 163.19 20.14 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.81 1.244 . . . . 10.0 110.723 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.23 174.06 15.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 10.0 108.607 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.32 133.68 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.726 -1.953 . . . . 10.0 105.726 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 tt -144.68 121.3 11.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.89 42.14 15.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.892 1.677 . . . . 10.0 112.664 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.53 0.79 74.26 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.216 0.912 . . . . 10.0 114.017 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.5 m -96.99 137.78 35.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -88.73 150.83 22.78 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -137.32 140.33 41.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.111 1.764 . . . . 10.0 106.277 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.1 158.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.519 1.128 . . . . 10.0 112.003 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.92 157.01 8.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.966 1.706 . . . . 10.0 112.495 171.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.67 -61.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.531 -1.223 . . . . 10.0 109.397 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 m -150.78 149.8 30.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.681 1.128 . . . . 10.0 111.025 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.65 156.73 44.25 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.908 0.883 . . . . 10.0 109.539 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.61 160.71 40.68 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.219 1.407 . . . . 10.0 108.725 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.51 120.08 34.2 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.12 81.81 6.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.333 -0.988 . . . . 10.0 108.333 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -53.23 -27.14 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.745 1.218 . . . . 10.0 113.342 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -64.23 -20.01 65.75 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.408 1.083 . . . . 10.0 112.952 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.0 -12.51 6.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.675 1.19 . . . . 10.0 111.911 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 41.96 32.84 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.748 0.69 . . . . 10.0 111.814 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 164.53 33.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.854 0.827 . . . . 10.0 110.574 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -78.57 150.03 32.88 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.17 153.78 24.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.585 -2.005 . . . . 10.0 105.585 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.71 162.92 34.92 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.283 -0.886 . . . . 10.0 113.088 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.6 mm -101.12 119.27 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.725 -3.435 . . . . 10.0 101.725 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.53 29.76 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -162.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.44 34.78 3.92 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.71 -1.219 . . . . 10.0 107.71 170.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.49 -56.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.317 0.962 . . . . 10.0 111.388 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.9 t90 . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 118.675 0.67 . . . . 10.0 111.128 -165.219 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.4 pt . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 122.103 0.954 . . . . 10.0 111.504 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -111.82 162.53 15.17 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.653 2.381 . . . . 10.0 106.259 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -123.43 135.2 53.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.117 -2.179 . . . . 10.0 105.117 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.64 148.84 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -165.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -139.48 127.46 22.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 170.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -161.12 151.66 14.99 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 119.47 1.032 . . . . 10.0 108.933 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.72 -27.7 26.36 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.958 1.772 . . . . 10.0 113.084 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -78.23 -25.09 46.78 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.473 0.916 . . . . 10.0 113.473 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.24 32.15 35.86 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.351 -1.249 . . . . 10.0 114.769 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -54.5 115.45 2.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.937 1.368 . . . . 10.0 111.434 -171.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -78.24 115.29 17.86 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.27 -11.58 23.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.77 -67.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.157 2.583 . . . . 10.0 114.608 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -165.47 162.88 19.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.852 1.261 . . . . 10.0 110.544 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -158.71 176.3 12.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.479 1.511 . . . . 10.0 108.751 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.31 130.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.782 -1.932 . . . . 10.0 105.782 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.18 138.12 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t0 45.94 51.21 10.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.152 1.781 . . . . 10.0 112.577 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.2 63.52 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.104 0.859 . . . . 10.0 113.487 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -132.98 143.37 49.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -90.71 150.63 21.56 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -137.07 140.27 41.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.14 156.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.46 1.104 . . . . 10.0 112.025 -167.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -57.85 154.77 11.5 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.266 1.826 . . . . 10.0 112.395 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -137.1 -61.6 0.65 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.449 -1.263 . . . . 10.0 109.277 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -161.37 154.88 21.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.706 1.593 . . . . 10.0 111.602 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -146.78 160.55 42.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.101 0.961 . . . . 10.0 109.378 166.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.16 158.26 43.74 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.318 1.447 . . . . 10.0 108.701 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -90.54 120.36 31.57 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -87.64 76.6 8.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -51.8 -28.3 15.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.031 1.332 . . . . 10.0 113.287 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -64.78 -17.38 64.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.668 1.187 . . . . 10.0 113.19 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -131.11 -15.63 3.29 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.457 1.103 . . . . 10.0 112.293 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 39.05 8.29 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.945 0.793 . . . . 10.0 112.515 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -148.54 163.64 36.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.042 0.921 . . . . 10.0 109.417 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -77.5 154.53 32.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.06 150.35 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.4 38.27 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.585 -0.817 . . . . 10.0 113.953 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.0 mt -114.5 118.66 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 101.636 -3.468 . . . . 10.0 101.636 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.3 134.54 20.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.969 -1.123 . . . . 10.0 107.969 -162.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -106.78 36.03 2.79 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.29 -46.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.43 1.014 . . . . 10.0 111.765 168.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 118.722 0.692 . . . . 10.0 109.879 -175.546 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 122.575 1.179 . . . . 10.0 112.386 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -120.51 165.33 15.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.751 2.82 . . . . 10.0 106.056 166.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.3 mt -127.18 137.92 53.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.51 148.12 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -168.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -144.21 115.34 7.92 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -153.69 149.59 21.41 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.698 0.799 . . . . 10.0 109.259 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.66 -26.99 32.74 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.982 1.788 . . . . 10.0 113.02 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -81.73 -19.13 42.07 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.04 45.85 26.49 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 119.204 0.911 . . . . 10.0 112.945 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -65.26 81.39 0.05 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.769 1.228 . . . . 10.0 112.195 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -57.95 121.49 10.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.294 1.438 . . . . 10.0 109.794 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.37 -10.19 19.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -173.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.25 -64.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.396 2.678 . . . . 10.0 115.012 -168.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -166.42 163.73 17.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.828 1.251 . . . . 10.0 110.818 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -158.49 178.09 10.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.84 1.656 . . . . 10.0 108.386 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.03 137.71 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 106.779 -1.563 . . . . 10.0 106.779 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 tp -149.33 127.18 11.81 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 44.87 46.35 8.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.08 1.752 . . . . 10.0 113.153 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.18 14.06 82.21 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.297 -0.724 . . . . 10.0 113.83 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.7 m -118.75 131.09 56.11 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -86.38 151.82 23.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.6 140.17 42.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.31 157.81 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 125.043 1.337 . . . . 10.0 111.695 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.61 155.32 4.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.225 1.81 . . . . 10.0 112.584 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -136.62 -64.89 0.57 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.444 -1.265 . . . . 10.0 109.083 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.0 m -152.38 151.01 30.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.376 1.444 . . . . 10.0 111.222 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -145.56 154.9 42.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.788 0.835 . . . . 10.0 109.66 169.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.0 156.81 38.09 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.77 1.228 . . . . 10.0 108.836 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -90.27 120.42 31.4 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -88.59 77.02 8.06 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.06 -28.79 18.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.86 1.264 . . . . 10.0 113.107 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -66.05 -17.6 64.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.475 1.11 . . . . 10.0 112.983 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -126.79 -17.35 4.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.339 1.056 . . . . 10.0 111.83 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.79 9.27 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.743 0.701 . . . . 10.0 112.349 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -148.65 163.46 37.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.282 1.041 . . . . 10.0 109.987 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -75.7 154.36 36.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.11 153.33 26.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.76 161.31 33.16 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.687 -0.633 . . . . 10.0 112.921 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.5 mt -103.67 124.25 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 101.778 -3.416 . . . . 10.0 101.778 166.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 131.6 18.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.468 -0.938 . . . . 10.0 108.468 -163.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -103.54 37.13 2.09 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -153.69 -49.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 119.283 0.947 . . . . 10.0 111.874 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 . . . . . 0 CA--C 1.535 0.376 0 CA-C-N 118.82 0.736 . . . . 10.0 110.203 -170.89 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.527 0.679 . . . . 10.0 111.227 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -113.34 161.75 16.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.575 1.95 . . . . 10.0 106.761 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.96 137.19 52.28 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.464 -2.051 . . . . 10.0 105.464 169.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.89 147.63 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -141.47 126.23 18.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.481 1.512 . . . . 10.0 106.946 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -166.9 146.6 4.75 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.43 -16.43 47.61 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.973 1.782 . . . . 10.0 112.367 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -63.82 -41.16 97.92 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.647 0.658 . . . . 10.0 111.598 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.9 28.06 15.6 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.762 1.172 . . . . 10.0 114.629 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.07 105.33 1.03 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.525 1.163 . . . . 10.0 110.64 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -66.31 108.32 2.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.19 -12.0 42.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.423 0.897 . . . . 10.0 113.423 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.5 -70.06 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.165 2.586 . . . . 10.0 114.2 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 163.29 19.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.028 1.331 . . . . 10.0 110.37 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -157.72 174.06 15.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.215 1.406 . . . . 10.0 109.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -135.25 129.64 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.94 -1.874 . . . . 10.0 105.94 173.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.95 131.48 14.81 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.551 -1.648 . . . . 10.0 106.551 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.18 51.52 9.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.764 2.026 . . . . 10.0 112.743 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.77 21.96 63.72 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.528 -0.76 . . . . 10.0 113.378 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -127.7 142.82 51.22 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -91.72 151.93 20.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -138.9 140.33 38.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.122 -1.807 . . . . 10.0 106.122 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.23 158.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.742 1.156 . . . . 10.0 112.438 -166.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -57.23 155.29 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.029 1.732 . . . . 10.0 112.386 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -138.77 -62.51 0.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 117.358 -1.306 . . . . 10.0 109.106 167.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 m -154.46 149.15 26.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.201 1.364 . . . . 10.0 111.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -146.42 160.89 41.48 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.329 -0.857 . . . . 10.0 110.0 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.07 164.15 38.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.639 1.576 . . . . 10.0 108.716 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -96.34 121.82 38.55 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -90.88 87.1 6.5 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.09 -16.75 5.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.696 1.199 . . . . 10.0 113.362 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -25.86 68.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.182 0.901 . . . . 10.0 111.838 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -134.64 -11.7 2.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.181 0.992 . . . . 10.0 112.558 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.85 43.06 9.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 118.901 0.773 . . . . 10.0 111.952 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -146.02 163.03 36.51 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.657 0.783 . . . . 10.0 109.524 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -75.98 153.28 36.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 171.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -136.96 151.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.377 -2.083 . . . . 10.0 105.377 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 169.5 38.9 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.621 -0.799 . . . . 10.0 113.856 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.78 120.36 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 101.254 -3.61 . . . . 10.0 101.254 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.31 149.79 36.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -165.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.3 31.03 6.81 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.67 -47.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.767 0.827 . . . . 10.0 111.556 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.1 t90 . . . . . 0 CA--C 1.532 0.278 0 CA-C-N 118.751 0.705 . . . . 10.0 110.464 -171.737 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 121.907 0.861 . . . . 10.0 111.425 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -109.32 165.02 11.94 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.893 2.077 . . . . 10.0 106.819 165.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.27 138.8 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.261 -2.126 . . . . 10.0 105.261 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.58 151.12 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -168.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.03 122.14 7.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.462 1.105 . . . . 10.0 108.264 171.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -154.25 151.61 24.63 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.791 1.236 . . . . 10.0 108.363 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.74 -25.07 40.18 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.894 1.729 . . . . 10.0 113.153 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -88.05 -15.87 35.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -172.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.47 36.1 37.77 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.203 -1.331 . . . . 10.0 113.954 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -53.16 98.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.128 1.371 . . . . 10.0 112.235 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.76 117.44 17.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.205 1.002 . . . . 10.0 108.927 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.35 -11.67 25.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.27 -64.78 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.162 2.585 . . . . 10.0 114.642 -167.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -166.59 162.99 16.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.836 1.254 . . . . 10.0 110.724 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -159.73 178.65 9.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 10.0 108.816 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -135.67 129.82 49.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -151.95 139.97 20.14 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t0 47.05 50.18 14.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.682 1.593 . . . . 10.0 112.434 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.25 64.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.14 0.876 . . . . 10.0 113.517 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -134.79 144.22 47.53 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 -173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -88.25 149.75 23.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -135.34 141.74 45.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.325 -1.732 . . . . 10.0 106.325 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 tt -152.25 156.92 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.213 . . . . 10.0 111.847 -168.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -58.0 153.7 13.93 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.577 1.551 . . . . 10.0 111.998 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -131.82 -70.18 0.58 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.345 -1.312 . . . . 10.0 108.318 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.2 m -153.47 149.46 27.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.312 1.414 . . . . 10.0 111.289 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -143.15 157.89 44.11 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.498 -0.751 . . . . 10.0 109.512 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -149.13 154.35 39.08 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.445 1.498 . . . . 10.0 108.352 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -88.82 119.85 29.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -85.07 82.24 8.52 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -55.83 -29.68 60.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.984 0.914 . . . . 10.0 112.269 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -25.39 68.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.867 1.267 . . . . 10.0 112.644 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -120.31 -18.07 8.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.851 0.86 . . . . 10.0 111.932 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.81 29.9 12.43 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.411 1.005 . . . . 10.0 113.003 168.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -153.53 163.74 39.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.882 1.341 . . . . 10.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -74.3 152.77 39.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -139.21 152.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.477 -2.046 . . . . 10.0 105.477 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.88 167.41 39.15 Favored Glycine 0 C--N 1.332 0.33 0 O-C-N 121.274 -0.891 . . . . 10.0 114.082 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -109.41 125.32 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 102.353 -3.202 . . . . 10.0 102.353 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.31 130.84 16.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -165.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -99.85 32.15 3.0 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 -48.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.69 1.132 . . . . 10.0 112.363 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t90 . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 118.644 0.657 . . . . 10.0 110.569 -174.1 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 122.105 0.955 . . . . 10.0 112.643 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.33 163.31 31.31 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.762 2.425 . . . . 10.0 106.512 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.89 135.43 54.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.809 -1.923 . . . . 10.0 105.809 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.07 145.4 27.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -144.74 119.19 9.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.16 -1.792 . . . . 10.0 106.16 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -168.11 153.16 6.52 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 125.292 1.437 . . . . 10.0 110.064 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.2 -27.08 17.1 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.466 2.111 . . . . 10.0 113.246 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -68.29 -29.99 68.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.954 0.797 . . . . 10.0 112.645 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.28 31.85 13.2 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.26 -1.3 . . . . 10.0 114.963 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 107.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.791 1.295 . . . . 10.0 111.546 -168.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.48 116.3 6.62 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.0 -8.49 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.413 0.894 . . . . 10.0 113.413 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.7 -69.26 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.313 2.645 . . . . 10.0 114.517 -171.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -164.86 162.54 20.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.867 1.267 . . . . 10.0 110.878 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -159.29 177.96 10.47 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.659 1.583 . . . . 10.0 109.061 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.14 129.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 105.943 -1.873 . . . . 10.0 105.943 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -154.97 142.97 20.12 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.362 1.465 . . . . 10.0 107.09 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.59 47.49 14.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.656 1.582 . . . . 10.0 112.644 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.45 23.72 62.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.238 0.923 . . . . 10.0 113.573 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.4 m -134.45 147.44 50.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.95 150.95 21.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -135.78 140.05 44.0 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 105.985 -1.857 . . . . 10.0 105.985 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -154.9 157.13 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.603 1.161 . . . . 10.0 111.384 -167.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -59.57 155.99 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.752 1.621 . . . . 10.0 112.19 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -136.83 -67.92 0.49 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.416 -1.278 . . . . 10.0 109.271 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.6 m -151.16 144.62 24.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.463 1.483 . . . . 10.0 111.259 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -148.75 151.48 34.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.915 0.886 . . . . 10.0 109.294 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.9 158.7 42.52 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.809 1.244 . . . . 10.0 108.997 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -91.18 119.3 31.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -88.33 81.43 7.27 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -53.85 -26.44 24.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.967 1.307 . . . . 10.0 113.437 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.2 m -63.0 -21.19 65.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.346 1.059 . . . . 10.0 112.901 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.64 -12.57 6.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.704 1.201 . . . . 10.0 111.916 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 42.33 28.31 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.78 166.45 26.61 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.624 0.77 . . . . 10.0 109.996 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -81.27 152.28 27.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.904 -0.776 . . . . 10.0 108.904 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -137.3 150.69 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.332 -2.099 . . . . 10.0 105.332 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.81 166.37 38.03 Favored Glycine 0 C--N 1.333 0.365 0 O-C-N 121.426 -0.796 . . . . 10.0 113.486 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -108.32 120.69 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 101.677 -3.453 . . . . 10.0 101.677 168.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.64 155.53 46.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -167.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -128.37 36.41 4.28 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 106.653 -1.61 . . . . 10.0 106.653 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.97 -45.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.63 1.105 . . . . 10.0 112.01 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.2 t90 . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 119.191 0.905 . . . . 10.0 109.533 -175.535 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.0 pt . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.831 0.824 . . . . 10.0 111.292 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.11 159.31 21.91 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.007 2.123 . . . . 10.0 106.36 166.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.85 128.12 56.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.672 -2.344 . . . . 10.0 104.672 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -139.21 147.73 24.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.23 -1.026 . . . . 10.0 108.23 -161.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -149.34 148.4 29.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.21 1.004 . . . . 10.0 108.524 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m 179.14 155.43 0.61 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 127.562 2.345 . . . . 10.0 108.17 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.41 -24.26 31.48 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.312 2.008 . . . . 10.0 113.254 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -68.08 -28.78 67.65 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.401 -0.809 . . . . 10.0 113.019 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.25 41.59 8.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.44 1.019 . . . . 10.0 114.348 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.23 91.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.159 1.384 . . . . 10.0 110.974 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.39 112.33 2.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.802 0.841 . . . . 10.0 108.892 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.65 -12.16 24.25 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.269 0.841 . . . . 10.0 113.269 -174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.07 -63.81 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.389 2.676 . . . . 10.0 114.567 -169.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -165.18 162.75 20.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.814 1.246 . . . . 10.0 110.569 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -158.01 177.5 11.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.687 1.595 . . . . 10.0 108.495 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 135.84 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.784 -1.561 . . . . 10.0 106.784 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.0 131.2 12.75 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 44.13 47.84 7.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.861 . . . . 10.0 113.086 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.34 18.14 76.6 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.352 -0.693 . . . . 10.0 113.707 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -125.18 136.17 53.32 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.36 152.97 21.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -137.55 140.43 41.04 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.337 -1.727 . . . . 10.0 106.337 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -154.68 159.31 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 119.591 1.087 . . . . 10.0 112.169 -167.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.03 156.4 9.42 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.69 1.596 . . . . 10.0 112.276 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -139.67 -63.26 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 117.265 -1.35 . . . . 10.0 109.445 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.9 m -151.7 149.52 29.18 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.092 1.314 . . . . 10.0 111.198 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -147.16 156.28 42.84 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.748 0.819 . . . . 10.0 109.719 168.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -155.13 160.7 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.955 1.302 . . . . 10.0 108.885 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -94.15 120.79 34.91 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.258 -1.386 . . . . 10.0 107.258 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.28 86.3 6.8 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.09 -0.708 . . . . 10.0 109.09 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -55.76 -15.94 3.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.483 1.113 . . . . 10.0 113.433 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -22.08 66.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.236 0.925 . . . . 10.0 112.161 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -139.4 -11.97 1.2 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.144 0.978 . . . . 10.0 112.826 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 45.29 7.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.15 0.886 . . . . 10.0 111.956 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.74 163.2 34.74 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.838 0.819 . . . . 10.0 109.629 172.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -76.49 153.17 35.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.25 153.05 23.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.911 2.084 . . . . 10.0 105.573 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.98 165.29 37.57 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 121.381 -0.825 . . . . 10.0 113.323 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.65 120.47 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 101.202 -3.629 . . . . 10.0 101.202 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.87 139.14 29.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 -164.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -109.36 30.08 6.95 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.64 -44.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.729 1.149 . . . . 10.0 113.041 171.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.7 t90 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 119.819 1.191 . . . . 10.0 109.971 -173.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 121.779 0.799 . . . . 10.0 111.771 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.85 166.75 11.15 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.692 1.997 . . . . 10.0 107.092 158.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.97 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.17 146.09 25.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.014 -0.736 . . . . 10.0 109.014 -162.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.68 141.5 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.894 1.278 . . . . 10.0 108.09 169.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -173.03 154.12 2.64 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 126.853 2.061 . . . . 10.0 107.97 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.21 -25.95 30.66 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.227 1.951 . . . . 10.0 113.091 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -69.74 -28.39 65.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.696 -0.669 . . . . 10.0 112.58 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.05 48.23 58.83 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 118.638 0.654 . . . . 10.0 112.012 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -71.44 73.94 0.74 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.739 1.215 . . . . 10.0 111.176 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.21 120.09 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.074 1.35 . . . . 10.0 109.591 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.86 -7.92 21.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.06 -70.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.032 2.533 . . . . 10.0 114.48 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.7 p -159.61 164.82 33.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.512 1.051 . . . . 10.0 110.634 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -157.76 179.48 9.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.322 1.449 . . . . 10.0 108.975 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.71 130.79 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.3 144.03 21.66 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.75 46.85 11.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.52 . . . . 10.0 112.419 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.4 24.5 63.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.189 0.9 . . . . 10.0 113.636 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -133.75 147.43 51.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.066 1.346 . . . . 10.0 107.553 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -83.0 146.38 28.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -133.31 140.25 47.33 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.511 -1.662 . . . . 10.0 106.511 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -154.37 158.32 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.624 1.17 . . . . 10.0 111.874 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.99 156.58 5.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.055 1.742 . . . . 10.0 112.677 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -138.45 -62.2 0.57 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 117.257 -1.354 . . . . 10.0 109.334 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -151.9 150.25 29.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.127 1.33 . . . . 10.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -145.09 157.0 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.598 0.759 . . . . 10.0 109.556 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.08 160.8 41.27 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.941 1.296 . . . . 10.0 108.716 170.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -94.14 116.19 28.57 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.17 87.55 7.39 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -58.36 -15.4 10.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.607 1.163 . . . . 10.0 113.218 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.61 -25.11 67.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.428 1.013 . . . . 10.0 111.625 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.66 -12.63 4.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.626 1.17 . . . . 10.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 42.97 19.68 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.703 0.668 . . . . 10.0 111.506 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.46 163.84 34.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.026 0.913 . . . . 10.0 110.974 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -78.68 150.64 32.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -140.23 152.84 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.805 2.042 . . . . 10.0 105.616 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.39 163.64 36.7 Favored Glycine 0 C--N 1.334 0.427 0 O-C-N 121.242 -0.911 . . . . 10.0 113.485 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.96 123.99 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 101.828 -3.397 . . . . 10.0 101.828 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.27 29.18 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.736 -0.838 . . . . 10.0 108.736 -163.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -115.31 35.72 4.25 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.97 -49.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.892 0.769 . . . . 10.0 112.202 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 . . . . . 0 CA--C 1.536 0.409 0 CA-C-N 119.137 0.881 . . . . 10.0 110.65 -171.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.912 0.863 . . . . 10.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -115.73 162.12 17.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.107 2.163 . . . . 10.0 106.585 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.72 136.62 53.24 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.4 -2.074 . . . . 10.0 105.4 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.9 146.89 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 -163.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.79 120.55 9.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.589 -1.634 . . . . 10.0 106.589 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m -158.99 150.99 17.27 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 119.739 1.154 . . . . 10.0 109.327 173.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.2 -27.19 35.36 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.035 1.823 . . . . 10.0 112.98 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -81.15 -17.43 49.84 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.792 1.034 . . . . 10.0 113.792 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.98 34.79 31.37 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.145 -1.364 . . . . 10.0 114.008 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -53.33 99.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.109 1.363 . . . . 10.0 112.408 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.8 117.26 15.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.501 1.12 . . . . 10.0 109.317 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.08 -11.81 27.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.98 -67.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.326 2.65 . . . . 10.0 114.2 -166.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -163.82 162.5 23.75 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.291 1.036 . . . . 10.0 110.366 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -158.55 176.4 12.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.04 1.336 . . . . 10.0 108.885 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -137.1 132.2 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -149.5 135.04 18.48 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.52 50.24 10.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.198 1.799 . . . . 10.0 112.757 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.19 69.17 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.822 0.725 . . . . 10.0 113.547 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -129.15 138.75 51.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.65 -1.611 . . . . 10.0 106.65 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -88.41 151.55 22.5 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.65 140.62 42.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.961 1.705 . . . . 10.0 106.518 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -152.58 155.02 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.153 1.381 . . . . 10.0 111.398 -163.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -57.59 156.02 8.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.565 1.546 . . . . 10.0 112.188 170.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -138.78 -64.99 0.5 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.538 -1.22 . . . . 10.0 109.465 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -152.15 149.75 29.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.203 1.365 . . . . 10.0 111.033 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 23.0 ttpt -149.97 143.61 25.32 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -150.84 154.76 37.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.739 1.216 . . . . 10.0 109.085 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -89.04 122.66 32.6 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.76 90.82 4.82 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.252 1.025 . . . . 10.0 108.88 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -57.4 -13.7 3.83 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.213 1.405 . . . . 10.0 113.399 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -62.71 -25.18 68.04 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.632 1.106 . . . . 10.0 111.876 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -131.59 -9.72 3.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.467 0.707 . . . . 10.0 111.959 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.58 8.69 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.469 -1.052 . . . . 10.0 110.469 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.32 163.17 34.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.317 1.047 . . . . 10.0 109.92 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.505 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 88.3 m95 -81.8 149.12 28.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -136.59 153.17 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.536 -2.024 . . . . 10.0 105.536 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.38 167.37 38.25 Favored Glycine 0 N--CA 1.45 -0.38 0 O-C-N 121.142 -0.974 . . . . 10.0 113.52 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.19 122.87 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 101.307 -3.59 . . . . 10.0 101.307 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.12 134.17 21.5 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -102.98 31.68 4.09 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 p -153.75 -47.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.913 1.233 . . . . 10.0 112.738 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 118.876 0.762 . . . . 10.0 110.696 -169.335 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.231 1.015 . . . . 10.0 112.41 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -116.67 163.56 15.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.372 2.269 . . . . 10.0 106.577 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.65 133.41 52.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.66 149.66 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.897 -0.779 . . . . 10.0 108.897 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -144.43 127.6 16.65 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.519 -2.03 . . . . 10.0 105.519 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -169.66 153.43 5.04 Favored Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 125.372 1.469 . . . . 10.0 109.151 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.78 -24.88 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.335 2.024 . . . . 10.0 113.123 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -81.77 -18.72 43.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.698 0.999 . . . . 10.0 113.698 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.39 37.66 18.95 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.365 -1.242 . . . . 10.0 113.818 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -54.06 99.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.89 1.276 . . . . 10.0 112.094 -170.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.06 116.88 16.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.082 0.953 . . . . 10.0 108.736 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.32 -11.82 27.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.576 0.954 . . . . 10.0 113.576 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.41 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.153 2.581 . . . . 10.0 114.673 -166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 p -167.46 164.49 14.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.826 1.25 . . . . 10.0 110.899 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -158.53 175.98 12.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.843 1.657 . . . . 10.0 108.486 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.7 132.74 48.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.872 -1.899 . . . . 10.0 105.872 171.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.3 tp -146.5 132.37 19.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.2 -1.407 . . . . 10.0 107.2 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.71 49.3 11.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.854 1.662 . . . . 10.0 112.774 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.9 72.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.806 0.717 . . . . 10.0 113.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -127.48 136.4 51.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -86.27 150.65 24.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -136.17 140.8 43.88 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.53 156.62 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 10.0 111.742 -168.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.91 152.82 15.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.515 1.526 . . . . 10.0 111.763 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -130.38 -70.29 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.416 -1.278 . . . . 10.0 108.112 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.51 149.24 27.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.185 1.357 . . . . 10.0 111.0 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.59 155.93 46.43 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.619 -0.676 . . . . 10.0 109.577 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -148.54 153.85 38.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.557 1.543 . . . . 10.0 108.082 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -89.1 118.47 28.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.344 -1.354 . . . . 10.0 107.344 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -83.97 94.13 8.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.4 m -64.73 -25.5 67.96 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.383 0.673 . . . . 10.0 112.725 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -70.03 -41.97 73.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.672 0.669 . . . . 10.0 110.249 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -84.22 -25.88 29.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.412 0.685 . . . . 10.0 111.68 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.79 40.86 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.154 0.883 . . . . 10.0 111.545 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.35 168.24 23.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.551 1.175 . . . . 10.0 111.014 173.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.0 152.48 36.96 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.077 -0.712 . . . . 10.0 109.077 167.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.16 153.67 27.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.752 2.021 . . . . 10.0 105.758 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.08 162.71 35.44 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 121.249 -0.907 . . . . 10.0 113.74 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.06 124.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 102.49 -3.152 . . . . 10.0 102.49 168.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.36 129.47 17.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -167.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -100.08 33.71 2.54 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.169 -1.048 . . . . 10.0 108.169 171.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.56 -48.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.565 1.075 . . . . 10.0 112.048 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t90 . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 118.805 0.73 . . . . 10.0 110.233 -175.678 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 pt . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 122.052 0.929 . . . . 10.0 111.646 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.9 165.14 17.9 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.971 2.508 . . . . 10.0 106.479 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.07 137.47 54.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.812 -1.921 . . . . 10.0 105.812 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.75 150.38 18.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 -168.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.51 14.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.511 1.124 . . . . 10.0 108.812 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.1 m -169.08 155.08 6.28 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.792 2.037 . . . . 10.0 107.943 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.01 -23.77 39.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.975 1.783 . . . . 10.0 112.754 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -71.25 -29.79 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.701 0.682 . . . . 10.0 112.361 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.1 42.23 71.26 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 118.973 -0.904 . . . . 10.0 112.513 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.18 98.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.017 0.927 . . . . 10.0 111.991 -163.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.96 121.53 17.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.455 0.702 . . . . 10.0 109.348 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.45 -8.94 17.79 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.18 -67.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.201 2.601 . . . . 10.0 114.814 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 p -165.04 162.7 20.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.158 1.383 . . . . 10.0 110.616 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -158.6 175.89 13.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.634 1.574 . . . . 10.0 108.602 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.99 132.31 47.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 105.786 -1.931 . . . . 10.0 105.786 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -149.57 134.46 17.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.161 -1.422 . . . . 10.0 107.161 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.33 49.94 10.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.108 1.763 . . . . 10.0 112.736 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.2 69.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.776 0.703 . . . . 10.0 113.508 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.2 m -128.86 140.21 51.8 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -90.34 150.38 21.91 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -136.24 139.12 42.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 tt -154.56 157.48 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.85 1.26 . . . . 10.0 111.975 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.55 154.29 4.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.943 1.697 . . . . 10.0 112.026 168.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -55.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.29 -1.338 . . . . 10.0 110.871 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.7 m -151.82 150.25 29.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.843 1.202 . . . . 10.0 110.794 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 25.6 ttpt -149.47 142.62 25.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -150.38 155.89 40.45 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.781 1.232 . . . . 10.0 109.197 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -93.2 122.2 35.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.465 -1.309 . . . . 10.0 107.465 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -96.81 89.99 5.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.94 -15.66 5.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.921 1.288 . . . . 10.0 113.386 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.48 -26.91 68.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.508 1.049 . . . . 10.0 111.632 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.79 -14.65 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.554 1.142 . . . . 10.0 111.635 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.13 13.24 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.556 -1.018 . . . . 10.0 110.556 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 166.09 26.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.661 0.784 . . . . 10.0 110.384 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 91.4 m95 -81.32 152.65 27.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.2 156.09 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.243 2.217 . . . . 10.0 105.267 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.34 169.35 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 O-C-N 120.905 -1.122 . . . . 10.0 113.386 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.77 113.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 101.442 -3.54 . . . . 10.0 101.442 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 133.35 28.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 -158.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -106.49 35.76 2.85 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.73 -48.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.679 1.127 . . . . 10.0 112.368 167.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 CA--C 1.536 0.427 0 CA-C-N 119.388 0.995 . . . . 10.0 109.299 -174.022 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 122.332 1.063 . . . . 10.0 111.976 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -119.48 160.71 21.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.234 2.214 . . . . 10.0 106.247 162.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.57 132.95 54.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.8 146.52 26.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.081 -1.081 . . . . 10.0 108.081 -161.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -156.5 127.7 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.767 0.827 . . . . 10.0 109.324 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 m -160.89 155.15 19.43 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.074 1.75 . . . . 10.0 107.794 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 -26.46 35.14 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.161 1.907 . . . . 10.0 113.14 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -70.75 -31.84 68.79 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.69 0.677 . . . . 10.0 112.549 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.03 32.4 82.09 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.903 -0.943 . . . . 10.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -53.94 97.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.131 1.772 . . . . 10.0 112.116 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -68.09 122.64 18.68 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.17 -3.87 16.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 50.6 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.143 2.577 . . . . 10.0 115.001 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -163.09 162.02 25.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.229 1.411 . . . . 10.0 110.441 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.86 177.63 10.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.401 1.481 . . . . 10.0 109.075 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.36 129.37 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.025 -1.842 . . . . 10.0 106.025 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.02 144.01 19.73 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.29 47.27 13.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.436 1.494 . . . . 10.0 112.511 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.65 23.68 63.28 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.181 0.896 . . . . 10.0 113.566 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -135.2 148.53 49.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.288 1.435 . . . . 10.0 107.274 -172.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -92.39 150.17 20.97 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -135.63 140.07 44.27 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.271 -1.752 . . . . 10.0 106.271 -170.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -155.19 157.18 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.433 1.093 . . . . 10.0 111.869 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -58.73 156.39 11.13 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.133 1.773 . . . . 10.0 112.48 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -137.0 -65.24 0.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 117.316 -1.326 . . . . 10.0 109.104 167.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -150.96 149.94 30.21 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.966 1.257 . . . . 10.0 111.711 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 20.9 ptmt -144.62 152.12 40.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.677 1.191 . . . . 10.0 108.601 168.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.86 156.86 41.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.242 1.417 . . . . 10.0 108.715 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.86 119.97 33.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.256 -1.386 . . . . 10.0 107.256 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -90.18 88.21 7.16 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.22 -17.1 6.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.825 1.25 . . . . 10.0 113.349 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -25.92 68.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.278 0.944 . . . . 10.0 111.616 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -130.5 -12.37 3.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.653 1.181 . . . . 10.0 112.099 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.94 45.94 15.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.45 164.42 34.22 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.007 0.923 . . . . 10.0 110.297 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 84.9 m95 -82.21 150.24 27.47 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.19 154.04 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 105.289 -2.115 . . . . 10.0 105.289 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.49 172.43 42.39 Favored Glycine 0 N--CA 1.451 -0.348 0 O-C-N 120.977 -1.077 . . . . 10.0 113.528 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.5 mt -117.89 119.56 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 101.679 -3.452 . . . . 10.0 101.679 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 134.9 22.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -162.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -108.51 37.06 2.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.01 -45.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.162 0.892 . . . . 10.0 111.699 168.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 t90 . . . . . 0 CA--C 1.536 0.414 0 CA-C-N 118.813 0.733 . . . . 10.0 110.628 -171.4 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.943 0.878 . . . . 10.0 111.394 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -137.34 162.4 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.515 2.326 . . . . 10.0 106.277 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -120.8 137.19 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.302 -1.74 . . . . 10.0 106.302 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.31 148.51 22.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -141.87 125.86 17.24 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -163.45 145.35 7.61 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 119.113 0.87 . . . . 10.0 108.809 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.58 -20.77 46.86 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.168 1.912 . . . . 10.0 112.317 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.0 -34.24 71.16 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.475 1.034 . . . . 10.0 111.542 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.1 27.98 71.39 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.787 -1.007 . . . . 10.0 114.519 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -52.27 108.82 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.697 1.599 . . . . 10.0 112.147 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.61 109.16 6.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 168.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.61 -2.31 51.63 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 49.32 -70.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.01 2.924 . . . . 10.0 115.983 -171.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -168.27 159.91 11.11 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.135 1.374 . . . . 10.0 110.211 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -159.32 176.08 12.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.543 1.137 . . . . 10.0 109.33 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.25 133.93 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.69 124.48 10.54 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -174.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t0 44.74 41.57 5.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.736 2.014 . . . . 10.0 112.833 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.7 48.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.425 1.012 . . . . 10.0 114.005 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -83.1 146.32 28.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 171.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -104.09 145.43 30.18 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.352 1.061 . . . . 10.0 108.466 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -136.31 144.49 44.73 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.384 1.074 . . . . 10.0 108.313 -168.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -160.23 159.78 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.857 1.263 . . . . 10.0 112.585 -168.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 68.4 t80 -58.07 157.44 8.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.009 1.724 . . . . 10.0 112.809 169.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -141.7 -63.13 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.271 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -151.13 144.66 24.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.911 1.232 . . . . 10.0 111.152 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -151.07 141.5 22.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -149.72 161.33 42.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.11 1.364 . . . . 10.0 109.628 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -92.9 123.48 36.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -92.67 78.05 4.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -52.65 -28.56 22.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.97 1.308 . . . . 10.0 113.323 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -63.41 -21.65 66.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.452 1.101 . . . . 10.0 112.93 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -125.14 -15.77 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.848 1.259 . . . . 10.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.82 37.84 21.6 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.762 0.71 . . . . 10.0 112.43 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.41 163.14 38.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.037 0.935 . . . . 10.0 109.299 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -76.12 153.65 36.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.02 150.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.657 1.983 . . . . 10.0 105.691 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.64 166.53 34.93 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 121.547 -0.721 . . . . 10.0 113.265 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.55 116.6 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 101.268 -3.605 . . . . 10.0 101.268 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -141.58 136.66 31.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 -163.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -103.81 30.72 4.91 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.457 -0.942 . . . . 10.0 108.457 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.99 -54.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-N 119.087 0.858 . . . . 10.0 111.108 167.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.4 t90 . . . . . 0 C--N 1.342 0.239 0 CA-C-N 118.59 0.632 . . . . 10.0 111.08 -165.391 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.97 0.89 . . . . 10.0 111.523 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -128.34 166.01 19.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.826 2.45 . . . . 10.0 106.566 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -122.32 138.66 54.44 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -140.68 147.96 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.083 -1.08 . . . . 10.0 108.083 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.53 116.39 9.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.42 1.488 . . . . 10.0 107.166 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -154.7 150.31 21.44 Favored Pre-proline 0 N--CA 1.466 0.341 0 C-N-CA 123.768 0.827 . . . . 10.0 110.032 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.8 -28.41 25.08 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.905 1.736 . . . . 10.0 112.796 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -71.86 -29.43 64.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.67 29.82 26.3 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.503 -1.165 . . . . 10.0 115.395 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -61.05 107.19 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.681 1.241 . . . . 10.0 111.392 -172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -65.39 118.02 8.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.774 0.83 . . . . 10.0 109.143 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.28 -8.62 26.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.871 1.063 . . . . 10.0 113.871 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.5 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.976 2.51 . . . . 10.0 114.695 -170.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 p -162.24 165.55 26.65 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.692 1.197 . . . . 10.0 111.022 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -157.22 174.36 15.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.861 1.664 . . . . 10.0 108.585 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.12 133.47 47.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.787 -1.931 . . . . 10.0 105.787 172.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -143.93 121.2 11.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.079 -1.822 . . . . 10.0 106.079 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.6 t0 47.62 43.33 16.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.839 1.656 . . . . 10.0 112.721 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 4.68 78.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.105 0.859 . . . . 10.0 113.968 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 m -102.25 136.88 41.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -87.5 150.72 23.56 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -136.81 139.82 42.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.403 1.881 . . . . 10.0 106.098 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -153.32 156.84 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.645 1.178 . . . . 10.0 111.852 -168.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.78 155.08 13.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.032 1.733 . . . . 10.0 112.19 171.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -137.44 -61.39 0.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.261 -1.352 . . . . 10.0 110.597 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.5 m -152.55 149.94 29.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.505 1.502 . . . . 10.0 111.136 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -150.01 152.48 34.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.391 1.076 . . . . 10.0 109.295 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.93 157.32 40.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.795 1.238 . . . . 10.0 109.143 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -89.5 120.27 30.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -88.57 77.37 8.01 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.34 -29.21 22.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.894 1.278 . . . . 10.0 113.164 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -65.01 -19.34 65.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.476 1.11 . . . . 10.0 112.933 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.4 -17.56 5.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.602 1.161 . . . . 10.0 111.97 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.07 36.75 10.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.727 0.694 . . . . 10.0 112.48 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.2 163.26 38.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.219 1.009 . . . . 10.0 109.618 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -75.8 154.61 36.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.43 0.633 . . . . 10.0 109.71 170.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.9 t -138.03 154.29 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.559 -2.015 . . . . 10.0 105.559 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.81 166.42 36.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.259 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.8 mt -112.86 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 101.613 -3.477 . . . . 10.0 101.613 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 140.07 30.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -160.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.62 36.66 3.34 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.79 -44.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.304 0.956 . . . . 10.0 111.676 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.1 t90 . . . . . 0 CA--C 1.536 0.425 0 CA-C-N 118.285 0.493 . . . . 10.0 110.776 -174.377 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 122.368 1.08 . . . . 10.0 111.954 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -126.31 164.02 21.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.748 2.419 . . . . 10.0 105.745 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.7 mt -123.55 137.01 54.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.61 150.83 19.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 -168.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -141.47 134.79 29.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.44 150.46 4.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.787 -0.819 . . . . 10.0 108.787 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.78 -25.24 39.78 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 121.805 1.67 . . . . 10.0 112.408 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -72.41 -32.16 66.12 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.592 0.633 . . . . 10.0 112.547 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.93 35.15 81.84 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.968 -0.907 . . . . 10.0 113.576 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -54.87 102.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.265 1.426 . . . . 10.0 111.96 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.18 116.1 10.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.51 -7.45 28.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.28 -72.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.053 2.541 . . . . 10.0 115.008 -170.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 164.19 19.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 10.0 110.729 -174.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -158.07 174.17 15.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.786 1.635 . . . . 10.0 108.558 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.33 133.77 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.788 -1.93 . . . . 10.0 105.788 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -144.07 120.72 11.14 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.44 43.2 15.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.912 1.685 . . . . 10.0 112.704 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.14 2.9 80.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.124 0.868 . . . . 10.0 114.047 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.5 m -99.95 136.49 39.78 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 173.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -87.71 150.61 23.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -137.15 139.94 41.5 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.188 -1.782 . . . . 10.0 106.188 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.16 156.75 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.825 1.25 . . . . 10.0 111.883 -168.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.84 155.56 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.008 1.723 . . . . 10.0 112.421 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -135.76 -66.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.403 -1.284 . . . . 10.0 109.009 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -150.97 151.33 31.94 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.887 1.221 . . . . 10.0 111.691 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -142.16 150.93 41.71 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.608 1.163 . . . . 10.0 108.649 168.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -151.41 154.85 37.43 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.028 1.331 . . . . 10.0 108.741 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -89.35 121.0 31.19 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.558 -1.275 . . . . 10.0 107.558 174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.0 85.89 7.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.006 -1.479 . . . . 10.0 107.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -57.64 -27.44 62.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.805 0.842 . . . . 10.0 112.764 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -71.47 -26.35 62.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.558 0.743 . . . . 10.0 111.621 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -109.63 -17.64 13.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.857 0.863 . . . . 10.0 112.234 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.43 38.57 20.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.056 0.836 . . . . 10.0 112.331 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.64 164.36 37.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.515 1.157 . . . . 10.0 110.473 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.419 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 85.9 m95 -73.46 153.68 40.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 168.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.29 156.08 32.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.942 2.097 . . . . 10.0 105.366 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.87 162.89 33.39 Favored Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.452 -0.78 . . . . 10.0 112.865 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.2 mt -106.94 118.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 101.612 -3.477 . . . . 10.0 101.612 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.38 127.54 16.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -162.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -101.14 37.88 1.67 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.847 -1.168 . . . . 10.0 107.847 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.96 -48.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.407 1.003 . . . . 10.0 111.847 167.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.0 t90 . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 118.771 0.714 . . . . 10.0 110.379 -169.744 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.0 pt . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 122.08 0.943 . . . . 10.0 111.466 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -119.55 165.27 14.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.863 2.465 . . . . 10.0 106.523 163.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.09 135.77 54.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.031 -2.211 . . . . 10.0 105.031 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -138.38 142.89 34.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 -167.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -145.28 101.48 3.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -152.15 149.87 24.24 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 118.828 0.74 . . . . 10.0 109.871 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.06 -27.75 19.98 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.082 1.855 . . . . 10.0 113.366 -173.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -72.09 -25.28 61.69 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.17 35.47 26.8 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.792 -1.004 . . . . 10.0 115.099 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -58.7 98.99 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.114 1.366 . . . . 10.0 111.514 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.32 110.72 4.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.682 0.793 . . . . 10.0 108.862 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.98 -12.19 31.33 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.52 -66.05 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.14 2.576 . . . . 10.0 114.606 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 p -164.52 161.74 21.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.943 1.297 . . . . 10.0 110.745 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.4 177.73 10.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.452 1.501 . . . . 10.0 109.099 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.41 129.82 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 106.042 -1.836 . . . . 10.0 106.042 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.7 tp -155.67 143.72 19.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.11 47.7 12.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.585 1.554 . . . . 10.0 112.512 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.81 63.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.116 0.865 . . . . 10.0 113.612 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -134.94 147.85 49.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.32 1.448 . . . . 10.0 107.19 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -91.1 150.24 21.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.816 -0.809 . . . . 10.0 108.816 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -135.24 140.37 45.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.413 -1.699 . . . . 10.0 106.413 -171.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.5 158.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.424 1.09 . . . . 10.0 112.002 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.04 157.32 8.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.223 1.809 . . . . 10.0 112.458 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -139.17 -61.94 0.55 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 117.608 -1.187 . . . . 10.0 109.529 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 m -152.58 149.3 28.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.889 1.222 . . . . 10.0 111.215 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -148.11 156.07 42.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.872 0.869 . . . . 10.0 109.696 169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -155.5 161.01 41.01 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.033 1.333 . . . . 10.0 108.877 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.87 118.93 31.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.227 -1.397 . . . . 10.0 107.227 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.59 80.34 8.04 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -53.02 -26.71 16.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.944 1.297 . . . . 10.0 113.451 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 m -63.0 -21.2 65.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.453 1.101 . . . . 10.0 112.983 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.57 -12.44 6.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.696 1.198 . . . . 10.0 112.065 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.47 41.8 29.15 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.62 0.645 . . . . 10.0 111.739 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.2 164.91 30.77 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.926 0.863 . . . . 10.0 110.555 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -79.52 149.48 31.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.5 t -135.8 149.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.576 -2.009 . . . . 10.0 105.576 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.44 165.98 36.98 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.58 -0.7 . . . . 10.0 113.204 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.9 mt -110.73 120.21 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 101.489 -3.522 . . . . 10.0 101.489 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.76 139.02 26.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 -162.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -111.88 35.56 3.65 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 170.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.51 -44.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.485 1.039 . . . . 10.0 112.003 168.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 . . . . . 0 CA--C 1.536 0.406 0 CA-C-N 119.293 0.951 . . . . 10.0 110.816 -172.181 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.566 0.698 . . . . 10.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -130.91 161.38 32.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.552 1.941 . . . . 10.0 106.832 167.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.76 134.78 51.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.579 -2.008 . . . . 10.0 105.579 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -140.48 148.25 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 -163.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -152.94 137.66 16.97 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.661 0.785 . . . . 10.0 109.911 171.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 m -161.03 153.04 16.65 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.043 1.337 . . . . 10.0 108.204 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.86 -28.17 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.885 1.723 . . . . 10.0 112.812 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -75.97 -16.56 59.97 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.86 1.059 . . . . 10.0 113.86 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.08 44.51 33.11 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.298 0.954 . . . . 10.0 112.787 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -65.81 78.04 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.848 1.259 . . . . 10.0 112.21 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -55.82 126.57 26.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.134 1.374 . . . . 10.0 109.712 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.57 -4.75 14.67 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.124 1.157 . . . . 10.0 114.124 -170.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.19 -68.4 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.271 2.628 . . . . 10.0 115.492 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.8 p -165.55 162.57 19.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.98 1.312 . . . . 10.0 110.508 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -158.74 174.49 14.95 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.296 1.438 . . . . 10.0 108.712 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.7 132.64 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.797 -1.927 . . . . 10.0 105.797 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.87 127.31 13.16 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.02 42.33 9.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.617 1.967 . . . . 10.0 112.695 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 1.28 57.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.27 0.938 . . . . 10.0 114.119 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -95.19 140.66 29.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.605 -1.628 . . . . 10.0 106.605 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.85 151.15 21.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -137.9 140.23 40.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.276 1.831 . . . . 10.0 106.358 -171.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 tt -153.39 159.83 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 119.617 1.099 . . . . 10.0 112.257 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.23 156.96 9.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.026 1.73 . . . . 10.0 112.371 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -138.17 -64.54 0.53 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 117.519 -1.229 . . . . 10.0 109.498 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -151.92 149.9 29.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.112 1.323 . . . . 10.0 111.112 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -147.56 157.24 43.48 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.789 0.836 . . . . 10.0 110.129 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -155.26 160.18 40.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.453 1.501 . . . . 10.0 108.774 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -92.76 122.05 34.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -89.58 79.48 6.85 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.755 -1.202 . . . . 10.0 107.755 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -52.13 -28.47 18.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.666 1.186 . . . . 10.0 113.235 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m -66.75 -19.98 65.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.353 1.061 . . . . 10.0 112.874 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -124.15 -17.04 6.31 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.635 1.174 . . . . 10.0 112.079 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.79 37.42 16.51 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.917 0.781 . . . . 10.0 112.508 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.46 163.06 37.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.316 1.058 . . . . 10.0 109.729 173.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.92 153.26 36.79 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 t -139.82 154.24 23.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.413 1.885 . . . . 10.0 105.972 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.19 165.17 37.04 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-O 121.998 0.777 . . . . 10.0 112.877 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.92 125.47 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 101.57 -3.492 . . . . 10.0 101.57 169.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.42 153.9 44.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.331 -0.618 . . . . 10.0 109.331 -166.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -124.72 31.47 5.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.827 -1.175 . . . . 10.0 107.827 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.61 -45.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 119.366 0.984 . . . . 10.0 112.156 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.2 t90 . . . . . 0 CA--C 1.534 0.336 0 CA-C-N 118.855 0.752 . . . . 10.0 110.184 -170.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt . . . . . 0 CA--C 1.535 0.375 0 CA-C-O 121.559 0.695 . . . . 10.0 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -110.69 162.93 14.25 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.242 1.817 . . . . 10.0 106.56 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.92 136.12 53.46 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.22 -2.141 . . . . 10.0 105.22 168.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.72 144.54 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 -164.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -145.54 106.81 4.18 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.147 1.379 . . . . 10.0 107.467 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -152.64 144.04 16.17 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 119.421 1.009 . . . . 10.0 110.027 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.8 -36.05 89.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.119 2.546 . . . . 10.0 114.6 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -73.83 -25.12 59.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.498 0.925 . . . . 10.0 113.498 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.0 28.8 26.1 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.603 -1.11 . . . . 10.0 115.644 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -52.01 112.44 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.244 1.417 . . . . 10.0 111.772 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -73.0 102.45 3.49 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.691 0.796 . . . . 10.0 108.974 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.12 -13.2 57.58 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.82 1.044 . . . . 10.0 113.82 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.85 -69.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.123 2.569 . . . . 10.0 114.481 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -165.16 164.16 20.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.848 1.259 . . . . 10.0 110.589 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.0 176.68 12.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.729 1.612 . . . . 10.0 108.669 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.75 135.92 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.04 128.79 12.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 45.64 44.25 10.09 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.104 1.762 . . . . 10.0 113.022 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.68 79.61 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.262 -0.744 . . . . 10.0 113.858 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -112.22 135.6 52.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -90.14 152.39 21.14 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.582 -0.896 . . . . 10.0 108.582 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -138.22 140.18 39.61 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 -171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.9 tt -153.89 157.24 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.562 1.074 . . . . 10.0 112.24 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.71 154.91 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.705 1.602 . . . . 10.0 112.223 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -135.28 -66.52 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.314 -1.326 . . . . 10.0 109.092 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 m -151.35 151.31 31.57 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.378 1.445 . . . . 10.0 111.352 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -145.54 153.17 40.82 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 10.0 109.698 170.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -153.63 157.77 40.13 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.296 1.439 . . . . 10.0 108.865 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -91.7 123.97 35.49 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -93.63 86.3 5.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.653 0.74 . . . . 10.0 109.115 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -56.09 -17.1 6.16 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.673 1.189 . . . . 10.0 113.443 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.67 70.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.202 0.91 . . . . 10.0 111.633 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.46 -13.08 3.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.275 1.03 . . . . 10.0 112.308 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.7 43.82 8.16 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.775 0.716 . . . . 10.0 111.759 171.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -145.86 162.78 36.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.773 0.787 . . . . 10.0 109.883 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.412 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 80.2 m95 -75.51 152.89 37.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.385 0.612 . . . . 10.0 109.369 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.4 t -135.16 153.19 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 162.04 33.96 Favored Glycine 0 N--CA 1.45 -0.433 0 O-C-N 121.575 -0.703 . . . . 10.0 112.983 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -102.0 121.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 101.641 -3.466 . . . . 10.0 101.641 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 137.18 25.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.336 -0.987 . . . . 10.0 108.336 -165.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -108.69 33.38 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.897 -1.149 . . . . 10.0 107.897 172.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.59 -44.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.341 0.973 . . . . 10.0 112.313 170.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 118.991 0.814 . . . . 10.0 111.492 -168.145 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.673 0.749 . . . . 10.0 110.968 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -122.22 159.21 27.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.316 2.246 . . . . 10.0 106.053 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.94 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.6 -2.0 . . . . 10.0 105.6 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.46 141.95 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -163.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -147.73 102.37 3.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.098 1.359 . . . . 10.0 107.912 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -153.19 150.13 23.17 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.687 0.676 . . . . 10.0 109.683 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.49 -26.58 28.72 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.28 1.987 . . . . 10.0 113.22 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -70.04 -33.18 71.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.756 0.707 . . . . 10.0 112.389 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.9 30.01 74.05 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.766 -1.019 . . . . 10.0 114.076 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -50.46 106.5 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.57 1.548 . . . . 10.0 112.06 -174.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -75.12 102.98 5.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -10.83 58.38 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.602 0.964 . . . . 10.0 113.602 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.05 -70.94 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.165 2.586 . . . . 10.0 114.489 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -163.92 162.78 23.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.969 1.308 . . . . 10.0 110.708 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -158.73 177.5 11.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.528 1.531 . . . . 10.0 109.026 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.16 129.83 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 tp -155.46 143.66 20.1 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.331 1.453 . . . . 10.0 107.271 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.61 47.41 11.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.487 1.515 . . . . 10.0 112.532 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.81 63.33 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.165 0.888 . . . . 10.0 113.698 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -134.93 148.44 50.05 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.337 1.455 . . . . 10.0 107.258 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -90.87 150.49 21.52 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -136.51 140.54 43.08 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.273 -1.751 . . . . 10.0 106.273 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.77 159.23 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.59 1.086 . . . . 10.0 112.286 -165.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -55.36 154.51 6.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.018 1.727 . . . . 10.0 112.621 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -136.09 -59.18 0.75 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-O 117.578 -1.201 . . . . 10.0 109.133 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -161.57 159.89 28.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.282 1.401 . . . . 10.0 112.354 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -141.24 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.231 1.412 . . . . 10.0 108.643 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -150.71 158.6 44.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.99 1.316 . . . . 10.0 108.233 162.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -91.57 123.22 34.82 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.095 -1.446 . . . . 10.0 107.095 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -95.64 88.78 5.12 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -56.75 -15.72 5.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.894 1.278 . . . . 10.0 113.383 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -64.17 -24.58 67.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.361 0.982 . . . . 10.0 111.855 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -130.23 -12.42 4.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.579 1.152 . . . . 10.0 112.016 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 46.32 16.87 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.34 167.44 22.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.556 0.743 . . . . 10.0 110.48 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.83 150.05 28.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.44 152.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.501 -2.037 . . . . 10.0 105.501 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.2 37.57 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 121.358 -0.839 . . . . 10.0 112.914 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.92 126.45 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 102.107 -3.294 . . . . 10.0 102.107 167.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 136.17 23.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -104.17 31.49 4.55 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.79 -50.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.505 1.048 . . . . 10.0 111.705 169.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.5 t90 . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 118.831 0.741 . . . . 10.0 110.453 -170.541 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 121.832 0.825 . . . . 10.0 111.312 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 159.32 27.25 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.247 2.219 . . . . 10.0 106.574 168.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -111.66 133.96 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.196 -2.15 . . . . 10.0 105.196 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.91 149.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -167.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.33 137.92 16.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 109.31 173.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -169.79 150.55 3.89 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 125.18 1.392 . . . . 10.0 107.603 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.27 -26.63 43.99 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.747 2.298 . . . . 10.0 113.194 166.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -63.83 -39.67 94.79 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.636 0.774 . . . . 10.0 112.226 -175.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.45 33.8 17.94 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.302 0.953 . . . . 10.0 114.001 -175.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -60.57 105.67 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.411 1.084 . . . . 10.0 111.08 -168.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.48 108.45 4.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.024 -0.732 . . . . 10.0 109.024 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.09 -10.63 38.29 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 -174.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.96 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.14 2.576 . . . . 10.0 114.582 -171.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -164.6 162.98 21.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.995 1.318 . . . . 10.0 110.314 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -157.75 176.97 11.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.527 1.531 . . . . 10.0 108.63 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.34 135.93 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 174.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -152.56 131.47 12.52 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.494 -1.298 . . . . 10.0 107.494 -174.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.0 t0 44.49 47.72 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.494 1.918 . . . . 10.0 113.021 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.29 75.85 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.797 0.713 . . . . 10.0 113.625 175.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.8 m -124.67 135.82 53.38 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.14 153.18 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 175.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.96 140.49 40.26 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.465 -1.68 . . . . 10.0 106.465 -172.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.08 157.23 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 119.379 0.991 . . . . 10.0 112.217 -167.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -57.1 154.27 10.23 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.781 1.633 . . . . 10.0 112.373 170.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -138.75 -55.82 0.62 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 117.516 -1.23 . . . . 10.0 109.914 165.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -159.82 153.36 22.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.519 1.509 . . . . 10.0 111.613 173.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -145.26 160.67 41.13 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.413 1.085 . . . . 10.0 108.615 161.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -152.51 162.48 41.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.701 1.6 . . . . 10.0 108.591 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -95.85 123.59 39.5 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -96.5 90.9 5.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.835 0.854 . . . . 10.0 108.718 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.71 -15.4 7.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.756 1.222 . . . . 10.0 113.416 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.78 -26.14 68.5 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.381 0.991 . . . . 10.0 111.576 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -129.95 -10.82 4.32 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.371 1.068 . . . . 10.0 112.114 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.7 46.36 18.68 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.794 -0.923 . . . . 10.0 110.794 175.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.96 164.78 31.85 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.953 0.901 . . . . 10.0 110.201 177.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -81.39 153.17 27.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.81 151.44 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 127.161 2.184 . . . . 10.0 105.194 176.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.93 173.22 39.95 Favored Glycine 0 C--N 1.334 0.418 0 O-C-N 120.904 -1.122 . . . . 10.0 113.973 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 54.1 mt -124.85 113.51 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 101.618 -3.475 . . . . 10.0 101.618 178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.81 139.43 32.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.792 -1.188 . . . . 10.0 107.792 -158.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -108.99 30.75 6.26 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 173.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.67 -45.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.174 0.897 . . . . 10.0 112.1 171.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.7 t90 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 118.985 0.811 . . . . 10.0 111.164 -169.801 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.7 pt -60.61 164.48 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.933 0.873 . . . . 10.0 112.219 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -127.92 162.79 25.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.831 2.452 . . . . 10.0 106.994 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.9 mt -117.06 134.32 54.9 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.446 -2.057 . . . . 10.0 105.446 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -139.78 147.2 24.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -164.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -145.3 126.11 14.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.193 1.397 . . . . 10.0 107.253 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -168.12 153.3 6.57 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.601 1.16 . . . . 10.0 110.377 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.24 -24.72 27.16 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.395 2.063 . . . . 10.0 113.292 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -76.28 -19.26 58.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.99 30.53 23.11 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.565 1.079 . . . . 10.0 114.668 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -52.75 105.71 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 10.0 111.887 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -74.53 105.52 5.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.833 0.853 . . . . 10.0 109.123 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.6 -10.26 56.12 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.862 1.06 . . . . 10.0 113.862 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.06 -72.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.277 2.631 . . . . 10.0 114.884 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.6 p -165.48 161.96 19.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.174 1.39 . . . . 10.0 110.32 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -158.99 175.3 13.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.233 1.413 . . . . 10.0 109.092 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.67 130.76 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 105.685 -1.968 . . . . 10.0 105.685 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -152.2 137.87 17.86 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.03 -1.47 . . . . 10.0 107.03 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.68 50.13 10.88 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.193 1.797 . . . . 10.0 112.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.79 23.24 63.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.104 0.859 . . . . 10.0 113.382 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -130.7 145.07 51.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.672 -1.603 . . . . 10.0 106.672 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.26 151.0 19.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.801 -0.814 . . . . 10.0 108.801 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -138.2 139.24 39.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 tt -155.11 158.18 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.371 1.068 . . . . 10.0 112.015 -168.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.19 156.94 3.76 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.328 1.851 . . . . 10.0 112.545 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -140.45 -61.52 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.533 -1.222 . . . . 10.0 109.569 168.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -154.23 147.28 24.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.045 1.293 . . . . 10.0 111.21 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.28 160.89 41.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.256 -0.903 . . . . 10.0 110.088 162.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.95 162.64 41.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.54 1.536 . . . . 10.0 108.819 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -94.01 123.16 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -93.62 82.1 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.412 -0.959 . . . . 10.0 108.412 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -54.35 -25.67 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.808 1.243 . . . . 10.0 113.452 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m -63.93 -20.17 65.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.436 1.094 . . . . 10.0 112.847 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -126.81 -16.56 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.143 1.377 . . . . 10.0 111.558 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.68 40.11 38.7 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.507 -0.637 . . . . 10.0 111.507 174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.92 166.85 23.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.759 0.779 . . . . 10.0 110.097 172.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -80.28 152.19 29.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.671 -0.862 . . . . 10.0 108.671 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.2 t -137.56 151.4 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.507 -2.035 . . . . 10.0 105.507 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 170.24 38.48 Favored Glycine 0 N--CA 1.45 -0.369 0 O-C-N 121.353 -0.842 . . . . 10.0 113.246 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -116.84 122.0 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 101.653 -3.462 . . . . 10.0 101.653 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.48 44.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 -164.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -127.09 36.78 4.38 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.13 -45.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.722 0.692 . . . . 10.0 111.512 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -63.18 142.1 58.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.847 0.748 . . . . 10.0 109.309 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -137.72 42.04 2.32 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 10.0 108.744 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 73.71 -16.2 0.52 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.393 2.277 . . . . 10.0 114.699 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tttp . . . . . 0 C--O 1.245 0.822 0 C-N-CA 124.153 0.981 . . . . 10.0 109.424 178.312 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.932 -0.395 . . . . 10.0 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt -60.52 163.24 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 122.054 0.93 . . . . 10.0 111.42 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -128.17 161.47 29.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.108 2.563 . . . . 10.0 106.176 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -108.31 130.95 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.456 -2.053 . . . . 10.0 105.456 172.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.16 142.92 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -162.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.56 140.88 16.62 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.818 0.847 . . . . 10.0 109.833 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.49 153.74 5.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.211 1.404 . . . . 10.0 108.497 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.42 -27.44 28.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.207 1.938 . . . . 10.0 112.786 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -69.29 -30.4 68.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.825 0.676 . . . . 10.0 112.825 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.84 46.83 93.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.377 -0.689 . . . . 10.0 111.377 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -73.29 70.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.065 1.346 . . . . 10.0 111.152 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -52.61 121.28 6.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.737 1.215 . . . . 10.0 109.77 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -9.12 18.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.621 0.971 . . . . 10.0 113.621 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.34 -65.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.348 2.659 . . . . 10.0 114.986 -170.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 p -165.26 163.19 20.14 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.81 1.244 . . . . 10.0 110.723 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.23 174.06 15.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 10.0 108.607 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.32 133.68 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.726 -1.953 . . . . 10.0 105.726 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 tt -144.68 121.3 11.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.89 42.14 15.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.892 1.677 . . . . 10.0 112.664 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.53 0.79 74.26 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.216 0.912 . . . . 10.0 114.017 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.5 m -96.99 137.78 35.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -88.73 150.83 22.78 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -137.32 140.33 41.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.111 1.764 . . . . 10.0 106.277 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.1 158.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.519 1.128 . . . . 10.0 112.003 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.92 157.01 8.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.966 1.706 . . . . 10.0 112.495 171.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.67 -61.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.531 -1.223 . . . . 10.0 109.397 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 m -150.78 149.8 30.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.681 1.128 . . . . 10.0 111.025 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.65 156.73 44.25 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.908 0.883 . . . . 10.0 109.539 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.61 160.71 40.68 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.219 1.407 . . . . 10.0 108.725 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.51 120.08 34.2 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.12 81.81 6.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.333 -0.988 . . . . 10.0 108.333 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -53.23 -27.14 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.745 1.218 . . . . 10.0 113.342 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -64.23 -20.01 65.75 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.408 1.083 . . . . 10.0 112.952 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.0 -12.51 6.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.675 1.19 . . . . 10.0 111.911 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 41.96 32.84 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.748 0.69 . . . . 10.0 111.814 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 164.53 33.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.854 0.827 . . . . 10.0 110.574 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -78.57 150.03 32.88 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.17 153.78 24.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.585 -2.005 . . . . 10.0 105.585 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.71 162.92 34.92 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.283 -0.886 . . . . 10.0 113.088 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.6 mm -101.12 119.27 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.725 -3.435 . . . . 10.0 101.725 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.53 29.76 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -162.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.44 34.78 3.92 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.71 -1.219 . . . . 10.0 107.71 170.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.49 -56.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.317 0.962 . . . . 10.0 111.388 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -60.39 152.79 24.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.675 0.67 . . . . 10.0 111.128 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -136.36 29.29 3.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.355 1.062 . . . . 10.0 110.244 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.281 1.2 ptm180 56.38 -8.71 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.884 3.274 . . . . 10.0 117.531 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.047 0.939 . . . . 10.0 108.87 169.121 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.883 -0.414 . . . . 10.0 109.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.4 pt -60.2 156.58 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.103 0.954 . . . . 10.0 111.504 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -111.82 162.53 15.17 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.653 2.381 . . . . 10.0 106.259 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -123.43 135.2 53.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.117 -2.179 . . . . 10.0 105.117 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.64 148.84 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -165.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -139.48 127.46 22.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 170.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -161.12 151.66 14.99 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 119.47 1.032 . . . . 10.0 108.933 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.72 -27.7 26.36 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.958 1.772 . . . . 10.0 113.084 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -78.23 -25.09 46.78 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.473 0.916 . . . . 10.0 113.473 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.24 32.15 35.86 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.351 -1.249 . . . . 10.0 114.769 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -54.5 115.45 2.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.937 1.368 . . . . 10.0 111.434 -171.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -78.24 115.29 17.86 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.27 -11.58 23.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.77 -67.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.157 2.583 . . . . 10.0 114.608 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -165.47 162.88 19.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.852 1.261 . . . . 10.0 110.544 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -158.71 176.3 12.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.479 1.511 . . . . 10.0 108.751 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.31 130.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.782 -1.932 . . . . 10.0 105.782 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.18 138.12 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t0 45.94 51.21 10.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.152 1.781 . . . . 10.0 112.577 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.2 63.52 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.104 0.859 . . . . 10.0 113.487 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -132.98 143.37 49.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -90.71 150.63 21.56 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -137.07 140.27 41.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.14 156.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.46 1.104 . . . . 10.0 112.025 -167.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -57.85 154.77 11.5 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.266 1.826 . . . . 10.0 112.395 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -137.1 -61.6 0.65 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.449 -1.263 . . . . 10.0 109.277 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -161.37 154.88 21.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.706 1.593 . . . . 10.0 111.602 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -146.78 160.55 42.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.101 0.961 . . . . 10.0 109.378 166.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.16 158.26 43.74 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.318 1.447 . . . . 10.0 108.701 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -90.54 120.36 31.57 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -87.64 76.6 8.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -51.8 -28.3 15.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.031 1.332 . . . . 10.0 113.287 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -64.78 -17.38 64.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.668 1.187 . . . . 10.0 113.19 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -131.11 -15.63 3.29 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.457 1.103 . . . . 10.0 112.293 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 39.05 8.29 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.945 0.793 . . . . 10.0 112.515 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -148.54 163.64 36.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.042 0.921 . . . . 10.0 109.417 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -77.5 154.53 32.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.06 150.35 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.4 38.27 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.585 -0.817 . . . . 10.0 113.953 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.0 mt -114.5 118.66 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 101.636 -3.468 . . . . 10.0 101.636 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.3 134.54 20.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.969 -1.123 . . . . 10.0 107.969 -162.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -106.78 36.03 2.79 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.29 -46.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.43 1.014 . . . . 10.0 111.765 168.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -64.07 146.27 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.722 0.692 . . . . 10.0 109.879 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.94 48.3 1.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.905 0.882 . . . . 10.0 110.24 -165.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.64 52.61 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.003 1.321 . . . . 10.0 110.69 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.252 1.223 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 169.615 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.65 164.05 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 122.575 1.179 . . . . 10.0 112.386 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -120.51 165.33 15.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.751 2.82 . . . . 10.0 106.056 166.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.3 mt -127.18 137.92 53.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.51 148.12 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -168.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -144.21 115.34 7.92 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -153.69 149.59 21.41 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.698 0.799 . . . . 10.0 109.259 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.66 -26.99 32.74 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.982 1.788 . . . . 10.0 113.02 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -81.73 -19.13 42.07 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.04 45.85 26.49 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 119.204 0.911 . . . . 10.0 112.945 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -65.26 81.39 0.05 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.769 1.228 . . . . 10.0 112.195 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -57.95 121.49 10.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.294 1.438 . . . . 10.0 109.794 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.37 -10.19 19.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -173.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.25 -64.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.396 2.678 . . . . 10.0 115.012 -168.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -166.42 163.73 17.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.828 1.251 . . . . 10.0 110.818 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -158.49 178.09 10.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.84 1.656 . . . . 10.0 108.386 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.03 137.71 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 106.779 -1.563 . . . . 10.0 106.779 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 tp -149.33 127.18 11.81 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 44.87 46.35 8.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.08 1.752 . . . . 10.0 113.153 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.18 14.06 82.21 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.297 -0.724 . . . . 10.0 113.83 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.7 m -118.75 131.09 56.11 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -86.38 151.82 23.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.6 140.17 42.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.31 157.81 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 125.043 1.337 . . . . 10.0 111.695 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.61 155.32 4.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.225 1.81 . . . . 10.0 112.584 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -136.62 -64.89 0.57 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.444 -1.265 . . . . 10.0 109.083 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.0 m -152.38 151.01 30.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.376 1.444 . . . . 10.0 111.222 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -145.56 154.9 42.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.788 0.835 . . . . 10.0 109.66 169.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.0 156.81 38.09 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.77 1.228 . . . . 10.0 108.836 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -90.27 120.42 31.4 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -88.59 77.02 8.06 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.06 -28.79 18.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.86 1.264 . . . . 10.0 113.107 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -66.05 -17.6 64.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.475 1.11 . . . . 10.0 112.983 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -126.79 -17.35 4.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.339 1.056 . . . . 10.0 111.83 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.79 9.27 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.743 0.701 . . . . 10.0 112.349 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -148.65 163.46 37.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.282 1.041 . . . . 10.0 109.987 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -75.7 154.36 36.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.11 153.33 26.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.76 161.31 33.16 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.687 -0.633 . . . . 10.0 112.921 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.5 mt -103.67 124.25 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 101.778 -3.416 . . . . 10.0 101.778 166.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 131.6 18.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.468 -0.938 . . . . 10.0 108.468 -163.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -103.54 37.13 2.09 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -153.69 -49.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 119.283 0.947 . . . . 10.0 111.874 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -65.98 145.08 56.31 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.82 0.736 . . . . 10.0 110.203 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -144.84 43.47 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.695 1.598 . . . . 10.0 108.775 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.252 5.6 ptp180 46.01 31.57 1.16 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.91 2.084 . . . . 10.0 114.471 -168.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.252 1.2 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 164.077 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.612 0.244 . . . . 10.0 110.586 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt -60.06 154.04 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.527 0.679 . . . . 10.0 111.227 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -113.34 161.75 16.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.575 1.95 . . . . 10.0 106.761 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.96 137.19 52.28 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.464 -2.051 . . . . 10.0 105.464 169.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.89 147.63 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -141.47 126.23 18.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.481 1.512 . . . . 10.0 106.946 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -166.9 146.6 4.75 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.43 -16.43 47.61 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.973 1.782 . . . . 10.0 112.367 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -63.82 -41.16 97.92 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.647 0.658 . . . . 10.0 111.598 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.9 28.06 15.6 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.762 1.172 . . . . 10.0 114.629 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.07 105.33 1.03 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.525 1.163 . . . . 10.0 110.64 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -66.31 108.32 2.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.19 -12.0 42.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.423 0.897 . . . . 10.0 113.423 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.5 -70.06 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.165 2.586 . . . . 10.0 114.2 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 163.29 19.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.028 1.331 . . . . 10.0 110.37 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -157.72 174.06 15.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.215 1.406 . . . . 10.0 109.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -135.25 129.64 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.94 -1.874 . . . . 10.0 105.94 173.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.95 131.48 14.81 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.551 -1.648 . . . . 10.0 106.551 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.18 51.52 9.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.764 2.026 . . . . 10.0 112.743 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.77 21.96 63.72 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.528 -0.76 . . . . 10.0 113.378 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -127.7 142.82 51.22 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -91.72 151.93 20.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -138.9 140.33 38.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.122 -1.807 . . . . 10.0 106.122 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.23 158.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.742 1.156 . . . . 10.0 112.438 -166.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -57.23 155.29 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.029 1.732 . . . . 10.0 112.386 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -138.77 -62.51 0.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 117.358 -1.306 . . . . 10.0 109.106 167.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 m -154.46 149.15 26.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.201 1.364 . . . . 10.0 111.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -146.42 160.89 41.48 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.329 -0.857 . . . . 10.0 110.0 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.07 164.15 38.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.639 1.576 . . . . 10.0 108.716 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -96.34 121.82 38.55 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -90.88 87.1 6.5 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.09 -16.75 5.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.696 1.199 . . . . 10.0 113.362 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -25.86 68.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.182 0.901 . . . . 10.0 111.838 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -134.64 -11.7 2.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.181 0.992 . . . . 10.0 112.558 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.85 43.06 9.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 118.901 0.773 . . . . 10.0 111.952 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -146.02 163.03 36.51 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.657 0.783 . . . . 10.0 109.524 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -75.98 153.28 36.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 171.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -136.96 151.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.377 -2.083 . . . . 10.0 105.377 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 169.5 38.9 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.621 -0.799 . . . . 10.0 113.856 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.78 120.36 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 101.254 -3.61 . . . . 10.0 101.254 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.31 149.79 36.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -165.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.3 31.03 6.81 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.67 -47.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.767 0.827 . . . . 10.0 111.556 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -66.23 147.26 53.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.751 0.705 . . . . 10.0 110.464 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -149.21 33.66 0.73 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.992 1.317 . . . . 10.0 109.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.279 41.1 ptt180 44.57 43.42 6.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.512 1.925 . . . . 10.0 114.793 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? . . . . . 0 C--O 1.251 1.16 0 C-N-CA 127.73 2.412 . . . . 10.0 112.949 170.639 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.781 0.325 . . . . 10.0 110.651 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt -59.28 155.32 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.907 0.861 . . . . 10.0 111.425 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -109.32 165.02 11.94 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.893 2.077 . . . . 10.0 106.819 165.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.27 138.8 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.261 -2.126 . . . . 10.0 105.261 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.58 151.12 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -168.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.03 122.14 7.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.462 1.105 . . . . 10.0 108.264 171.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -154.25 151.61 24.63 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.791 1.236 . . . . 10.0 108.363 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.74 -25.07 40.18 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.894 1.729 . . . . 10.0 113.153 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -88.05 -15.87 35.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -172.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.47 36.1 37.77 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.203 -1.331 . . . . 10.0 113.954 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -53.16 98.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.128 1.371 . . . . 10.0 112.235 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.76 117.44 17.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.205 1.002 . . . . 10.0 108.927 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.35 -11.67 25.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.27 -64.78 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.162 2.585 . . . . 10.0 114.642 -167.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -166.59 162.99 16.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.836 1.254 . . . . 10.0 110.724 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -159.73 178.65 9.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 10.0 108.816 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -135.67 129.82 49.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -151.95 139.97 20.14 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t0 47.05 50.18 14.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.682 1.593 . . . . 10.0 112.434 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.25 64.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.14 0.876 . . . . 10.0 113.517 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -134.79 144.22 47.53 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 -173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -88.25 149.75 23.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -135.34 141.74 45.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.325 -1.732 . . . . 10.0 106.325 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 tt -152.25 156.92 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.213 . . . . 10.0 111.847 -168.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -58.0 153.7 13.93 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.577 1.551 . . . . 10.0 111.998 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -131.82 -70.18 0.58 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.345 -1.312 . . . . 10.0 108.318 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.2 m -153.47 149.46 27.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.312 1.414 . . . . 10.0 111.289 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -143.15 157.89 44.11 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.498 -0.751 . . . . 10.0 109.512 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -149.13 154.35 39.08 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.445 1.498 . . . . 10.0 108.352 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -88.82 119.85 29.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -85.07 82.24 8.52 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -55.83 -29.68 60.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.984 0.914 . . . . 10.0 112.269 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -25.39 68.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.867 1.267 . . . . 10.0 112.644 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -120.31 -18.07 8.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.851 0.86 . . . . 10.0 111.932 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.81 29.9 12.43 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.411 1.005 . . . . 10.0 113.003 168.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -153.53 163.74 39.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.882 1.341 . . . . 10.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -74.3 152.77 39.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -139.21 152.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.477 -2.046 . . . . 10.0 105.477 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.88 167.41 39.15 Favored Glycine 0 C--N 1.332 0.33 0 O-C-N 121.274 -0.891 . . . . 10.0 114.082 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -109.41 125.32 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 102.353 -3.202 . . . . 10.0 102.353 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.31 130.84 16.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -165.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -99.85 32.15 3.0 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 -48.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.69 1.132 . . . . 10.0 112.363 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -67.25 160.96 25.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.644 0.657 . . . . 10.0 110.569 -174.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.83 -48.17 0.42 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.363 -0.827 . . . . 10.0 112.338 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.03 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.99 0.814 . . . . 10.0 111.655 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.367 1.067 . . . . 10.0 110.36 -171.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt -56.23 165.25 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.426 1.09 . . . . 10.0 112.643 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.33 163.31 31.31 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.762 2.425 . . . . 10.0 106.512 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.89 135.43 54.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.809 -1.923 . . . . 10.0 105.809 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.07 145.4 27.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -144.74 119.19 9.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.16 -1.792 . . . . 10.0 106.16 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -168.11 153.16 6.52 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 125.292 1.437 . . . . 10.0 110.064 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.2 -27.08 17.1 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.466 2.111 . . . . 10.0 113.246 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -68.29 -29.99 68.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.954 0.797 . . . . 10.0 112.645 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.28 31.85 13.2 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.26 -1.3 . . . . 10.0 114.963 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 107.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.791 1.295 . . . . 10.0 111.546 -168.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.48 116.3 6.62 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.0 -8.49 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.413 0.894 . . . . 10.0 113.413 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.7 -69.26 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.313 2.645 . . . . 10.0 114.517 -171.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -164.86 162.54 20.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.867 1.267 . . . . 10.0 110.878 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -159.29 177.96 10.47 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.659 1.583 . . . . 10.0 109.061 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.14 129.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 105.943 -1.873 . . . . 10.0 105.943 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -154.97 142.97 20.12 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.362 1.465 . . . . 10.0 107.09 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.59 47.49 14.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.656 1.582 . . . . 10.0 112.644 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.45 23.72 62.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.238 0.923 . . . . 10.0 113.573 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.4 m -134.45 147.44 50.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.95 150.95 21.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -135.78 140.05 44.0 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 105.985 -1.857 . . . . 10.0 105.985 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -154.9 157.13 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.603 1.161 . . . . 10.0 111.384 -167.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -59.57 155.99 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.752 1.621 . . . . 10.0 112.19 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -136.83 -67.92 0.49 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.416 -1.278 . . . . 10.0 109.271 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.6 m -151.16 144.62 24.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.463 1.483 . . . . 10.0 111.259 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -148.75 151.48 34.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.915 0.886 . . . . 10.0 109.294 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.9 158.7 42.52 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.809 1.244 . . . . 10.0 108.997 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -91.18 119.3 31.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -88.33 81.43 7.27 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -53.85 -26.44 24.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.967 1.307 . . . . 10.0 113.437 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.2 m -63.0 -21.19 65.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.346 1.059 . . . . 10.0 112.901 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.64 -12.57 6.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.704 1.201 . . . . 10.0 111.916 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 42.33 28.31 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.78 166.45 26.61 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.624 0.77 . . . . 10.0 109.996 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -81.27 152.28 27.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.904 -0.776 . . . . 10.0 108.904 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -137.3 150.69 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.332 -2.099 . . . . 10.0 105.332 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.81 166.37 38.03 Favored Glycine 0 C--N 1.333 0.365 0 O-C-N 121.426 -0.796 . . . . 10.0 113.486 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -108.32 120.69 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 101.677 -3.453 . . . . 10.0 101.677 168.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.64 155.53 46.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -167.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -128.37 36.41 4.28 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 106.653 -1.61 . . . . 10.0 106.653 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.97 -45.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.63 1.105 . . . . 10.0 112.01 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -61.57 142.04 57.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.191 0.905 . . . . 10.0 109.533 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.53 54.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.968 1.307 . . . . 10.0 107.742 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.271 7.6 ptp180 52.11 -0.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.99 2.916 . . . . 10.0 116.614 -170.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.253 1.251 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 167.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 119.264 -0.398 . . . . 10.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.0 pt -58.09 155.61 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.831 0.824 . . . . 10.0 111.292 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.11 159.31 21.91 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.007 2.123 . . . . 10.0 106.36 166.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.85 128.12 56.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.672 -2.344 . . . . 10.0 104.672 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -139.21 147.73 24.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.23 -1.026 . . . . 10.0 108.23 -161.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -149.34 148.4 29.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.21 1.004 . . . . 10.0 108.524 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m 179.14 155.43 0.61 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 127.562 2.345 . . . . 10.0 108.17 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.41 -24.26 31.48 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.312 2.008 . . . . 10.0 113.254 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -68.08 -28.78 67.65 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.401 -0.809 . . . . 10.0 113.019 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.25 41.59 8.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.44 1.019 . . . . 10.0 114.348 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.23 91.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.159 1.384 . . . . 10.0 110.974 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.39 112.33 2.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.802 0.841 . . . . 10.0 108.892 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.65 -12.16 24.25 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.269 0.841 . . . . 10.0 113.269 -174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.07 -63.81 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.389 2.676 . . . . 10.0 114.567 -169.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -165.18 162.75 20.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.814 1.246 . . . . 10.0 110.569 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -158.01 177.5 11.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.687 1.595 . . . . 10.0 108.495 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 135.84 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.784 -1.561 . . . . 10.0 106.784 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.0 131.2 12.75 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 44.13 47.84 7.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.861 . . . . 10.0 113.086 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.34 18.14 76.6 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.352 -0.693 . . . . 10.0 113.707 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -125.18 136.17 53.32 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.36 152.97 21.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -137.55 140.43 41.04 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.337 -1.727 . . . . 10.0 106.337 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -154.68 159.31 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 119.591 1.087 . . . . 10.0 112.169 -167.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.03 156.4 9.42 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.69 1.596 . . . . 10.0 112.276 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -139.67 -63.26 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 117.265 -1.35 . . . . 10.0 109.445 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.9 m -151.7 149.52 29.18 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.092 1.314 . . . . 10.0 111.198 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -147.16 156.28 42.84 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.748 0.819 . . . . 10.0 109.719 168.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -155.13 160.7 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.955 1.302 . . . . 10.0 108.885 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -94.15 120.79 34.91 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.258 -1.386 . . . . 10.0 107.258 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.28 86.3 6.8 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.09 -0.708 . . . . 10.0 109.09 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -55.76 -15.94 3.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.483 1.113 . . . . 10.0 113.433 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -22.08 66.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.236 0.925 . . . . 10.0 112.161 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -139.4 -11.97 1.2 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.144 0.978 . . . . 10.0 112.826 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 45.29 7.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.15 0.886 . . . . 10.0 111.956 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.74 163.2 34.74 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.838 0.819 . . . . 10.0 109.629 172.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -76.49 153.17 35.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.25 153.05 23.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.911 2.084 . . . . 10.0 105.573 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.98 165.29 37.57 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 121.381 -0.825 . . . . 10.0 113.323 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.65 120.47 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 101.202 -3.629 . . . . 10.0 101.202 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.87 139.14 29.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 -164.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -109.36 30.08 6.95 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.64 -44.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.729 1.149 . . . . 10.0 113.041 171.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -61.97 146.07 51.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.819 1.191 . . . . 10.0 109.971 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -139.55 47.41 1.86 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.201 1.401 . . . . 10.0 108.413 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.286 0.0 OUTLIER 56.18 -12.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 130.189 3.396 . . . . 10.0 117.577 -173.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 tptm . . . . . 0 C--O 1.248 1.005 0 CA-C-O 116.909 -1.52 . . . . 10.0 107.786 -172.003 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 pt -62.68 152.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.779 0.799 . . . . 10.0 111.771 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.85 166.75 11.15 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.692 1.997 . . . . 10.0 107.092 158.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.97 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.17 146.09 25.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.014 -0.736 . . . . 10.0 109.014 -162.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.68 141.5 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.894 1.278 . . . . 10.0 108.09 169.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -173.03 154.12 2.64 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 126.853 2.061 . . . . 10.0 107.97 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.21 -25.95 30.66 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.227 1.951 . . . . 10.0 113.091 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -69.74 -28.39 65.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.696 -0.669 . . . . 10.0 112.58 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.05 48.23 58.83 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 118.638 0.654 . . . . 10.0 112.012 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -71.44 73.94 0.74 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.739 1.215 . . . . 10.0 111.176 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.21 120.09 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.074 1.35 . . . . 10.0 109.591 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.86 -7.92 21.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.06 -70.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.032 2.533 . . . . 10.0 114.48 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.7 p -159.61 164.82 33.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.512 1.051 . . . . 10.0 110.634 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -157.76 179.48 9.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.322 1.449 . . . . 10.0 108.975 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.71 130.79 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.3 144.03 21.66 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.75 46.85 11.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.52 . . . . 10.0 112.419 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.4 24.5 63.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.189 0.9 . . . . 10.0 113.636 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -133.75 147.43 51.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.066 1.346 . . . . 10.0 107.553 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -83.0 146.38 28.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -133.31 140.25 47.33 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.511 -1.662 . . . . 10.0 106.511 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -154.37 158.32 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.624 1.17 . . . . 10.0 111.874 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.99 156.58 5.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.055 1.742 . . . . 10.0 112.677 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -138.45 -62.2 0.57 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 117.257 -1.354 . . . . 10.0 109.334 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -151.9 150.25 29.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.127 1.33 . . . . 10.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -145.09 157.0 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.598 0.759 . . . . 10.0 109.556 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.08 160.8 41.27 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.941 1.296 . . . . 10.0 108.716 170.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -94.14 116.19 28.57 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.17 87.55 7.39 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -58.36 -15.4 10.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.607 1.163 . . . . 10.0 113.218 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.61 -25.11 67.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.428 1.013 . . . . 10.0 111.625 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.66 -12.63 4.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.626 1.17 . . . . 10.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 42.97 19.68 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.703 0.668 . . . . 10.0 111.506 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.46 163.84 34.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.026 0.913 . . . . 10.0 110.974 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -78.68 150.64 32.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -140.23 152.84 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.805 2.042 . . . . 10.0 105.616 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.39 163.64 36.7 Favored Glycine 0 C--N 1.334 0.427 0 O-C-N 121.242 -0.911 . . . . 10.0 113.485 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.96 123.99 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 101.828 -3.397 . . . . 10.0 101.828 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.27 29.18 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.736 -0.838 . . . . 10.0 108.736 -163.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -115.31 35.72 4.25 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.97 -49.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.892 0.769 . . . . 10.0 112.202 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -67.44 155.16 39.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.137 0.881 . . . . 10.0 110.65 -171.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.35 36.56 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 10.0 110.207 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 78.8 -34.94 0.17 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.635 2.374 . . . . 10.0 112.198 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.0 mttp . . . . . 0 C--O 1.247 0.968 0 C-N-CA 126.691 1.996 . . . . 10.0 110.691 -178.414 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.884 0.374 . . . . 10.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.0 pt -59.65 157.98 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.912 0.863 . . . . 10.0 111.297 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -115.73 162.12 17.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.107 2.163 . . . . 10.0 106.585 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.72 136.62 53.24 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.4 -2.074 . . . . 10.0 105.4 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.9 146.89 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 -163.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.79 120.55 9.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.589 -1.634 . . . . 10.0 106.589 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m -158.99 150.99 17.27 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 119.739 1.154 . . . . 10.0 109.327 173.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.2 -27.19 35.36 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.035 1.823 . . . . 10.0 112.98 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -81.15 -17.43 49.84 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.792 1.034 . . . . 10.0 113.792 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.98 34.79 31.37 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.145 -1.364 . . . . 10.0 114.008 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -53.33 99.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.109 1.363 . . . . 10.0 112.408 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.8 117.26 15.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.501 1.12 . . . . 10.0 109.317 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.08 -11.81 27.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.98 -67.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.326 2.65 . . . . 10.0 114.2 -166.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -163.82 162.5 23.75 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.291 1.036 . . . . 10.0 110.366 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -158.55 176.4 12.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.04 1.336 . . . . 10.0 108.885 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -137.1 132.2 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -149.5 135.04 18.48 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.52 50.24 10.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.198 1.799 . . . . 10.0 112.757 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.19 69.17 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.822 0.725 . . . . 10.0 113.547 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -129.15 138.75 51.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.65 -1.611 . . . . 10.0 106.65 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -88.41 151.55 22.5 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.65 140.62 42.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.961 1.705 . . . . 10.0 106.518 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -152.58 155.02 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.153 1.381 . . . . 10.0 111.398 -163.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -57.59 156.02 8.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.565 1.546 . . . . 10.0 112.188 170.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -138.78 -64.99 0.5 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.538 -1.22 . . . . 10.0 109.465 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -152.15 149.75 29.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.203 1.365 . . . . 10.0 111.033 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 23.0 ttpt -149.97 143.61 25.32 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -150.84 154.76 37.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.739 1.216 . . . . 10.0 109.085 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -89.04 122.66 32.6 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.76 90.82 4.82 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.252 1.025 . . . . 10.0 108.88 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -57.4 -13.7 3.83 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.213 1.405 . . . . 10.0 113.399 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -62.71 -25.18 68.04 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.632 1.106 . . . . 10.0 111.876 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -131.59 -9.72 3.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.467 0.707 . . . . 10.0 111.959 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.58 8.69 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.469 -1.052 . . . . 10.0 110.469 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.32 163.17 34.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.317 1.047 . . . . 10.0 109.92 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 88.3 m95 -81.8 149.12 28.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -136.59 153.17 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.536 -2.024 . . . . 10.0 105.536 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.38 167.37 38.25 Favored Glycine 0 N--CA 1.45 -0.38 0 O-C-N 121.142 -0.974 . . . . 10.0 113.52 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.19 122.87 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 101.307 -3.59 . . . . 10.0 101.307 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.12 134.17 21.5 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -102.98 31.68 4.09 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 p -153.75 -47.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.913 1.233 . . . . 10.0 112.738 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -63.7 149.13 47.35 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.876 0.762 . . . . 10.0 110.696 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -137.53 34.8 2.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.64 1.176 . . . . 10.0 111.081 -165.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 58.13 43.27 20.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.28 1.432 . . . . 10.0 112.874 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.331 -1.729 . . . . 10.0 106.331 174.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 119.214 -0.422 . . . . 10.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp -56.29 156.74 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 122.231 1.015 . . . . 10.0 112.41 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -116.67 163.56 15.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.372 2.269 . . . . 10.0 106.577 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.65 133.41 52.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.66 149.66 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.897 -0.779 . . . . 10.0 108.897 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -144.43 127.6 16.65 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.519 -2.03 . . . . 10.0 105.519 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -169.66 153.43 5.04 Favored Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 125.372 1.469 . . . . 10.0 109.151 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.78 -24.88 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.335 2.024 . . . . 10.0 113.123 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -81.77 -18.72 43.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.698 0.999 . . . . 10.0 113.698 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.39 37.66 18.95 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.365 -1.242 . . . . 10.0 113.818 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -54.06 99.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.89 1.276 . . . . 10.0 112.094 -170.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.06 116.88 16.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.082 0.953 . . . . 10.0 108.736 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.32 -11.82 27.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.576 0.954 . . . . 10.0 113.576 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.41 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.153 2.581 . . . . 10.0 114.673 -166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 p -167.46 164.49 14.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.826 1.25 . . . . 10.0 110.899 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -158.53 175.98 12.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.843 1.657 . . . . 10.0 108.486 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.7 132.74 48.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.872 -1.899 . . . . 10.0 105.872 171.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.3 tp -146.5 132.37 19.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.2 -1.407 . . . . 10.0 107.2 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.71 49.3 11.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.854 1.662 . . . . 10.0 112.774 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.9 72.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.806 0.717 . . . . 10.0 113.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -127.48 136.4 51.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -86.27 150.65 24.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -136.17 140.8 43.88 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.53 156.62 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 10.0 111.742 -168.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.91 152.82 15.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.515 1.526 . . . . 10.0 111.763 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -130.38 -70.29 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.416 -1.278 . . . . 10.0 108.112 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.51 149.24 27.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.185 1.357 . . . . 10.0 111.0 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.59 155.93 46.43 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.619 -0.676 . . . . 10.0 109.577 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -148.54 153.85 38.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.557 1.543 . . . . 10.0 108.082 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -89.1 118.47 28.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.344 -1.354 . . . . 10.0 107.344 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -83.97 94.13 8.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.4 m -64.73 -25.5 67.96 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.383 0.673 . . . . 10.0 112.725 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -70.03 -41.97 73.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.672 0.669 . . . . 10.0 110.249 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -84.22 -25.88 29.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.412 0.685 . . . . 10.0 111.68 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.79 40.86 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.154 0.883 . . . . 10.0 111.545 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.35 168.24 23.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.551 1.175 . . . . 10.0 111.014 173.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.0 152.48 36.96 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.077 -0.712 . . . . 10.0 109.077 167.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.16 153.67 27.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.752 2.021 . . . . 10.0 105.758 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.08 162.71 35.44 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 121.249 -0.907 . . . . 10.0 113.74 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.06 124.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 102.49 -3.152 . . . . 10.0 102.49 168.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.36 129.47 17.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -167.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -100.08 33.71 2.54 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.169 -1.048 . . . . 10.0 108.169 171.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.56 -48.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.565 1.075 . . . . 10.0 112.048 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -66.55 159.47 27.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.805 0.73 . . . . 10.0 110.233 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.78 -46.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.652 0.781 . . . . 10.0 111.95 -174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.83 -44.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.786 -1.102 . . . . 10.0 110.328 -170.831 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.01 159.79 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.052 0.929 . . . . 10.0 111.646 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.9 165.14 17.9 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.971 2.508 . . . . 10.0 106.479 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.07 137.47 54.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.812 -1.921 . . . . 10.0 105.812 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.75 150.38 18.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 -168.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.51 14.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.511 1.124 . . . . 10.0 108.812 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.1 m -169.08 155.08 6.28 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.792 2.037 . . . . 10.0 107.943 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.01 -23.77 39.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.975 1.783 . . . . 10.0 112.754 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -71.25 -29.79 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.701 0.682 . . . . 10.0 112.361 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.1 42.23 71.26 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 118.973 -0.904 . . . . 10.0 112.513 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.18 98.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.017 0.927 . . . . 10.0 111.991 -163.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.96 121.53 17.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.455 0.702 . . . . 10.0 109.348 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.45 -8.94 17.79 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.18 -67.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.201 2.601 . . . . 10.0 114.814 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 p -165.04 162.7 20.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.158 1.383 . . . . 10.0 110.616 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -158.6 175.89 13.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.634 1.574 . . . . 10.0 108.602 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.99 132.31 47.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 105.786 -1.931 . . . . 10.0 105.786 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -149.57 134.46 17.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.161 -1.422 . . . . 10.0 107.161 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.33 49.94 10.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.108 1.763 . . . . 10.0 112.736 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.2 69.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.776 0.703 . . . . 10.0 113.508 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.2 m -128.86 140.21 51.8 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -90.34 150.38 21.91 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -136.24 139.12 42.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 tt -154.56 157.48 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.85 1.26 . . . . 10.0 111.975 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.55 154.29 4.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.943 1.697 . . . . 10.0 112.026 168.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -55.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.29 -1.338 . . . . 10.0 110.871 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.7 m -151.82 150.25 29.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.843 1.202 . . . . 10.0 110.794 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 25.6 ttpt -149.47 142.62 25.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -150.38 155.89 40.45 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.781 1.232 . . . . 10.0 109.197 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -93.2 122.2 35.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.465 -1.309 . . . . 10.0 107.465 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -96.81 89.99 5.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.94 -15.66 5.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.921 1.288 . . . . 10.0 113.386 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.48 -26.91 68.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.508 1.049 . . . . 10.0 111.632 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.79 -14.65 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.554 1.142 . . . . 10.0 111.635 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.13 13.24 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.556 -1.018 . . . . 10.0 110.556 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 166.09 26.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.661 0.784 . . . . 10.0 110.384 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 91.4 m95 -81.32 152.65 27.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.2 156.09 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.243 2.217 . . . . 10.0 105.267 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.34 169.35 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 O-C-N 120.905 -1.122 . . . . 10.0 113.386 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.77 113.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 101.442 -3.54 . . . . 10.0 101.442 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 133.35 28.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 -158.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -106.49 35.76 2.85 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.73 -48.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.679 1.127 . . . . 10.0 112.368 167.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -63.18 141.41 58.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.388 0.995 . . . . 10.0 109.299 -174.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -127.55 27.22 5.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 10.0 109.883 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.9 ttt-85 69.09 -38.49 0.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.364 2.666 . . . . 10.0 113.608 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt . . . . . 0 C--O 1.249 1.078 0 C-N-CA 125.782 1.633 . . . . 10.0 109.402 -175.016 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.7 164.11 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 122.332 1.063 . . . . 10.0 111.976 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -119.48 160.71 21.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.234 2.214 . . . . 10.0 106.247 162.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.57 132.95 54.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.8 146.52 26.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.081 -1.081 . . . . 10.0 108.081 -161.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -156.5 127.7 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.767 0.827 . . . . 10.0 109.324 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 m -160.89 155.15 19.43 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.074 1.75 . . . . 10.0 107.794 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 -26.46 35.14 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.161 1.907 . . . . 10.0 113.14 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -70.75 -31.84 68.79 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.69 0.677 . . . . 10.0 112.549 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.03 32.4 82.09 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.903 -0.943 . . . . 10.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -53.94 97.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.131 1.772 . . . . 10.0 112.116 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -68.09 122.64 18.68 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.17 -3.87 16.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 50.6 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.143 2.577 . . . . 10.0 115.001 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -163.09 162.02 25.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.229 1.411 . . . . 10.0 110.441 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.86 177.63 10.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.401 1.481 . . . . 10.0 109.075 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.36 129.37 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.025 -1.842 . . . . 10.0 106.025 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.02 144.01 19.73 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.29 47.27 13.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.436 1.494 . . . . 10.0 112.511 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.65 23.68 63.28 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.181 0.896 . . . . 10.0 113.566 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -135.2 148.53 49.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.288 1.435 . . . . 10.0 107.274 -172.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -92.39 150.17 20.97 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -135.63 140.07 44.27 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.271 -1.752 . . . . 10.0 106.271 -170.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -155.19 157.18 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.433 1.093 . . . . 10.0 111.869 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -58.73 156.39 11.13 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.133 1.773 . . . . 10.0 112.48 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -137.0 -65.24 0.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 117.316 -1.326 . . . . 10.0 109.104 167.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -150.96 149.94 30.21 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.966 1.257 . . . . 10.0 111.711 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 20.9 ptmt -144.62 152.12 40.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.677 1.191 . . . . 10.0 108.601 168.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.86 156.86 41.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.242 1.417 . . . . 10.0 108.715 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.86 119.97 33.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.256 -1.386 . . . . 10.0 107.256 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -90.18 88.21 7.16 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.22 -17.1 6.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.825 1.25 . . . . 10.0 113.349 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -25.92 68.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.278 0.944 . . . . 10.0 111.616 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -130.5 -12.37 3.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.653 1.181 . . . . 10.0 112.099 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.94 45.94 15.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.45 164.42 34.22 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.007 0.923 . . . . 10.0 110.297 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 84.9 m95 -82.21 150.24 27.47 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.19 154.04 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 105.289 -2.115 . . . . 10.0 105.289 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.49 172.43 42.39 Favored Glycine 0 N--CA 1.451 -0.348 0 O-C-N 120.977 -1.077 . . . . 10.0 113.528 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.5 mt -117.89 119.56 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 101.679 -3.452 . . . . 10.0 101.679 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 134.9 22.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -162.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -108.51 37.06 2.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.01 -45.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.162 0.892 . . . . 10.0 111.699 168.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -65.4 151.17 46.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.813 0.733 . . . . 10.0 110.628 -171.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.86 32.76 2.68 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.516 1.526 . . . . 10.0 109.886 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.252 0.7 OUTLIER 68.04 -23.19 0.13 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.781 2.833 . . . . 10.0 115.711 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt . . . . . 0 C--O 1.25 1.091 0 C-N-CA 124.246 1.018 . . . . 10.0 109.645 175.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 119.249 -0.405 . . . . 10.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.24 164.12 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.943 0.878 . . . . 10.0 111.394 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -137.34 162.4 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.515 2.326 . . . . 10.0 106.277 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -120.8 137.19 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.302 -1.74 . . . . 10.0 106.302 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.31 148.51 22.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -141.87 125.86 17.24 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -163.45 145.35 7.61 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 119.113 0.87 . . . . 10.0 108.809 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.58 -20.77 46.86 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.168 1.912 . . . . 10.0 112.317 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.0 -34.24 71.16 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.475 1.034 . . . . 10.0 111.542 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.1 27.98 71.39 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.787 -1.007 . . . . 10.0 114.519 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -52.27 108.82 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.697 1.599 . . . . 10.0 112.147 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.61 109.16 6.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 168.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.61 -2.31 51.63 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 49.32 -70.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.01 2.924 . . . . 10.0 115.983 -171.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -168.27 159.91 11.11 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.135 1.374 . . . . 10.0 110.211 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -159.32 176.08 12.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.543 1.137 . . . . 10.0 109.33 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.25 133.93 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.69 124.48 10.54 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -174.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t0 44.74 41.57 5.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.736 2.014 . . . . 10.0 112.833 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.7 48.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.425 1.012 . . . . 10.0 114.005 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -83.1 146.32 28.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 171.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -104.09 145.43 30.18 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.352 1.061 . . . . 10.0 108.466 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -136.31 144.49 44.73 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.384 1.074 . . . . 10.0 108.313 -168.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -160.23 159.78 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.857 1.263 . . . . 10.0 112.585 -168.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 68.4 t80 -58.07 157.44 8.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.009 1.724 . . . . 10.0 112.809 169.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -141.7 -63.13 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.271 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -151.13 144.66 24.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.911 1.232 . . . . 10.0 111.152 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -151.07 141.5 22.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -149.72 161.33 42.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.11 1.364 . . . . 10.0 109.628 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -92.9 123.48 36.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -92.67 78.05 4.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -52.65 -28.56 22.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.97 1.308 . . . . 10.0 113.323 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -63.41 -21.65 66.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.452 1.101 . . . . 10.0 112.93 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -125.14 -15.77 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.848 1.259 . . . . 10.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.82 37.84 21.6 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.762 0.71 . . . . 10.0 112.43 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.41 163.14 38.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.037 0.935 . . . . 10.0 109.299 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -76.12 153.65 36.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.02 150.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.657 1.983 . . . . 10.0 105.691 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.64 166.53 34.93 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 121.547 -0.721 . . . . 10.0 113.265 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.55 116.6 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 101.268 -3.605 . . . . 10.0 101.268 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -141.58 136.66 31.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 -163.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -103.81 30.72 4.91 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.457 -0.942 . . . . 10.0 108.457 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.99 -54.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-N 119.087 0.858 . . . . 10.0 111.108 167.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.69 143.93 45.11 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.59 0.632 . . . . 10.0 111.08 -165.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -133.58 27.2 4.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.598 1.159 . . . . 10.0 110.777 -166.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 62.24 14.21 6.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.092 1.757 . . . . 10.0 113.11 -171.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.364 -1.303 . . . . 10.0 107.595 169.611 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.928 -0.397 . . . . 10.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 pt -59.42 160.38 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.97 0.89 . . . . 10.0 111.523 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -128.34 166.01 19.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.826 2.45 . . . . 10.0 106.566 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -122.32 138.66 54.44 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -140.68 147.96 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.083 -1.08 . . . . 10.0 108.083 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.53 116.39 9.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.42 1.488 . . . . 10.0 107.166 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -154.7 150.31 21.44 Favored Pre-proline 0 N--CA 1.466 0.341 0 C-N-CA 123.768 0.827 . . . . 10.0 110.032 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.8 -28.41 25.08 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.905 1.736 . . . . 10.0 112.796 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -71.86 -29.43 64.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.67 29.82 26.3 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.503 -1.165 . . . . 10.0 115.395 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -61.05 107.19 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.681 1.241 . . . . 10.0 111.392 -172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -65.39 118.02 8.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.774 0.83 . . . . 10.0 109.143 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.28 -8.62 26.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.871 1.063 . . . . 10.0 113.871 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.5 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.976 2.51 . . . . 10.0 114.695 -170.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 p -162.24 165.55 26.65 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.692 1.197 . . . . 10.0 111.022 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -157.22 174.36 15.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.861 1.664 . . . . 10.0 108.585 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.12 133.47 47.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.787 -1.931 . . . . 10.0 105.787 172.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -143.93 121.2 11.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.079 -1.822 . . . . 10.0 106.079 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.6 t0 47.62 43.33 16.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.839 1.656 . . . . 10.0 112.721 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 4.68 78.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.105 0.859 . . . . 10.0 113.968 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 m -102.25 136.88 41.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -87.5 150.72 23.56 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -136.81 139.82 42.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.403 1.881 . . . . 10.0 106.098 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -153.32 156.84 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.645 1.178 . . . . 10.0 111.852 -168.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.78 155.08 13.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.032 1.733 . . . . 10.0 112.19 171.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -137.44 -61.39 0.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.261 -1.352 . . . . 10.0 110.597 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.5 m -152.55 149.94 29.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.505 1.502 . . . . 10.0 111.136 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -150.01 152.48 34.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.391 1.076 . . . . 10.0 109.295 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.93 157.32 40.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.795 1.238 . . . . 10.0 109.143 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -89.5 120.27 30.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -88.57 77.37 8.01 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.34 -29.21 22.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.894 1.278 . . . . 10.0 113.164 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -65.01 -19.34 65.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.476 1.11 . . . . 10.0 112.933 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.4 -17.56 5.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.602 1.161 . . . . 10.0 111.97 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.07 36.75 10.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.727 0.694 . . . . 10.0 112.48 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.2 163.26 38.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.219 1.009 . . . . 10.0 109.618 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -75.8 154.61 36.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.43 0.633 . . . . 10.0 109.71 170.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.9 t -138.03 154.29 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.559 -2.015 . . . . 10.0 105.559 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.81 166.42 36.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.259 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.8 mt -112.86 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 101.613 -3.477 . . . . 10.0 101.613 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 140.07 30.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -160.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.62 36.66 3.34 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.79 -44.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.304 0.956 . . . . 10.0 111.676 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -66.83 160.8 25.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.285 0.493 . . . . 10.0 110.776 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -141.44 -40.38 0.38 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.762 0.825 . . . . 10.0 112.395 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -172.0 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.405 1.082 . . . . 10.0 111.569 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 105.755 -1.943 . . . . 10.0 105.755 170.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -59.98 163.2 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 122.368 1.08 . . . . 10.0 111.954 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -126.31 164.02 21.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.748 2.419 . . . . 10.0 105.745 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.7 mt -123.55 137.01 54.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.61 150.83 19.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 -168.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -141.47 134.79 29.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.44 150.46 4.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.787 -0.819 . . . . 10.0 108.787 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.78 -25.24 39.78 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 121.805 1.67 . . . . 10.0 112.408 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -72.41 -32.16 66.12 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.592 0.633 . . . . 10.0 112.547 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.93 35.15 81.84 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.968 -0.907 . . . . 10.0 113.576 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -54.87 102.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.265 1.426 . . . . 10.0 111.96 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.18 116.1 10.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.51 -7.45 28.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.28 -72.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.053 2.541 . . . . 10.0 115.008 -170.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 164.19 19.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 10.0 110.729 -174.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -158.07 174.17 15.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.786 1.635 . . . . 10.0 108.558 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.33 133.77 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.788 -1.93 . . . . 10.0 105.788 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -144.07 120.72 11.14 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.44 43.2 15.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.912 1.685 . . . . 10.0 112.704 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.14 2.9 80.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.124 0.868 . . . . 10.0 114.047 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.5 m -99.95 136.49 39.78 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 173.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -87.71 150.61 23.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -137.15 139.94 41.5 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.188 -1.782 . . . . 10.0 106.188 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.16 156.75 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.825 1.25 . . . . 10.0 111.883 -168.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.84 155.56 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.008 1.723 . . . . 10.0 112.421 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -135.76 -66.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.403 -1.284 . . . . 10.0 109.009 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -150.97 151.33 31.94 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.887 1.221 . . . . 10.0 111.691 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -142.16 150.93 41.71 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.608 1.163 . . . . 10.0 108.649 168.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -151.41 154.85 37.43 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.028 1.331 . . . . 10.0 108.741 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -89.35 121.0 31.19 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.558 -1.275 . . . . 10.0 107.558 174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.0 85.89 7.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.006 -1.479 . . . . 10.0 107.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -57.64 -27.44 62.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.805 0.842 . . . . 10.0 112.764 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -71.47 -26.35 62.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.558 0.743 . . . . 10.0 111.621 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -109.63 -17.64 13.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.857 0.863 . . . . 10.0 112.234 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.43 38.57 20.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.056 0.836 . . . . 10.0 112.331 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.64 164.36 37.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.515 1.157 . . . . 10.0 110.473 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.419 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 85.9 m95 -73.46 153.68 40.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 168.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.29 156.08 32.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.942 2.097 . . . . 10.0 105.366 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.87 162.89 33.39 Favored Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.452 -0.78 . . . . 10.0 112.865 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.2 mt -106.94 118.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 101.612 -3.477 . . . . 10.0 101.612 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.38 127.54 16.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -162.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -101.14 37.88 1.67 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.847 -1.168 . . . . 10.0 107.847 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.96 -48.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.407 1.003 . . . . 10.0 111.847 167.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -64.68 146.91 54.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.771 0.714 . . . . 10.0 110.379 -169.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.95 37.21 1.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.453 1.501 . . . . 10.0 109.535 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 56.07 26.94 10.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.692 1.597 . . . . 10.0 112.702 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.248 0.982 0 N-CA-C 107.308 -1.367 . . . . 10.0 107.308 167.836 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.0 pt -60.67 160.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 122.08 0.943 . . . . 10.0 111.466 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -119.55 165.27 14.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.863 2.465 . . . . 10.0 106.523 163.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.09 135.77 54.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.031 -2.211 . . . . 10.0 105.031 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -138.38 142.89 34.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 -167.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -145.28 101.48 3.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -152.15 149.87 24.24 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 118.828 0.74 . . . . 10.0 109.871 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.06 -27.75 19.98 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.082 1.855 . . . . 10.0 113.366 -173.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -72.09 -25.28 61.69 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.17 35.47 26.8 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.792 -1.004 . . . . 10.0 115.099 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -58.7 98.99 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.114 1.366 . . . . 10.0 111.514 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.32 110.72 4.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.682 0.793 . . . . 10.0 108.862 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.98 -12.19 31.33 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.52 -66.05 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.14 2.576 . . . . 10.0 114.606 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 p -164.52 161.74 21.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.943 1.297 . . . . 10.0 110.745 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.4 177.73 10.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.452 1.501 . . . . 10.0 109.099 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.41 129.82 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 106.042 -1.836 . . . . 10.0 106.042 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.7 tp -155.67 143.72 19.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.11 47.7 12.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.585 1.554 . . . . 10.0 112.512 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.81 63.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.116 0.865 . . . . 10.0 113.612 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -134.94 147.85 49.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.32 1.448 . . . . 10.0 107.19 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -91.1 150.24 21.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.816 -0.809 . . . . 10.0 108.816 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -135.24 140.37 45.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.413 -1.699 . . . . 10.0 106.413 -171.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.5 158.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.424 1.09 . . . . 10.0 112.002 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.04 157.32 8.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.223 1.809 . . . . 10.0 112.458 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -139.17 -61.94 0.55 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 117.608 -1.187 . . . . 10.0 109.529 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 m -152.58 149.3 28.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.889 1.222 . . . . 10.0 111.215 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -148.11 156.07 42.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.872 0.869 . . . . 10.0 109.696 169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -155.5 161.01 41.01 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.033 1.333 . . . . 10.0 108.877 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.87 118.93 31.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.227 -1.397 . . . . 10.0 107.227 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.59 80.34 8.04 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -53.02 -26.71 16.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.944 1.297 . . . . 10.0 113.451 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 m -63.0 -21.2 65.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.453 1.101 . . . . 10.0 112.983 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.57 -12.44 6.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.696 1.198 . . . . 10.0 112.065 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.47 41.8 29.15 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.62 0.645 . . . . 10.0 111.739 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.2 164.91 30.77 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.926 0.863 . . . . 10.0 110.555 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -79.52 149.48 31.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.5 t -135.8 149.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.576 -2.009 . . . . 10.0 105.576 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.44 165.98 36.98 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.58 -0.7 . . . . 10.0 113.204 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.9 mt -110.73 120.21 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 101.489 -3.522 . . . . 10.0 101.489 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.76 139.02 26.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 -162.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -111.88 35.56 3.65 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 170.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.51 -44.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.485 1.039 . . . . 10.0 112.003 168.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -66.1 152.76 44.01 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.293 0.951 . . . . 10.0 110.816 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.81 38.15 0.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.967 1.307 . . . . 10.0 109.76 -167.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 65.86 -33.12 0.17 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.018 2.527 . . . . 10.0 114.491 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 tptt . . . . . 0 C--O 1.248 1.016 0 C-N-CA 124.83 1.252 . . . . 10.0 109.853 176.64 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.506 0.193 . . . . 10.0 110.961 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.2 165.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.566 0.698 . . . . 10.0 111.452 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -130.91 161.38 32.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.552 1.941 . . . . 10.0 106.832 167.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.76 134.78 51.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.579 -2.008 . . . . 10.0 105.579 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -140.48 148.25 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 -163.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -152.94 137.66 16.97 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.661 0.785 . . . . 10.0 109.911 171.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 m -161.03 153.04 16.65 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.043 1.337 . . . . 10.0 108.204 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.86 -28.17 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.885 1.723 . . . . 10.0 112.812 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -75.97 -16.56 59.97 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.86 1.059 . . . . 10.0 113.86 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.08 44.51 33.11 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.298 0.954 . . . . 10.0 112.787 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -65.81 78.04 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.848 1.259 . . . . 10.0 112.21 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -55.82 126.57 26.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.134 1.374 . . . . 10.0 109.712 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.57 -4.75 14.67 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.124 1.157 . . . . 10.0 114.124 -170.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.19 -68.4 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.271 2.628 . . . . 10.0 115.492 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.8 p -165.55 162.57 19.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.98 1.312 . . . . 10.0 110.508 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -158.74 174.49 14.95 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.296 1.438 . . . . 10.0 108.712 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.7 132.64 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.797 -1.927 . . . . 10.0 105.797 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.87 127.31 13.16 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.02 42.33 9.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.617 1.967 . . . . 10.0 112.695 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 1.28 57.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.27 0.938 . . . . 10.0 114.119 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -95.19 140.66 29.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.605 -1.628 . . . . 10.0 106.605 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.85 151.15 21.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -137.9 140.23 40.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.276 1.831 . . . . 10.0 106.358 -171.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 tt -153.39 159.83 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 119.617 1.099 . . . . 10.0 112.257 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.23 156.96 9.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.026 1.73 . . . . 10.0 112.371 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -138.17 -64.54 0.53 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 117.519 -1.229 . . . . 10.0 109.498 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -151.92 149.9 29.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.112 1.323 . . . . 10.0 111.112 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -147.56 157.24 43.48 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.789 0.836 . . . . 10.0 110.129 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -155.26 160.18 40.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.453 1.501 . . . . 10.0 108.774 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -92.76 122.05 34.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -89.58 79.48 6.85 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.755 -1.202 . . . . 10.0 107.755 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -52.13 -28.47 18.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.666 1.186 . . . . 10.0 113.235 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m -66.75 -19.98 65.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.353 1.061 . . . . 10.0 112.874 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -124.15 -17.04 6.31 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.635 1.174 . . . . 10.0 112.079 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.79 37.42 16.51 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.917 0.781 . . . . 10.0 112.508 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.46 163.06 37.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.316 1.058 . . . . 10.0 109.729 173.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.92 153.26 36.79 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 t -139.82 154.24 23.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.413 1.885 . . . . 10.0 105.972 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.19 165.17 37.04 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-O 121.998 0.777 . . . . 10.0 112.877 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.92 125.47 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 101.57 -3.492 . . . . 10.0 101.57 169.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.42 153.9 44.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.331 -0.618 . . . . 10.0 109.331 -166.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -124.72 31.47 5.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.827 -1.175 . . . . 10.0 107.827 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.61 -45.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 119.366 0.984 . . . . 10.0 112.156 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -64.61 148.77 50.2 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 0.752 . . . . 10.0 110.184 -170.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -140.78 39.07 1.82 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.261 1.024 . . . . 10.0 110.738 -168.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 58.53 43.34 19.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.411 1.484 . . . . 10.0 113.248 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.244 0.798 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 174.176 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.544 0.211 . . . . 10.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt -58.76 151.93 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.559 0.695 . . . . 10.0 110.979 171.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -110.69 162.93 14.25 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.242 1.817 . . . . 10.0 106.56 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.92 136.12 53.46 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.22 -2.141 . . . . 10.0 105.22 168.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.72 144.54 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 -164.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -145.54 106.81 4.18 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.147 1.379 . . . . 10.0 107.467 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -152.64 144.04 16.17 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 119.421 1.009 . . . . 10.0 110.027 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.8 -36.05 89.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.119 2.546 . . . . 10.0 114.6 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -73.83 -25.12 59.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.498 0.925 . . . . 10.0 113.498 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.0 28.8 26.1 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.603 -1.11 . . . . 10.0 115.644 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -52.01 112.44 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.244 1.417 . . . . 10.0 111.772 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -73.0 102.45 3.49 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.691 0.796 . . . . 10.0 108.974 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.12 -13.2 57.58 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.82 1.044 . . . . 10.0 113.82 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.85 -69.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.123 2.569 . . . . 10.0 114.481 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -165.16 164.16 20.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.848 1.259 . . . . 10.0 110.589 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.0 176.68 12.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.729 1.612 . . . . 10.0 108.669 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.75 135.92 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.04 128.79 12.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 45.64 44.25 10.09 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.104 1.762 . . . . 10.0 113.022 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.68 79.61 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.262 -0.744 . . . . 10.0 113.858 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -112.22 135.6 52.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -90.14 152.39 21.14 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.582 -0.896 . . . . 10.0 108.582 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -138.22 140.18 39.61 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 -171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.9 tt -153.89 157.24 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.562 1.074 . . . . 10.0 112.24 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.71 154.91 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.705 1.602 . . . . 10.0 112.223 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -135.28 -66.52 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.314 -1.326 . . . . 10.0 109.092 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 m -151.35 151.31 31.57 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.378 1.445 . . . . 10.0 111.352 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -145.54 153.17 40.82 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 10.0 109.698 170.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -153.63 157.77 40.13 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.296 1.439 . . . . 10.0 108.865 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -91.7 123.97 35.49 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -93.63 86.3 5.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.653 0.74 . . . . 10.0 109.115 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -56.09 -17.1 6.16 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.673 1.189 . . . . 10.0 113.443 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.67 70.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.202 0.91 . . . . 10.0 111.633 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.46 -13.08 3.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.275 1.03 . . . . 10.0 112.308 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.7 43.82 8.16 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.775 0.716 . . . . 10.0 111.759 171.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -145.86 162.78 36.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.773 0.787 . . . . 10.0 109.883 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.412 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 80.2 m95 -75.51 152.89 37.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.385 0.612 . . . . 10.0 109.369 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.4 t -135.16 153.19 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 162.04 33.96 Favored Glycine 0 N--CA 1.45 -0.433 0 O-C-N 121.575 -0.703 . . . . 10.0 112.983 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -102.0 121.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 101.641 -3.466 . . . . 10.0 101.641 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 137.18 25.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.336 -0.987 . . . . 10.0 108.336 -165.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -108.69 33.38 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.897 -1.149 . . . . 10.0 107.897 172.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.59 -44.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.341 0.973 . . . . 10.0 112.313 170.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -66.07 153.07 43.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.991 0.814 . . . . 10.0 111.492 -168.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -148.35 34.53 0.8 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.496 1.518 . . . . 10.0 109.801 -167.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 69.83 -25.84 0.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.848 2.459 . . . . 10.0 114.406 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm . . . . . 0 C--O 1.247 0.958 0 C-N-CA 124.289 1.036 . . . . 10.0 109.999 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 119.523 -0.275 . . . . 10.0 110.512 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 pt -57.71 156.89 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.673 0.749 . . . . 10.0 110.968 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -122.22 159.21 27.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.316 2.246 . . . . 10.0 106.053 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.94 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.6 -2.0 . . . . 10.0 105.6 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.46 141.95 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -163.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -147.73 102.37 3.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.098 1.359 . . . . 10.0 107.912 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -153.19 150.13 23.17 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.687 0.676 . . . . 10.0 109.683 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.49 -26.58 28.72 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.28 1.987 . . . . 10.0 113.22 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -70.04 -33.18 71.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.756 0.707 . . . . 10.0 112.389 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.9 30.01 74.05 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.766 -1.019 . . . . 10.0 114.076 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -50.46 106.5 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.57 1.548 . . . . 10.0 112.06 -174.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -75.12 102.98 5.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -10.83 58.38 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.602 0.964 . . . . 10.0 113.602 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.05 -70.94 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.165 2.586 . . . . 10.0 114.489 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -163.92 162.78 23.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.969 1.308 . . . . 10.0 110.708 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -158.73 177.5 11.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.528 1.531 . . . . 10.0 109.026 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.16 129.83 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 tp -155.46 143.66 20.1 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.331 1.453 . . . . 10.0 107.271 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.61 47.41 11.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.487 1.515 . . . . 10.0 112.532 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.81 63.33 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.165 0.888 . . . . 10.0 113.698 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -134.93 148.44 50.05 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.337 1.455 . . . . 10.0 107.258 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -90.87 150.49 21.52 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -136.51 140.54 43.08 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.273 -1.751 . . . . 10.0 106.273 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.77 159.23 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.59 1.086 . . . . 10.0 112.286 -165.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -55.36 154.51 6.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.018 1.727 . . . . 10.0 112.621 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -136.09 -59.18 0.75 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-O 117.578 -1.201 . . . . 10.0 109.133 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -161.57 159.89 28.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.282 1.401 . . . . 10.0 112.354 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -141.24 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.231 1.412 . . . . 10.0 108.643 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -150.71 158.6 44.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.99 1.316 . . . . 10.0 108.233 162.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -91.57 123.22 34.82 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.095 -1.446 . . . . 10.0 107.095 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -95.64 88.78 5.12 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -56.75 -15.72 5.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.894 1.278 . . . . 10.0 113.383 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -64.17 -24.58 67.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.361 0.982 . . . . 10.0 111.855 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -130.23 -12.42 4.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.579 1.152 . . . . 10.0 112.016 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 46.32 16.87 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.34 167.44 22.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.556 0.743 . . . . 10.0 110.48 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.83 150.05 28.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.44 152.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.501 -2.037 . . . . 10.0 105.501 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.2 37.57 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 121.358 -0.839 . . . . 10.0 112.914 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.92 126.45 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 102.107 -3.294 . . . . 10.0 102.107 167.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 136.17 23.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -104.17 31.49 4.55 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.79 -50.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.505 1.048 . . . . 10.0 111.705 169.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -67.54 148.27 51.69 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.831 0.741 . . . . 10.0 110.453 -170.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.09 47.4 0.77 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.848 1.259 . . . . 10.0 109.734 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 62.41 10.78 4.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.363 1.865 . . . . 10.0 113.977 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.248 1.019 0 C-N-CA 124.111 0.964 . . . . 10.0 108.576 174.285 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 119.471 -0.299 . . . . 10.0 110.842 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 pt -60.17 159.15 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.832 0.825 . . . . 10.0 111.312 174.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 159.32 27.25 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.247 2.219 . . . . 10.0 106.574 168.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -111.66 133.96 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.196 -2.15 . . . . 10.0 105.196 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.91 149.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -167.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.33 137.92 16.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 109.31 173.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -169.79 150.55 3.89 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 125.18 1.392 . . . . 10.0 107.603 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.27 -26.63 43.99 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.747 2.298 . . . . 10.0 113.194 166.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -63.83 -39.67 94.79 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.636 0.774 . . . . 10.0 112.226 -175.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.45 33.8 17.94 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.302 0.953 . . . . 10.0 114.001 -175.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -60.57 105.67 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.411 1.084 . . . . 10.0 111.08 -168.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.48 108.45 4.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.024 -0.732 . . . . 10.0 109.024 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.09 -10.63 38.29 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 -174.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.96 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.14 2.576 . . . . 10.0 114.582 -171.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -164.6 162.98 21.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.995 1.318 . . . . 10.0 110.314 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -157.75 176.97 11.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.527 1.531 . . . . 10.0 108.63 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.34 135.93 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 174.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -152.56 131.47 12.52 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.494 -1.298 . . . . 10.0 107.494 -174.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.0 t0 44.49 47.72 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.494 1.918 . . . . 10.0 113.021 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.29 75.85 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.797 0.713 . . . . 10.0 113.625 175.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.8 m -124.67 135.82 53.38 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.14 153.18 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 175.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.96 140.49 40.26 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.465 -1.68 . . . . 10.0 106.465 -172.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.08 157.23 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 119.379 0.991 . . . . 10.0 112.217 -167.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -57.1 154.27 10.23 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.781 1.633 . . . . 10.0 112.373 170.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -138.75 -55.82 0.62 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 117.516 -1.23 . . . . 10.0 109.914 165.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -159.82 153.36 22.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.519 1.509 . . . . 10.0 111.613 173.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -145.26 160.67 41.13 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.413 1.085 . . . . 10.0 108.615 161.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -152.51 162.48 41.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.701 1.6 . . . . 10.0 108.591 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -95.85 123.59 39.5 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -96.5 90.9 5.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.835 0.854 . . . . 10.0 108.718 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.71 -15.4 7.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.756 1.222 . . . . 10.0 113.416 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.78 -26.14 68.5 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.381 0.991 . . . . 10.0 111.576 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -129.95 -10.82 4.32 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.371 1.068 . . . . 10.0 112.114 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.7 46.36 18.68 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.794 -0.923 . . . . 10.0 110.794 175.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.96 164.78 31.85 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.953 0.901 . . . . 10.0 110.201 177.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -81.39 153.17 27.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.81 151.44 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 127.161 2.184 . . . . 10.0 105.194 176.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.93 173.22 39.95 Favored Glycine 0 C--N 1.334 0.418 0 O-C-N 120.904 -1.122 . . . . 10.0 113.973 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 54.1 mt -124.85 113.51 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 101.618 -3.475 . . . . 10.0 101.618 178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.81 139.43 32.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.792 -1.188 . . . . 10.0 107.792 -158.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -108.99 30.75 6.26 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 173.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.67 -45.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.174 0.897 . . . . 10.0 112.1 171.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -65.99 154.05 40.48 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.985 0.811 . . . . 10.0 111.164 -169.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.47 31.59 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 10.0 110.103 -166.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 67.4 -23.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 127.983 2.513 . . . . 10.0 114.403 -175.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm . . . . . 0 C--O 1.251 1.17 0 C-N-CA 124.253 1.021 . . . . 10.0 110.187 178.708 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 121.933 0.873 . . . . 10.0 112.219 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -127.92 162.79 25.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.831 2.452 . . . . 10.0 106.994 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.9 mt -117.06 134.32 54.9 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.446 -2.057 . . . . 10.0 105.446 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -139.78 147.2 24.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -164.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -145.3 126.11 14.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.193 1.397 . . . . 10.0 107.253 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -168.12 153.3 6.57 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.601 1.16 . . . . 10.0 110.377 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.24 -24.72 27.16 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.395 2.063 . . . . 10.0 113.292 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -76.28 -19.26 58.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.99 30.53 23.11 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.565 1.079 . . . . 10.0 114.668 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -52.75 105.71 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 10.0 111.887 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -74.53 105.52 5.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.833 0.853 . . . . 10.0 109.123 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.6 -10.26 56.12 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.862 1.06 . . . . 10.0 113.862 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.06 -72.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.277 2.631 . . . . 10.0 114.884 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.6 p -165.48 161.96 19.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.174 1.39 . . . . 10.0 110.32 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -158.99 175.3 13.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.233 1.413 . . . . 10.0 109.092 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.67 130.76 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 105.685 -1.968 . . . . 10.0 105.685 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -152.2 137.87 17.86 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.03 -1.47 . . . . 10.0 107.03 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.68 50.13 10.88 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.193 1.797 . . . . 10.0 112.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.79 23.24 63.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.104 0.859 . . . . 10.0 113.382 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -130.7 145.07 51.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.672 -1.603 . . . . 10.0 106.672 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.26 151.0 19.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.801 -0.814 . . . . 10.0 108.801 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -138.2 139.24 39.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 tt -155.11 158.18 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.371 1.068 . . . . 10.0 112.015 -168.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.19 156.94 3.76 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.328 1.851 . . . . 10.0 112.545 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -140.45 -61.52 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.533 -1.222 . . . . 10.0 109.569 168.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -154.23 147.28 24.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.045 1.293 . . . . 10.0 111.21 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.28 160.89 41.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.256 -0.903 . . . . 10.0 110.088 162.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.95 162.64 41.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.54 1.536 . . . . 10.0 108.819 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -94.01 123.16 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -93.62 82.1 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.412 -0.959 . . . . 10.0 108.412 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -54.35 -25.67 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.808 1.243 . . . . 10.0 113.452 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m -63.93 -20.17 65.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.436 1.094 . . . . 10.0 112.847 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -126.81 -16.56 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.143 1.377 . . . . 10.0 111.558 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.68 40.11 38.7 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.507 -0.637 . . . . 10.0 111.507 174.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.92 166.85 23.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.759 0.779 . . . . 10.0 110.097 172.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -80.28 152.19 29.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.671 -0.862 . . . . 10.0 108.671 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.2 t -137.56 151.4 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.507 -2.035 . . . . 10.0 105.507 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 170.24 38.48 Favored Glycine 0 N--CA 1.45 -0.369 0 O-C-N 121.353 -0.842 . . . . 10.0 113.246 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -116.84 122.0 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 101.653 -3.462 . . . . 10.0 101.653 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.48 44.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 -164.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -127.09 36.78 4.38 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.13 -45.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.722 0.692 . . . . 10.0 111.512 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.1 t90 . . . . . 0 CA--C 1.532 0.257 0 CA-C-N 118.847 0.748 . . . . 10.0 109.309 -174.564 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 122.054 0.93 . . . . 10.0 111.42 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -128.17 161.47 29.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.108 2.563 . . . . 10.0 106.176 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -108.31 130.95 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.456 -2.053 . . . . 10.0 105.456 172.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.16 142.92 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -162.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.56 140.88 16.62 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.818 0.847 . . . . 10.0 109.833 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.49 153.74 5.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.211 1.404 . . . . 10.0 108.497 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.42 -27.44 28.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.207 1.938 . . . . 10.0 112.786 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -69.29 -30.4 68.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.825 0.676 . . . . 10.0 112.825 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.84 46.83 93.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.377 -0.689 . . . . 10.0 111.377 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -73.29 70.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.065 1.346 . . . . 10.0 111.152 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -52.61 121.28 6.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.737 1.215 . . . . 10.0 109.77 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -9.12 18.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.621 0.971 . . . . 10.0 113.621 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.34 -65.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.348 2.659 . . . . 10.0 114.986 -170.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 p -165.26 163.19 20.14 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.81 1.244 . . . . 10.0 110.723 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.23 174.06 15.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 10.0 108.607 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.32 133.68 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.726 -1.953 . . . . 10.0 105.726 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 tt -144.68 121.3 11.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.89 42.14 15.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.892 1.677 . . . . 10.0 112.664 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.53 0.79 74.26 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.216 0.912 . . . . 10.0 114.017 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.5 m -96.99 137.78 35.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -88.73 150.83 22.78 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -137.32 140.33 41.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.111 1.764 . . . . 10.0 106.277 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.1 158.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.519 1.128 . . . . 10.0 112.003 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.92 157.01 8.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.966 1.706 . . . . 10.0 112.495 171.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.67 -61.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.531 -1.223 . . . . 10.0 109.397 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 m -150.78 149.8 30.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.681 1.128 . . . . 10.0 111.025 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.65 156.73 44.25 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.908 0.883 . . . . 10.0 109.539 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.61 160.71 40.68 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.219 1.407 . . . . 10.0 108.725 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.51 120.08 34.2 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.12 81.81 6.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.333 -0.988 . . . . 10.0 108.333 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -53.23 -27.14 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.745 1.218 . . . . 10.0 113.342 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -64.23 -20.01 65.75 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.408 1.083 . . . . 10.0 112.952 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.0 -12.51 6.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.675 1.19 . . . . 10.0 111.911 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 41.96 32.84 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.748 0.69 . . . . 10.0 111.814 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 164.53 33.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.854 0.827 . . . . 10.0 110.574 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -78.57 150.03 32.88 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.17 153.78 24.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.585 -2.005 . . . . 10.0 105.585 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.71 162.92 34.92 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.283 -0.886 . . . . 10.0 113.088 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.6 mm -101.12 119.27 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.725 -3.435 . . . . 10.0 101.725 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.53 29.76 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -162.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.44 34.78 3.92 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.71 -1.219 . . . . 10.0 107.71 170.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.49 -56.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.317 0.962 . . . . 10.0 111.388 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.9 t90 . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 118.675 0.67 . . . . 10.0 111.128 -165.219 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.4 pt . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 122.103 0.954 . . . . 10.0 111.504 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -111.82 162.53 15.17 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.653 2.381 . . . . 10.0 106.259 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -123.43 135.2 53.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.117 -2.179 . . . . 10.0 105.117 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.64 148.84 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -165.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -139.48 127.46 22.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 170.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -161.12 151.66 14.99 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 119.47 1.032 . . . . 10.0 108.933 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.72 -27.7 26.36 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.958 1.772 . . . . 10.0 113.084 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -78.23 -25.09 46.78 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.473 0.916 . . . . 10.0 113.473 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.24 32.15 35.86 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.351 -1.249 . . . . 10.0 114.769 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -54.5 115.45 2.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.937 1.368 . . . . 10.0 111.434 -171.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -78.24 115.29 17.86 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.27 -11.58 23.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.77 -67.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.157 2.583 . . . . 10.0 114.608 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -165.47 162.88 19.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.852 1.261 . . . . 10.0 110.544 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -158.71 176.3 12.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.479 1.511 . . . . 10.0 108.751 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.31 130.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.782 -1.932 . . . . 10.0 105.782 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.18 138.12 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t0 45.94 51.21 10.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.152 1.781 . . . . 10.0 112.577 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.2 63.52 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.104 0.859 . . . . 10.0 113.487 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -132.98 143.37 49.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -90.71 150.63 21.56 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -137.07 140.27 41.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.14 156.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.46 1.104 . . . . 10.0 112.025 -167.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -57.85 154.77 11.5 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.266 1.826 . . . . 10.0 112.395 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -137.1 -61.6 0.65 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.449 -1.263 . . . . 10.0 109.277 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -161.37 154.88 21.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.706 1.593 . . . . 10.0 111.602 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -146.78 160.55 42.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.101 0.961 . . . . 10.0 109.378 166.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.16 158.26 43.74 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.318 1.447 . . . . 10.0 108.701 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -90.54 120.36 31.57 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -87.64 76.6 8.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -51.8 -28.3 15.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.031 1.332 . . . . 10.0 113.287 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -64.78 -17.38 64.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.668 1.187 . . . . 10.0 113.19 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -131.11 -15.63 3.29 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.457 1.103 . . . . 10.0 112.293 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 39.05 8.29 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.945 0.793 . . . . 10.0 112.515 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -148.54 163.64 36.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.042 0.921 . . . . 10.0 109.417 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -77.5 154.53 32.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.06 150.35 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.4 38.27 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.585 -0.817 . . . . 10.0 113.953 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.0 mt -114.5 118.66 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 101.636 -3.468 . . . . 10.0 101.636 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.3 134.54 20.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.969 -1.123 . . . . 10.0 107.969 -162.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -106.78 36.03 2.79 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.29 -46.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.43 1.014 . . . . 10.0 111.765 168.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 118.722 0.692 . . . . 10.0 109.879 -175.546 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 122.575 1.179 . . . . 10.0 112.386 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -120.51 165.33 15.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.751 2.82 . . . . 10.0 106.056 166.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.3 mt -127.18 137.92 53.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.51 148.12 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -168.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -144.21 115.34 7.92 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -153.69 149.59 21.41 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.698 0.799 . . . . 10.0 109.259 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.66 -26.99 32.74 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.982 1.788 . . . . 10.0 113.02 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -81.73 -19.13 42.07 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.04 45.85 26.49 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 119.204 0.911 . . . . 10.0 112.945 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -65.26 81.39 0.05 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.769 1.228 . . . . 10.0 112.195 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -57.95 121.49 10.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.294 1.438 . . . . 10.0 109.794 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.37 -10.19 19.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -173.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.25 -64.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.396 2.678 . . . . 10.0 115.012 -168.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -166.42 163.73 17.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.828 1.251 . . . . 10.0 110.818 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -158.49 178.09 10.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.84 1.656 . . . . 10.0 108.386 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.03 137.71 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 106.779 -1.563 . . . . 10.0 106.779 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 tp -149.33 127.18 11.81 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 44.87 46.35 8.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.08 1.752 . . . . 10.0 113.153 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.18 14.06 82.21 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.297 -0.724 . . . . 10.0 113.83 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.7 m -118.75 131.09 56.11 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -86.38 151.82 23.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.6 140.17 42.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.31 157.81 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 125.043 1.337 . . . . 10.0 111.695 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.61 155.32 4.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.225 1.81 . . . . 10.0 112.584 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -136.62 -64.89 0.57 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.444 -1.265 . . . . 10.0 109.083 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.0 m -152.38 151.01 30.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.376 1.444 . . . . 10.0 111.222 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -145.56 154.9 42.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.788 0.835 . . . . 10.0 109.66 169.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.0 156.81 38.09 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.77 1.228 . . . . 10.0 108.836 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -90.27 120.42 31.4 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -88.59 77.02 8.06 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.06 -28.79 18.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.86 1.264 . . . . 10.0 113.107 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -66.05 -17.6 64.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.475 1.11 . . . . 10.0 112.983 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -126.79 -17.35 4.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.339 1.056 . . . . 10.0 111.83 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.79 9.27 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.743 0.701 . . . . 10.0 112.349 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -148.65 163.46 37.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.282 1.041 . . . . 10.0 109.987 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -75.7 154.36 36.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.11 153.33 26.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.76 161.31 33.16 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.687 -0.633 . . . . 10.0 112.921 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.5 mt -103.67 124.25 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 101.778 -3.416 . . . . 10.0 101.778 166.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 131.6 18.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.468 -0.938 . . . . 10.0 108.468 -163.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -103.54 37.13 2.09 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -153.69 -49.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 119.283 0.947 . . . . 10.0 111.874 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 . . . . . 0 CA--C 1.535 0.376 0 CA-C-N 118.82 0.736 . . . . 10.0 110.203 -170.89 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.527 0.679 . . . . 10.0 111.227 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -113.34 161.75 16.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.575 1.95 . . . . 10.0 106.761 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.96 137.19 52.28 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.464 -2.051 . . . . 10.0 105.464 169.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.89 147.63 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -141.47 126.23 18.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.481 1.512 . . . . 10.0 106.946 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -166.9 146.6 4.75 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.43 -16.43 47.61 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.973 1.782 . . . . 10.0 112.367 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -63.82 -41.16 97.92 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.647 0.658 . . . . 10.0 111.598 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.9 28.06 15.6 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.762 1.172 . . . . 10.0 114.629 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.07 105.33 1.03 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.525 1.163 . . . . 10.0 110.64 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -66.31 108.32 2.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.19 -12.0 42.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.423 0.897 . . . . 10.0 113.423 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.5 -70.06 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.165 2.586 . . . . 10.0 114.2 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 163.29 19.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.028 1.331 . . . . 10.0 110.37 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -157.72 174.06 15.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.215 1.406 . . . . 10.0 109.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -135.25 129.64 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.94 -1.874 . . . . 10.0 105.94 173.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.95 131.48 14.81 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.551 -1.648 . . . . 10.0 106.551 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.18 51.52 9.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.764 2.026 . . . . 10.0 112.743 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.77 21.96 63.72 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.528 -0.76 . . . . 10.0 113.378 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -127.7 142.82 51.22 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -91.72 151.93 20.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -138.9 140.33 38.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.122 -1.807 . . . . 10.0 106.122 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.23 158.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.742 1.156 . . . . 10.0 112.438 -166.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -57.23 155.29 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.029 1.732 . . . . 10.0 112.386 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -138.77 -62.51 0.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 117.358 -1.306 . . . . 10.0 109.106 167.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 m -154.46 149.15 26.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.201 1.364 . . . . 10.0 111.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -146.42 160.89 41.48 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.329 -0.857 . . . . 10.0 110.0 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.07 164.15 38.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.639 1.576 . . . . 10.0 108.716 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -96.34 121.82 38.55 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -90.88 87.1 6.5 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.09 -16.75 5.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.696 1.199 . . . . 10.0 113.362 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -25.86 68.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.182 0.901 . . . . 10.0 111.838 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -134.64 -11.7 2.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.181 0.992 . . . . 10.0 112.558 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.85 43.06 9.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 118.901 0.773 . . . . 10.0 111.952 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -146.02 163.03 36.51 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.657 0.783 . . . . 10.0 109.524 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -75.98 153.28 36.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 171.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -136.96 151.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.377 -2.083 . . . . 10.0 105.377 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 169.5 38.9 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.621 -0.799 . . . . 10.0 113.856 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.78 120.36 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 101.254 -3.61 . . . . 10.0 101.254 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.31 149.79 36.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -165.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.3 31.03 6.81 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.67 -47.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.767 0.827 . . . . 10.0 111.556 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.1 t90 . . . . . 0 CA--C 1.532 0.278 0 CA-C-N 118.751 0.705 . . . . 10.0 110.464 -171.737 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 121.907 0.861 . . . . 10.0 111.425 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -109.32 165.02 11.94 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.893 2.077 . . . . 10.0 106.819 165.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.27 138.8 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.261 -2.126 . . . . 10.0 105.261 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.58 151.12 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -168.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.03 122.14 7.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.462 1.105 . . . . 10.0 108.264 171.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -154.25 151.61 24.63 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.791 1.236 . . . . 10.0 108.363 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.74 -25.07 40.18 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.894 1.729 . . . . 10.0 113.153 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -88.05 -15.87 35.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -172.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.47 36.1 37.77 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.203 -1.331 . . . . 10.0 113.954 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -53.16 98.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.128 1.371 . . . . 10.0 112.235 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.76 117.44 17.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.205 1.002 . . . . 10.0 108.927 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.35 -11.67 25.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.27 -64.78 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.162 2.585 . . . . 10.0 114.642 -167.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -166.59 162.99 16.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.836 1.254 . . . . 10.0 110.724 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -159.73 178.65 9.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 10.0 108.816 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -135.67 129.82 49.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -151.95 139.97 20.14 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t0 47.05 50.18 14.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.682 1.593 . . . . 10.0 112.434 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.25 64.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.14 0.876 . . . . 10.0 113.517 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -134.79 144.22 47.53 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 -173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -88.25 149.75 23.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -135.34 141.74 45.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.325 -1.732 . . . . 10.0 106.325 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 tt -152.25 156.92 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.213 . . . . 10.0 111.847 -168.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -58.0 153.7 13.93 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.577 1.551 . . . . 10.0 111.998 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -131.82 -70.18 0.58 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.345 -1.312 . . . . 10.0 108.318 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.2 m -153.47 149.46 27.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.312 1.414 . . . . 10.0 111.289 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -143.15 157.89 44.11 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.498 -0.751 . . . . 10.0 109.512 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -149.13 154.35 39.08 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.445 1.498 . . . . 10.0 108.352 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -88.82 119.85 29.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -85.07 82.24 8.52 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -55.83 -29.68 60.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.984 0.914 . . . . 10.0 112.269 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -25.39 68.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.867 1.267 . . . . 10.0 112.644 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -120.31 -18.07 8.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.851 0.86 . . . . 10.0 111.932 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.81 29.9 12.43 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.411 1.005 . . . . 10.0 113.003 168.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -153.53 163.74 39.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.882 1.341 . . . . 10.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -74.3 152.77 39.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -139.21 152.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.477 -2.046 . . . . 10.0 105.477 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.88 167.41 39.15 Favored Glycine 0 C--N 1.332 0.33 0 O-C-N 121.274 -0.891 . . . . 10.0 114.082 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -109.41 125.32 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 102.353 -3.202 . . . . 10.0 102.353 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.31 130.84 16.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -165.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -99.85 32.15 3.0 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 -48.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.69 1.132 . . . . 10.0 112.363 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t90 . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 118.644 0.657 . . . . 10.0 110.569 -174.1 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 122.105 0.955 . . . . 10.0 112.643 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.33 163.31 31.31 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.762 2.425 . . . . 10.0 106.512 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.89 135.43 54.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.809 -1.923 . . . . 10.0 105.809 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.07 145.4 27.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -144.74 119.19 9.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.16 -1.792 . . . . 10.0 106.16 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -168.11 153.16 6.52 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 125.292 1.437 . . . . 10.0 110.064 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.2 -27.08 17.1 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.466 2.111 . . . . 10.0 113.246 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -68.29 -29.99 68.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.954 0.797 . . . . 10.0 112.645 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.28 31.85 13.2 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.26 -1.3 . . . . 10.0 114.963 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 107.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.791 1.295 . . . . 10.0 111.546 -168.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.48 116.3 6.62 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.0 -8.49 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.413 0.894 . . . . 10.0 113.413 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.7 -69.26 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.313 2.645 . . . . 10.0 114.517 -171.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -164.86 162.54 20.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.867 1.267 . . . . 10.0 110.878 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -159.29 177.96 10.47 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.659 1.583 . . . . 10.0 109.061 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.14 129.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 105.943 -1.873 . . . . 10.0 105.943 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -154.97 142.97 20.12 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.362 1.465 . . . . 10.0 107.09 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.59 47.49 14.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.656 1.582 . . . . 10.0 112.644 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.45 23.72 62.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.238 0.923 . . . . 10.0 113.573 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.4 m -134.45 147.44 50.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.95 150.95 21.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -135.78 140.05 44.0 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 105.985 -1.857 . . . . 10.0 105.985 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -154.9 157.13 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.603 1.161 . . . . 10.0 111.384 -167.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -59.57 155.99 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.752 1.621 . . . . 10.0 112.19 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -136.83 -67.92 0.49 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.416 -1.278 . . . . 10.0 109.271 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.6 m -151.16 144.62 24.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.463 1.483 . . . . 10.0 111.259 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -148.75 151.48 34.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.915 0.886 . . . . 10.0 109.294 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.9 158.7 42.52 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.809 1.244 . . . . 10.0 108.997 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -91.18 119.3 31.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -88.33 81.43 7.27 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -53.85 -26.44 24.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.967 1.307 . . . . 10.0 113.437 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.2 m -63.0 -21.19 65.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.346 1.059 . . . . 10.0 112.901 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.64 -12.57 6.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.704 1.201 . . . . 10.0 111.916 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 42.33 28.31 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.78 166.45 26.61 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.624 0.77 . . . . 10.0 109.996 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -81.27 152.28 27.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.904 -0.776 . . . . 10.0 108.904 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -137.3 150.69 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.332 -2.099 . . . . 10.0 105.332 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.81 166.37 38.03 Favored Glycine 0 C--N 1.333 0.365 0 O-C-N 121.426 -0.796 . . . . 10.0 113.486 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -108.32 120.69 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 101.677 -3.453 . . . . 10.0 101.677 168.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.64 155.53 46.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -167.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -128.37 36.41 4.28 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 106.653 -1.61 . . . . 10.0 106.653 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.97 -45.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.63 1.105 . . . . 10.0 112.01 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.2 t90 . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 119.191 0.905 . . . . 10.0 109.533 -175.535 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.0 pt . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.831 0.824 . . . . 10.0 111.292 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.11 159.31 21.91 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.007 2.123 . . . . 10.0 106.36 166.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.85 128.12 56.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.672 -2.344 . . . . 10.0 104.672 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -139.21 147.73 24.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.23 -1.026 . . . . 10.0 108.23 -161.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -149.34 148.4 29.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.21 1.004 . . . . 10.0 108.524 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m 179.14 155.43 0.61 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 127.562 2.345 . . . . 10.0 108.17 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.41 -24.26 31.48 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.312 2.008 . . . . 10.0 113.254 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -68.08 -28.78 67.65 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.401 -0.809 . . . . 10.0 113.019 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.25 41.59 8.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.44 1.019 . . . . 10.0 114.348 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.23 91.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.159 1.384 . . . . 10.0 110.974 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.39 112.33 2.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.802 0.841 . . . . 10.0 108.892 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.65 -12.16 24.25 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.269 0.841 . . . . 10.0 113.269 -174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.07 -63.81 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.389 2.676 . . . . 10.0 114.567 -169.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -165.18 162.75 20.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.814 1.246 . . . . 10.0 110.569 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -158.01 177.5 11.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.687 1.595 . . . . 10.0 108.495 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 135.84 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.784 -1.561 . . . . 10.0 106.784 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.0 131.2 12.75 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 44.13 47.84 7.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.861 . . . . 10.0 113.086 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.34 18.14 76.6 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.352 -0.693 . . . . 10.0 113.707 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -125.18 136.17 53.32 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.36 152.97 21.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -137.55 140.43 41.04 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.337 -1.727 . . . . 10.0 106.337 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -154.68 159.31 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 119.591 1.087 . . . . 10.0 112.169 -167.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.03 156.4 9.42 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.69 1.596 . . . . 10.0 112.276 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -139.67 -63.26 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 117.265 -1.35 . . . . 10.0 109.445 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.9 m -151.7 149.52 29.18 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.092 1.314 . . . . 10.0 111.198 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -147.16 156.28 42.84 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.748 0.819 . . . . 10.0 109.719 168.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -155.13 160.7 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.955 1.302 . . . . 10.0 108.885 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -94.15 120.79 34.91 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.258 -1.386 . . . . 10.0 107.258 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.28 86.3 6.8 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.09 -0.708 . . . . 10.0 109.09 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -55.76 -15.94 3.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.483 1.113 . . . . 10.0 113.433 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -22.08 66.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.236 0.925 . . . . 10.0 112.161 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -139.4 -11.97 1.2 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.144 0.978 . . . . 10.0 112.826 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 45.29 7.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.15 0.886 . . . . 10.0 111.956 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.74 163.2 34.74 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.838 0.819 . . . . 10.0 109.629 172.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -76.49 153.17 35.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.25 153.05 23.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.911 2.084 . . . . 10.0 105.573 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.98 165.29 37.57 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 121.381 -0.825 . . . . 10.0 113.323 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.65 120.47 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 101.202 -3.629 . . . . 10.0 101.202 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.87 139.14 29.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 -164.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -109.36 30.08 6.95 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.64 -44.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.729 1.149 . . . . 10.0 113.041 171.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.7 t90 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 119.819 1.191 . . . . 10.0 109.971 -173.793 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 121.779 0.799 . . . . 10.0 111.771 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.85 166.75 11.15 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.692 1.997 . . . . 10.0 107.092 158.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.97 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.17 146.09 25.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.014 -0.736 . . . . 10.0 109.014 -162.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.68 141.5 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.894 1.278 . . . . 10.0 108.09 169.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -173.03 154.12 2.64 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 126.853 2.061 . . . . 10.0 107.97 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.21 -25.95 30.66 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.227 1.951 . . . . 10.0 113.091 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -69.74 -28.39 65.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.696 -0.669 . . . . 10.0 112.58 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.05 48.23 58.83 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 118.638 0.654 . . . . 10.0 112.012 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -71.44 73.94 0.74 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.739 1.215 . . . . 10.0 111.176 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.21 120.09 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.074 1.35 . . . . 10.0 109.591 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.86 -7.92 21.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.06 -70.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.032 2.533 . . . . 10.0 114.48 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.7 p -159.61 164.82 33.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.512 1.051 . . . . 10.0 110.634 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -157.76 179.48 9.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.322 1.449 . . . . 10.0 108.975 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.71 130.79 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.3 144.03 21.66 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.75 46.85 11.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.52 . . . . 10.0 112.419 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.4 24.5 63.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.189 0.9 . . . . 10.0 113.636 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -133.75 147.43 51.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.066 1.346 . . . . 10.0 107.553 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -83.0 146.38 28.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -133.31 140.25 47.33 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.511 -1.662 . . . . 10.0 106.511 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -154.37 158.32 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.624 1.17 . . . . 10.0 111.874 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.99 156.58 5.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.055 1.742 . . . . 10.0 112.677 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -138.45 -62.2 0.57 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 117.257 -1.354 . . . . 10.0 109.334 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -151.9 150.25 29.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.127 1.33 . . . . 10.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -145.09 157.0 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.598 0.759 . . . . 10.0 109.556 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.08 160.8 41.27 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.941 1.296 . . . . 10.0 108.716 170.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -94.14 116.19 28.57 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.17 87.55 7.39 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -58.36 -15.4 10.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.607 1.163 . . . . 10.0 113.218 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.61 -25.11 67.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.428 1.013 . . . . 10.0 111.625 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.66 -12.63 4.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.626 1.17 . . . . 10.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 42.97 19.68 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.703 0.668 . . . . 10.0 111.506 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.46 163.84 34.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.026 0.913 . . . . 10.0 110.974 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -78.68 150.64 32.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -140.23 152.84 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.805 2.042 . . . . 10.0 105.616 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.39 163.64 36.7 Favored Glycine 0 C--N 1.334 0.427 0 O-C-N 121.242 -0.911 . . . . 10.0 113.485 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.96 123.99 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 101.828 -3.397 . . . . 10.0 101.828 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.27 29.18 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.736 -0.838 . . . . 10.0 108.736 -163.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -115.31 35.72 4.25 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.97 -49.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.892 0.769 . . . . 10.0 112.202 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 . . . . . 0 CA--C 1.536 0.409 0 CA-C-N 119.137 0.881 . . . . 10.0 110.65 -171.353 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.912 0.863 . . . . 10.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -115.73 162.12 17.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.107 2.163 . . . . 10.0 106.585 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.72 136.62 53.24 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.4 -2.074 . . . . 10.0 105.4 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.9 146.89 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 -163.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.79 120.55 9.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.589 -1.634 . . . . 10.0 106.589 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m -158.99 150.99 17.27 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 119.739 1.154 . . . . 10.0 109.327 173.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.2 -27.19 35.36 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.035 1.823 . . . . 10.0 112.98 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -81.15 -17.43 49.84 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.792 1.034 . . . . 10.0 113.792 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.98 34.79 31.37 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.145 -1.364 . . . . 10.0 114.008 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -53.33 99.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.109 1.363 . . . . 10.0 112.408 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.8 117.26 15.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.501 1.12 . . . . 10.0 109.317 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.08 -11.81 27.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.98 -67.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.326 2.65 . . . . 10.0 114.2 -166.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -163.82 162.5 23.75 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.291 1.036 . . . . 10.0 110.366 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -158.55 176.4 12.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.04 1.336 . . . . 10.0 108.885 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -137.1 132.2 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -149.5 135.04 18.48 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.52 50.24 10.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.198 1.799 . . . . 10.0 112.757 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.19 69.17 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.822 0.725 . . . . 10.0 113.547 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -129.15 138.75 51.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.65 -1.611 . . . . 10.0 106.65 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -88.41 151.55 22.5 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.65 140.62 42.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.961 1.705 . . . . 10.0 106.518 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -152.58 155.02 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.153 1.381 . . . . 10.0 111.398 -163.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -57.59 156.02 8.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.565 1.546 . . . . 10.0 112.188 170.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -138.78 -64.99 0.5 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.538 -1.22 . . . . 10.0 109.465 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -152.15 149.75 29.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.203 1.365 . . . . 10.0 111.033 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 23.0 ttpt -149.97 143.61 25.32 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -150.84 154.76 37.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.739 1.216 . . . . 10.0 109.085 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -89.04 122.66 32.6 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.76 90.82 4.82 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.252 1.025 . . . . 10.0 108.88 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -57.4 -13.7 3.83 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.213 1.405 . . . . 10.0 113.399 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -62.71 -25.18 68.04 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.632 1.106 . . . . 10.0 111.876 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -131.59 -9.72 3.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.467 0.707 . . . . 10.0 111.959 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.58 8.69 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.469 -1.052 . . . . 10.0 110.469 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.32 163.17 34.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.317 1.047 . . . . 10.0 109.92 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.524 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 88.3 m95 -81.8 149.12 28.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -136.59 153.17 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.536 -2.024 . . . . 10.0 105.536 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.38 167.37 38.25 Favored Glycine 0 N--CA 1.45 -0.38 0 O-C-N 121.142 -0.974 . . . . 10.0 113.52 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.19 122.87 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 101.307 -3.59 . . . . 10.0 101.307 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.12 134.17 21.5 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -102.98 31.68 4.09 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 p -153.75 -47.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.913 1.233 . . . . 10.0 112.738 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 118.876 0.762 . . . . 10.0 110.696 -169.335 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.231 1.015 . . . . 10.0 112.41 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -116.67 163.56 15.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.372 2.269 . . . . 10.0 106.577 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.65 133.41 52.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.66 149.66 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.897 -0.779 . . . . 10.0 108.897 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -144.43 127.6 16.65 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.519 -2.03 . . . . 10.0 105.519 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -169.66 153.43 5.04 Favored Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 125.372 1.469 . . . . 10.0 109.151 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.78 -24.88 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.335 2.024 . . . . 10.0 113.123 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -81.77 -18.72 43.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.698 0.999 . . . . 10.0 113.698 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.39 37.66 18.95 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.365 -1.242 . . . . 10.0 113.818 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -54.06 99.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.89 1.276 . . . . 10.0 112.094 -170.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.06 116.88 16.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.082 0.953 . . . . 10.0 108.736 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.32 -11.82 27.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.576 0.954 . . . . 10.0 113.576 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.41 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.153 2.581 . . . . 10.0 114.673 -166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 p -167.46 164.49 14.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.826 1.25 . . . . 10.0 110.899 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -158.53 175.98 12.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.843 1.657 . . . . 10.0 108.486 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.7 132.74 48.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.872 -1.899 . . . . 10.0 105.872 171.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.3 tp -146.5 132.37 19.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.2 -1.407 . . . . 10.0 107.2 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.71 49.3 11.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.854 1.662 . . . . 10.0 112.774 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.9 72.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.806 0.717 . . . . 10.0 113.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -127.48 136.4 51.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -86.27 150.65 24.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -136.17 140.8 43.88 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.53 156.62 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 10.0 111.742 -168.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.91 152.82 15.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.515 1.526 . . . . 10.0 111.763 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -130.38 -70.29 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.416 -1.278 . . . . 10.0 108.112 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.51 149.24 27.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.185 1.357 . . . . 10.0 111.0 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.59 155.93 46.43 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.619 -0.676 . . . . 10.0 109.577 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -148.54 153.85 38.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.557 1.543 . . . . 10.0 108.082 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -89.1 118.47 28.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.344 -1.354 . . . . 10.0 107.344 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -83.97 94.13 8.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.4 m -64.73 -25.5 67.96 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.383 0.673 . . . . 10.0 112.725 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -70.03 -41.97 73.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.672 0.669 . . . . 10.0 110.249 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -84.22 -25.88 29.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.412 0.685 . . . . 10.0 111.68 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.79 40.86 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.154 0.883 . . . . 10.0 111.545 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.35 168.24 23.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.551 1.175 . . . . 10.0 111.014 173.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.0 152.48 36.96 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.077 -0.712 . . . . 10.0 109.077 167.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.16 153.67 27.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.752 2.021 . . . . 10.0 105.758 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.08 162.71 35.44 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 121.249 -0.907 . . . . 10.0 113.74 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.06 124.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 102.49 -3.152 . . . . 10.0 102.49 168.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.36 129.47 17.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -167.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -100.08 33.71 2.54 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.169 -1.048 . . . . 10.0 108.169 171.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.56 -48.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.565 1.075 . . . . 10.0 112.048 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t90 . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 118.805 0.73 . . . . 10.0 110.233 -175.678 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 pt . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 122.052 0.929 . . . . 10.0 111.646 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.9 165.14 17.9 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.971 2.508 . . . . 10.0 106.479 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.07 137.47 54.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.812 -1.921 . . . . 10.0 105.812 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.75 150.38 18.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 -168.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.51 14.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.511 1.124 . . . . 10.0 108.812 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.1 m -169.08 155.08 6.28 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.792 2.037 . . . . 10.0 107.943 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.01 -23.77 39.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.975 1.783 . . . . 10.0 112.754 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -71.25 -29.79 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.701 0.682 . . . . 10.0 112.361 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.1 42.23 71.26 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 118.973 -0.904 . . . . 10.0 112.513 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.18 98.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.017 0.927 . . . . 10.0 111.991 -163.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.96 121.53 17.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.455 0.702 . . . . 10.0 109.348 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.45 -8.94 17.79 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.18 -67.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.201 2.601 . . . . 10.0 114.814 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 p -165.04 162.7 20.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.158 1.383 . . . . 10.0 110.616 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -158.6 175.89 13.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.634 1.574 . . . . 10.0 108.602 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.99 132.31 47.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 105.786 -1.931 . . . . 10.0 105.786 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -149.57 134.46 17.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.161 -1.422 . . . . 10.0 107.161 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.33 49.94 10.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.108 1.763 . . . . 10.0 112.736 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.2 69.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.776 0.703 . . . . 10.0 113.508 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.2 m -128.86 140.21 51.8 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -90.34 150.38 21.91 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -136.24 139.12 42.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 tt -154.56 157.48 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.85 1.26 . . . . 10.0 111.975 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.55 154.29 4.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.943 1.697 . . . . 10.0 112.026 168.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -55.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.29 -1.338 . . . . 10.0 110.871 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.7 m -151.82 150.25 29.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.843 1.202 . . . . 10.0 110.794 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 25.6 ttpt -149.47 142.62 25.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -150.38 155.89 40.45 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.781 1.232 . . . . 10.0 109.197 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -93.2 122.2 35.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.465 -1.309 . . . . 10.0 107.465 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -96.81 89.99 5.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.94 -15.66 5.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.921 1.288 . . . . 10.0 113.386 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.48 -26.91 68.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.508 1.049 . . . . 10.0 111.632 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.79 -14.65 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.554 1.142 . . . . 10.0 111.635 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.13 13.24 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.556 -1.018 . . . . 10.0 110.556 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 166.09 26.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.661 0.784 . . . . 10.0 110.384 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 91.4 m95 -81.32 152.65 27.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.2 156.09 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.243 2.217 . . . . 10.0 105.267 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.34 169.35 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 O-C-N 120.905 -1.122 . . . . 10.0 113.386 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.77 113.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 101.442 -3.54 . . . . 10.0 101.442 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 133.35 28.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 -158.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -106.49 35.76 2.85 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.73 -48.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.679 1.127 . . . . 10.0 112.368 167.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 CA--C 1.536 0.427 0 CA-C-N 119.388 0.995 . . . . 10.0 109.299 -174.022 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 122.332 1.063 . . . . 10.0 111.976 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -119.48 160.71 21.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.234 2.214 . . . . 10.0 106.247 162.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.57 132.95 54.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.8 146.52 26.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.081 -1.081 . . . . 10.0 108.081 -161.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -156.5 127.7 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.767 0.827 . . . . 10.0 109.324 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 m -160.89 155.15 19.43 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.074 1.75 . . . . 10.0 107.794 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 -26.46 35.14 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.161 1.907 . . . . 10.0 113.14 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -70.75 -31.84 68.79 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.69 0.677 . . . . 10.0 112.549 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.03 32.4 82.09 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.903 -0.943 . . . . 10.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -53.94 97.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.131 1.772 . . . . 10.0 112.116 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -68.09 122.64 18.68 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.17 -3.87 16.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 50.6 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.143 2.577 . . . . 10.0 115.001 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -163.09 162.02 25.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.229 1.411 . . . . 10.0 110.441 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.86 177.63 10.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.401 1.481 . . . . 10.0 109.075 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.36 129.37 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.025 -1.842 . . . . 10.0 106.025 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.02 144.01 19.73 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.29 47.27 13.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.436 1.494 . . . . 10.0 112.511 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.65 23.68 63.28 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.181 0.896 . . . . 10.0 113.566 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -135.2 148.53 49.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.288 1.435 . . . . 10.0 107.274 -172.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -92.39 150.17 20.97 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -135.63 140.07 44.27 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.271 -1.752 . . . . 10.0 106.271 -170.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -155.19 157.18 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.433 1.093 . . . . 10.0 111.869 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -58.73 156.39 11.13 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.133 1.773 . . . . 10.0 112.48 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -137.0 -65.24 0.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 117.316 -1.326 . . . . 10.0 109.104 167.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -150.96 149.94 30.21 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.966 1.257 . . . . 10.0 111.711 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 20.9 ptmt -144.62 152.12 40.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.677 1.191 . . . . 10.0 108.601 168.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.86 156.86 41.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.242 1.417 . . . . 10.0 108.715 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.86 119.97 33.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.256 -1.386 . . . . 10.0 107.256 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -90.18 88.21 7.16 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.22 -17.1 6.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.825 1.25 . . . . 10.0 113.349 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -25.92 68.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.278 0.944 . . . . 10.0 111.616 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -130.5 -12.37 3.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.653 1.181 . . . . 10.0 112.099 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.94 45.94 15.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.45 164.42 34.22 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.007 0.923 . . . . 10.0 110.297 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 84.9 m95 -82.21 150.24 27.47 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.19 154.04 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 105.289 -2.115 . . . . 10.0 105.289 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.49 172.43 42.39 Favored Glycine 0 N--CA 1.451 -0.348 0 O-C-N 120.977 -1.077 . . . . 10.0 113.528 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.5 mt -117.89 119.56 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 101.679 -3.452 . . . . 10.0 101.679 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 134.9 22.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -162.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -108.51 37.06 2.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.01 -45.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.162 0.892 . . . . 10.0 111.699 168.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 t90 . . . . . 0 CA--C 1.536 0.414 0 CA-C-N 118.813 0.733 . . . . 10.0 110.628 -171.4 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.943 0.878 . . . . 10.0 111.394 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -137.34 162.4 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.515 2.326 . . . . 10.0 106.277 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -120.8 137.19 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.302 -1.74 . . . . 10.0 106.302 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.31 148.51 22.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -141.87 125.86 17.24 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -163.45 145.35 7.61 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 119.113 0.87 . . . . 10.0 108.809 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.58 -20.77 46.86 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.168 1.912 . . . . 10.0 112.317 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.0 -34.24 71.16 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.475 1.034 . . . . 10.0 111.542 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.1 27.98 71.39 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.787 -1.007 . . . . 10.0 114.519 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -52.27 108.82 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.697 1.599 . . . . 10.0 112.147 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.61 109.16 6.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 168.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.61 -2.31 51.63 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 49.32 -70.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.01 2.924 . . . . 10.0 115.983 -171.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -168.27 159.91 11.11 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.135 1.374 . . . . 10.0 110.211 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -159.32 176.08 12.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.543 1.137 . . . . 10.0 109.33 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.25 133.93 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.69 124.48 10.54 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -174.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t0 44.74 41.57 5.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.736 2.014 . . . . 10.0 112.833 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.7 48.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.425 1.012 . . . . 10.0 114.005 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -83.1 146.32 28.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 171.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -104.09 145.43 30.18 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.352 1.061 . . . . 10.0 108.466 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -136.31 144.49 44.73 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.384 1.074 . . . . 10.0 108.313 -168.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -160.23 159.78 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.857 1.263 . . . . 10.0 112.585 -168.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -58.07 157.44 8.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.009 1.724 . . . . 10.0 112.809 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -141.7 -63.13 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.271 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -151.13 144.66 24.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.911 1.232 . . . . 10.0 111.152 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -151.07 141.5 22.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -149.72 161.33 42.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.11 1.364 . . . . 10.0 109.628 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -92.9 123.48 36.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -92.67 78.05 4.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -52.65 -28.56 22.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.97 1.308 . . . . 10.0 113.323 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -63.41 -21.65 66.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.452 1.101 . . . . 10.0 112.93 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -125.14 -15.77 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.848 1.259 . . . . 10.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.82 37.84 21.6 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.762 0.71 . . . . 10.0 112.43 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.41 163.14 38.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.037 0.935 . . . . 10.0 109.299 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -76.12 153.65 36.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.02 150.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.657 1.983 . . . . 10.0 105.691 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.64 166.53 34.93 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 121.547 -0.721 . . . . 10.0 113.265 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.55 116.6 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 101.268 -3.605 . . . . 10.0 101.268 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.58 136.66 31.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 -163.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -103.81 30.72 4.91 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.457 -0.942 . . . . 10.0 108.457 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.99 -54.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-N 119.087 0.858 . . . . 10.0 111.108 167.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.4 t90 . . . . . 0 C--N 1.342 0.239 0 CA-C-N 118.59 0.632 . . . . 10.0 111.08 -165.391 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.97 0.89 . . . . 10.0 111.523 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -128.34 166.01 19.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.826 2.45 . . . . 10.0 106.566 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -122.32 138.66 54.44 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -140.68 147.96 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.083 -1.08 . . . . 10.0 108.083 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.53 116.39 9.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.42 1.488 . . . . 10.0 107.166 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -154.7 150.31 21.44 Favored Pre-proline 0 N--CA 1.466 0.341 0 C-N-CA 123.768 0.827 . . . . 10.0 110.032 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.8 -28.41 25.08 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.905 1.736 . . . . 10.0 112.796 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -71.86 -29.43 64.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.67 29.82 26.3 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.503 -1.165 . . . . 10.0 115.395 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -61.05 107.19 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.681 1.241 . . . . 10.0 111.392 -172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -65.39 118.02 8.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.774 0.83 . . . . 10.0 109.143 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.28 -8.62 26.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.871 1.063 . . . . 10.0 113.871 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.5 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.976 2.51 . . . . 10.0 114.695 -170.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 p -162.24 165.55 26.65 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.692 1.197 . . . . 10.0 111.022 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -157.22 174.36 15.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.861 1.664 . . . . 10.0 108.585 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.12 133.47 47.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.787 -1.931 . . . . 10.0 105.787 172.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -143.93 121.2 11.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.079 -1.822 . . . . 10.0 106.079 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.6 t0 47.62 43.33 16.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.839 1.656 . . . . 10.0 112.721 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 4.68 78.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.105 0.859 . . . . 10.0 113.968 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 m -102.25 136.88 41.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -87.5 150.72 23.56 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -136.81 139.82 42.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.403 1.881 . . . . 10.0 106.098 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -153.32 156.84 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.645 1.178 . . . . 10.0 111.852 -168.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.78 155.08 13.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.032 1.733 . . . . 10.0 112.19 171.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -137.44 -61.39 0.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.261 -1.352 . . . . 10.0 110.597 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.5 m -152.55 149.94 29.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.505 1.502 . . . . 10.0 111.136 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -150.01 152.48 34.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.391 1.076 . . . . 10.0 109.295 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.93 157.32 40.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.795 1.238 . . . . 10.0 109.143 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -89.5 120.27 30.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -88.57 77.37 8.01 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.34 -29.21 22.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.894 1.278 . . . . 10.0 113.164 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -65.01 -19.34 65.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.476 1.11 . . . . 10.0 112.933 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.4 -17.56 5.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.602 1.161 . . . . 10.0 111.97 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.07 36.75 10.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.727 0.694 . . . . 10.0 112.48 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.2 163.26 38.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.219 1.009 . . . . 10.0 109.618 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -75.8 154.61 36.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.43 0.633 . . . . 10.0 109.71 170.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.9 t -138.03 154.29 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.559 -2.015 . . . . 10.0 105.559 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.81 166.42 36.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.259 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.8 mt -112.86 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 101.613 -3.477 . . . . 10.0 101.613 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 140.07 30.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -160.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.62 36.66 3.34 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.79 -44.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.304 0.956 . . . . 10.0 111.676 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.1 t90 . . . . . 0 CA--C 1.536 0.425 0 CA-C-N 118.285 0.493 . . . . 10.0 110.776 -174.377 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 122.368 1.08 . . . . 10.0 111.954 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -126.31 164.02 21.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.748 2.419 . . . . 10.0 105.745 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.7 mt -123.55 137.01 54.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.61 150.83 19.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 -168.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -141.47 134.79 29.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.44 150.46 4.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.787 -0.819 . . . . 10.0 108.787 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.78 -25.24 39.78 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 121.805 1.67 . . . . 10.0 112.408 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -72.41 -32.16 66.12 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.592 0.633 . . . . 10.0 112.547 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.93 35.15 81.84 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.968 -0.907 . . . . 10.0 113.576 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -54.87 102.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.265 1.426 . . . . 10.0 111.96 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.18 116.1 10.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.51 -7.45 28.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.28 -72.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.053 2.541 . . . . 10.0 115.008 -170.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 164.19 19.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 10.0 110.729 -174.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -158.07 174.17 15.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.786 1.635 . . . . 10.0 108.558 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.33 133.77 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.788 -1.93 . . . . 10.0 105.788 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -144.07 120.72 11.14 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.44 43.2 15.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.912 1.685 . . . . 10.0 112.704 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.14 2.9 80.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.124 0.868 . . . . 10.0 114.047 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.5 m -99.95 136.49 39.78 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 173.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -87.71 150.61 23.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -137.15 139.94 41.5 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.188 -1.782 . . . . 10.0 106.188 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.16 156.75 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.825 1.25 . . . . 10.0 111.883 -168.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.84 155.56 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.008 1.723 . . . . 10.0 112.421 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -135.76 -66.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.403 -1.284 . . . . 10.0 109.009 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -150.97 151.33 31.94 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.887 1.221 . . . . 10.0 111.691 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -142.16 150.93 41.71 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.608 1.163 . . . . 10.0 108.649 168.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -151.41 154.85 37.43 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.028 1.331 . . . . 10.0 108.741 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -89.35 121.0 31.19 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.558 -1.275 . . . . 10.0 107.558 174.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.0 85.89 7.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.006 -1.479 . . . . 10.0 107.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -57.64 -27.44 62.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.805 0.842 . . . . 10.0 112.764 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -71.47 -26.35 62.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.558 0.743 . . . . 10.0 111.621 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.5 mmpt? -109.63 -17.64 13.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.857 0.863 . . . . 10.0 112.234 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.43 38.57 20.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.056 0.836 . . . . 10.0 112.331 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.64 164.36 37.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.515 1.157 . . . . 10.0 110.473 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 85.9 m95 -73.46 153.68 40.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 168.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.29 156.08 32.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.942 2.097 . . . . 10.0 105.366 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.87 162.89 33.39 Favored Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.452 -0.78 . . . . 10.0 112.865 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.2 mt -106.94 118.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 101.612 -3.477 . . . . 10.0 101.612 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.38 127.54 16.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -162.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -101.14 37.88 1.67 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.847 -1.168 . . . . 10.0 107.847 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.96 -48.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.407 1.003 . . . . 10.0 111.847 167.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.0 t90 . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 118.771 0.714 . . . . 10.0 110.379 -169.744 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.0 pt . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 122.08 0.943 . . . . 10.0 111.466 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -119.55 165.27 14.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.863 2.465 . . . . 10.0 106.523 163.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.09 135.77 54.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.031 -2.211 . . . . 10.0 105.031 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -138.38 142.89 34.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 -167.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -145.28 101.48 3.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -152.15 149.87 24.24 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 118.828 0.74 . . . . 10.0 109.871 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.06 -27.75 19.98 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.082 1.855 . . . . 10.0 113.366 -173.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -72.09 -25.28 61.69 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.17 35.47 26.8 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.792 -1.004 . . . . 10.0 115.099 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -58.7 98.99 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.114 1.366 . . . . 10.0 111.514 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.32 110.72 4.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.682 0.793 . . . . 10.0 108.862 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.98 -12.19 31.33 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.52 -66.05 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.14 2.576 . . . . 10.0 114.606 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 p -164.52 161.74 21.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.943 1.297 . . . . 10.0 110.745 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.4 177.73 10.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.452 1.501 . . . . 10.0 109.099 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.41 129.82 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 106.042 -1.836 . . . . 10.0 106.042 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.7 tp -155.67 143.72 19.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.11 47.7 12.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.585 1.554 . . . . 10.0 112.512 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.81 63.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.116 0.865 . . . . 10.0 113.612 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -134.94 147.85 49.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.32 1.448 . . . . 10.0 107.19 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -91.1 150.24 21.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.816 -0.809 . . . . 10.0 108.816 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -135.24 140.37 45.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.413 -1.699 . . . . 10.0 106.413 -171.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.5 158.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.424 1.09 . . . . 10.0 112.002 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.04 157.32 8.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.223 1.809 . . . . 10.0 112.458 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -139.17 -61.94 0.55 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 117.608 -1.187 . . . . 10.0 109.529 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 m -152.58 149.3 28.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.889 1.222 . . . . 10.0 111.215 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -148.11 156.07 42.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.872 0.869 . . . . 10.0 109.696 169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -155.5 161.01 41.01 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.033 1.333 . . . . 10.0 108.877 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.87 118.93 31.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.227 -1.397 . . . . 10.0 107.227 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.59 80.34 8.04 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -53.02 -26.71 16.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.944 1.297 . . . . 10.0 113.451 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 m -63.0 -21.2 65.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.453 1.101 . . . . 10.0 112.983 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.57 -12.44 6.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.696 1.198 . . . . 10.0 112.065 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.47 41.8 29.15 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.62 0.645 . . . . 10.0 111.739 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.2 164.91 30.77 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.926 0.863 . . . . 10.0 110.555 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -79.52 149.48 31.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.5 t -135.8 149.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.576 -2.009 . . . . 10.0 105.576 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.44 165.98 36.98 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.58 -0.7 . . . . 10.0 113.204 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.9 mt -110.73 120.21 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 101.489 -3.522 . . . . 10.0 101.489 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.76 139.02 26.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 -162.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -111.88 35.56 3.65 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 170.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.51 -44.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.485 1.039 . . . . 10.0 112.003 168.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 . . . . . 0 CA--C 1.536 0.406 0 CA-C-N 119.293 0.951 . . . . 10.0 110.816 -172.181 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.566 0.698 . . . . 10.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -130.91 161.38 32.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.552 1.941 . . . . 10.0 106.832 167.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.76 134.78 51.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.579 -2.008 . . . . 10.0 105.579 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -140.48 148.25 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 -163.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -152.94 137.66 16.97 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.661 0.785 . . . . 10.0 109.911 171.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 m -161.03 153.04 16.65 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.043 1.337 . . . . 10.0 108.204 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.86 -28.17 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.885 1.723 . . . . 10.0 112.812 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -75.97 -16.56 59.97 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.86 1.059 . . . . 10.0 113.86 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.08 44.51 33.11 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.298 0.954 . . . . 10.0 112.787 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -65.81 78.04 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.848 1.259 . . . . 10.0 112.21 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -55.82 126.57 26.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.134 1.374 . . . . 10.0 109.712 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.57 -4.75 14.67 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.124 1.157 . . . . 10.0 114.124 -170.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.19 -68.4 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.271 2.628 . . . . 10.0 115.492 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.8 p -165.55 162.57 19.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.98 1.312 . . . . 10.0 110.508 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -158.74 174.49 14.95 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.296 1.438 . . . . 10.0 108.712 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.7 132.64 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.797 -1.927 . . . . 10.0 105.797 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.87 127.31 13.16 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.02 42.33 9.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.617 1.967 . . . . 10.0 112.695 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 1.28 57.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.27 0.938 . . . . 10.0 114.119 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -95.19 140.66 29.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.605 -1.628 . . . . 10.0 106.605 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.85 151.15 21.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -137.9 140.23 40.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.276 1.831 . . . . 10.0 106.358 -171.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 tt -153.39 159.83 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 119.617 1.099 . . . . 10.0 112.257 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.23 156.96 9.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.026 1.73 . . . . 10.0 112.371 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -138.17 -64.54 0.53 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 117.519 -1.229 . . . . 10.0 109.498 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -151.92 149.9 29.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.112 1.323 . . . . 10.0 111.112 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -147.56 157.24 43.48 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.789 0.836 . . . . 10.0 110.129 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -155.26 160.18 40.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.453 1.501 . . . . 10.0 108.774 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -92.76 122.05 34.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -89.58 79.48 6.85 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.755 -1.202 . . . . 10.0 107.755 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -52.13 -28.47 18.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.666 1.186 . . . . 10.0 113.235 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m -66.75 -19.98 65.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.353 1.061 . . . . 10.0 112.874 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -124.15 -17.04 6.31 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.635 1.174 . . . . 10.0 112.079 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.79 37.42 16.51 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.917 0.781 . . . . 10.0 112.508 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.46 163.06 37.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.316 1.058 . . . . 10.0 109.729 173.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.92 153.26 36.79 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 t -139.82 154.24 23.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.413 1.885 . . . . 10.0 105.972 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.19 165.17 37.04 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-O 121.998 0.777 . . . . 10.0 112.877 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.92 125.47 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 101.57 -3.492 . . . . 10.0 101.57 169.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.42 153.9 44.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.331 -0.618 . . . . 10.0 109.331 -166.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -124.72 31.47 5.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.827 -1.175 . . . . 10.0 107.827 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.61 -45.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 119.366 0.984 . . . . 10.0 112.156 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.2 t90 . . . . . 0 CA--C 1.534 0.336 0 CA-C-N 118.855 0.752 . . . . 10.0 110.184 -170.925 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt . . . . . 0 CA--C 1.535 0.375 0 CA-C-O 121.559 0.695 . . . . 10.0 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -110.69 162.93 14.25 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.242 1.817 . . . . 10.0 106.56 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.92 136.12 53.46 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.22 -2.141 . . . . 10.0 105.22 168.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.72 144.54 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 -164.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -145.54 106.81 4.18 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.147 1.379 . . . . 10.0 107.467 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -152.64 144.04 16.17 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 119.421 1.009 . . . . 10.0 110.027 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.8 -36.05 89.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.119 2.546 . . . . 10.0 114.6 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -73.83 -25.12 59.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.498 0.925 . . . . 10.0 113.498 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.0 28.8 26.1 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.603 -1.11 . . . . 10.0 115.644 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -52.01 112.44 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.244 1.417 . . . . 10.0 111.772 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -73.0 102.45 3.49 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.691 0.796 . . . . 10.0 108.974 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.12 -13.2 57.58 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.82 1.044 . . . . 10.0 113.82 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.85 -69.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.123 2.569 . . . . 10.0 114.481 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -165.16 164.16 20.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.848 1.259 . . . . 10.0 110.589 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.0 176.68 12.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.729 1.612 . . . . 10.0 108.669 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.75 135.92 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.04 128.79 12.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 45.64 44.25 10.09 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.104 1.762 . . . . 10.0 113.022 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.68 79.61 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.262 -0.744 . . . . 10.0 113.858 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -112.22 135.6 52.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -90.14 152.39 21.14 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.582 -0.896 . . . . 10.0 108.582 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -138.22 140.18 39.61 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 -171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.9 tt -153.89 157.24 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.562 1.074 . . . . 10.0 112.24 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.71 154.91 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.705 1.602 . . . . 10.0 112.223 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -135.28 -66.52 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.314 -1.326 . . . . 10.0 109.092 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 m -151.35 151.31 31.57 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.378 1.445 . . . . 10.0 111.352 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -145.54 153.17 40.82 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 10.0 109.698 170.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -153.63 157.77 40.13 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.296 1.439 . . . . 10.0 108.865 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -91.7 123.97 35.49 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -93.63 86.3 5.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.653 0.74 . . . . 10.0 109.115 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -56.09 -17.1 6.16 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.673 1.189 . . . . 10.0 113.443 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.67 70.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.202 0.91 . . . . 10.0 111.633 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.46 -13.08 3.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.275 1.03 . . . . 10.0 112.308 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.7 43.82 8.16 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.775 0.716 . . . . 10.0 111.759 171.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -145.86 162.78 36.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.773 0.787 . . . . 10.0 109.883 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 80.2 m95 -75.51 152.89 37.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.385 0.612 . . . . 10.0 109.369 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.4 t -135.16 153.19 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 162.04 33.96 Favored Glycine 0 N--CA 1.45 -0.433 0 O-C-N 121.575 -0.703 . . . . 10.0 112.983 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -102.0 121.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 101.641 -3.466 . . . . 10.0 101.641 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 137.18 25.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.336 -0.987 . . . . 10.0 108.336 -165.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -108.69 33.38 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.897 -1.149 . . . . 10.0 107.897 172.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.59 -44.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.341 0.973 . . . . 10.0 112.313 170.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 118.991 0.814 . . . . 10.0 111.492 -168.145 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.673 0.749 . . . . 10.0 110.968 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -122.22 159.21 27.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.316 2.246 . . . . 10.0 106.053 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.94 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.6 -2.0 . . . . 10.0 105.6 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.46 141.95 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -163.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -147.73 102.37 3.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.098 1.359 . . . . 10.0 107.912 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -153.19 150.13 23.17 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.687 0.676 . . . . 10.0 109.683 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.49 -26.58 28.72 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.28 1.987 . . . . 10.0 113.22 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -70.04 -33.18 71.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.756 0.707 . . . . 10.0 112.389 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.9 30.01 74.05 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.766 -1.019 . . . . 10.0 114.076 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -50.46 106.5 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.57 1.548 . . . . 10.0 112.06 -174.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -75.12 102.98 5.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -10.83 58.38 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.602 0.964 . . . . 10.0 113.602 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.05 -70.94 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.165 2.586 . . . . 10.0 114.489 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -163.92 162.78 23.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.969 1.308 . . . . 10.0 110.708 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -158.73 177.5 11.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.528 1.531 . . . . 10.0 109.026 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.16 129.83 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 tp -155.46 143.66 20.1 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.331 1.453 . . . . 10.0 107.271 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.61 47.41 11.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.487 1.515 . . . . 10.0 112.532 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.81 63.33 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.165 0.888 . . . . 10.0 113.698 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -134.93 148.44 50.05 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.337 1.455 . . . . 10.0 107.258 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -90.87 150.49 21.52 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -136.51 140.54 43.08 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.273 -1.751 . . . . 10.0 106.273 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.77 159.23 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.59 1.086 . . . . 10.0 112.286 -165.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -55.36 154.51 6.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.018 1.727 . . . . 10.0 112.621 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -136.09 -59.18 0.75 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-O 117.578 -1.201 . . . . 10.0 109.133 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -161.57 159.89 28.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.282 1.401 . . . . 10.0 112.354 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -141.24 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.231 1.412 . . . . 10.0 108.643 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -150.71 158.6 44.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.99 1.316 . . . . 10.0 108.233 162.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -91.57 123.22 34.82 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.095 -1.446 . . . . 10.0 107.095 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -95.64 88.78 5.12 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -56.75 -15.72 5.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.894 1.278 . . . . 10.0 113.383 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -64.17 -24.58 67.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.361 0.982 . . . . 10.0 111.855 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -130.23 -12.42 4.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.579 1.152 . . . . 10.0 112.016 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 46.32 16.87 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.34 167.44 22.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.556 0.743 . . . . 10.0 110.48 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.83 150.05 28.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.44 152.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.501 -2.037 . . . . 10.0 105.501 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.2 37.57 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 121.358 -0.839 . . . . 10.0 112.914 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.92 126.45 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 102.107 -3.294 . . . . 10.0 102.107 167.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 136.17 23.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -104.17 31.49 4.55 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.79 -50.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.505 1.048 . . . . 10.0 111.705 169.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.5 t90 . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 118.831 0.741 . . . . 10.0 110.453 -170.541 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 121.832 0.825 . . . . 10.0 111.312 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 159.32 27.25 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.247 2.219 . . . . 10.0 106.574 168.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -111.66 133.96 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.196 -2.15 . . . . 10.0 105.196 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.91 149.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -167.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.33 137.92 16.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 109.31 173.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -169.79 150.55 3.89 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 125.18 1.392 . . . . 10.0 107.603 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.27 -26.63 43.99 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.747 2.298 . . . . 10.0 113.194 166.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -63.83 -39.67 94.79 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.636 0.774 . . . . 10.0 112.226 -175.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.45 33.8 17.94 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.302 0.953 . . . . 10.0 114.001 -175.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -60.57 105.67 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.411 1.084 . . . . 10.0 111.08 -168.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.48 108.45 4.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.024 -0.732 . . . . 10.0 109.024 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.09 -10.63 38.29 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 -174.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.96 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.14 2.576 . . . . 10.0 114.582 -171.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -164.6 162.98 21.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.995 1.318 . . . . 10.0 110.314 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -157.75 176.97 11.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.527 1.531 . . . . 10.0 108.63 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.34 135.93 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 174.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -152.56 131.47 12.52 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.494 -1.298 . . . . 10.0 107.494 -174.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.0 t0 44.49 47.72 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.494 1.918 . . . . 10.0 113.021 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.29 75.85 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.797 0.713 . . . . 10.0 113.625 175.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.8 m -124.67 135.82 53.38 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.14 153.18 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 175.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.96 140.49 40.26 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.465 -1.68 . . . . 10.0 106.465 -172.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.08 157.23 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 119.379 0.991 . . . . 10.0 112.217 -167.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -57.1 154.27 10.23 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.781 1.633 . . . . 10.0 112.373 170.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -138.75 -55.82 0.62 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 117.516 -1.23 . . . . 10.0 109.914 165.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -159.82 153.36 22.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.519 1.509 . . . . 10.0 111.613 173.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -145.26 160.67 41.13 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.413 1.085 . . . . 10.0 108.615 161.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -152.51 162.48 41.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.701 1.6 . . . . 10.0 108.591 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -95.85 123.59 39.5 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -96.5 90.9 5.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.835 0.854 . . . . 10.0 108.718 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.71 -15.4 7.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.756 1.222 . . . . 10.0 113.416 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.78 -26.14 68.5 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.381 0.991 . . . . 10.0 111.576 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -129.95 -10.82 4.32 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.371 1.068 . . . . 10.0 112.114 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.7 46.36 18.68 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.794 -0.923 . . . . 10.0 110.794 175.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.96 164.78 31.85 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.953 0.901 . . . . 10.0 110.201 177.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -81.39 153.17 27.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.81 151.44 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 127.161 2.184 . . . . 10.0 105.194 176.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.93 173.22 39.95 Favored Glycine 0 C--N 1.334 0.418 0 O-C-N 120.904 -1.122 . . . . 10.0 113.973 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 54.1 mt -124.85 113.51 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 101.618 -3.475 . . . . 10.0 101.618 178.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.81 139.43 32.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.792 -1.188 . . . . 10.0 107.792 -158.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -108.99 30.75 6.26 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 173.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.67 -45.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.174 0.897 . . . . 10.0 112.1 171.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.7 t90 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 118.985 0.811 . . . . 10.0 111.164 -169.801 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.7 pt -60.61 164.48 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.933 0.873 . . . . 10.0 112.219 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -127.92 162.79 25.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.831 2.452 . . . . 10.0 106.994 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.9 mt -117.06 134.32 54.9 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.446 -2.057 . . . . 10.0 105.446 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -139.78 147.2 24.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -164.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -145.3 126.11 14.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.193 1.397 . . . . 10.0 107.253 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -168.12 153.3 6.57 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.601 1.16 . . . . 10.0 110.377 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.24 -24.72 27.16 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.395 2.063 . . . . 10.0 113.292 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -76.28 -19.26 58.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.99 30.53 23.11 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.565 1.079 . . . . 10.0 114.668 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -52.75 105.71 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 10.0 111.887 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -74.53 105.52 5.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.833 0.853 . . . . 10.0 109.123 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.6 -10.26 56.12 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.862 1.06 . . . . 10.0 113.862 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.06 -72.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.277 2.631 . . . . 10.0 114.884 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.6 p -165.48 161.96 19.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.174 1.39 . . . . 10.0 110.32 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -158.99 175.3 13.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.233 1.413 . . . . 10.0 109.092 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.67 130.76 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 105.685 -1.968 . . . . 10.0 105.685 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -152.2 137.87 17.86 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.03 -1.47 . . . . 10.0 107.03 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.68 50.13 10.88 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.193 1.797 . . . . 10.0 112.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.79 23.24 63.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.104 0.859 . . . . 10.0 113.382 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -130.7 145.07 51.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.672 -1.603 . . . . 10.0 106.672 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.26 151.0 19.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.801 -0.814 . . . . 10.0 108.801 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -138.2 139.24 39.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 tt -155.11 158.18 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.371 1.068 . . . . 10.0 112.015 -168.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.19 156.94 3.76 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.328 1.851 . . . . 10.0 112.545 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -140.45 -61.52 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.533 -1.222 . . . . 10.0 109.569 168.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -154.23 147.28 24.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.045 1.293 . . . . 10.0 111.21 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.28 160.89 41.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.256 -0.903 . . . . 10.0 110.088 162.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.95 162.64 41.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.54 1.536 . . . . 10.0 108.819 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -94.01 123.16 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -93.62 82.1 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.412 -0.959 . . . . 10.0 108.412 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -54.35 -25.67 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.808 1.243 . . . . 10.0 113.452 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m -63.93 -20.17 65.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.436 1.094 . . . . 10.0 112.847 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -126.81 -16.56 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.143 1.377 . . . . 10.0 111.558 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.68 40.11 38.7 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.507 -0.637 . . . . 10.0 111.507 174.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.92 166.85 23.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.759 0.779 . . . . 10.0 110.097 172.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -80.28 152.19 29.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.671 -0.862 . . . . 10.0 108.671 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.2 t -137.56 151.4 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.507 -2.035 . . . . 10.0 105.507 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 170.24 38.48 Favored Glycine 0 N--CA 1.45 -0.369 0 O-C-N 121.353 -0.842 . . . . 10.0 113.246 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -116.84 122.0 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 101.653 -3.462 . . . . 10.0 101.653 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.48 44.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 -164.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -127.09 36.78 4.38 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.13 -45.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.722 0.692 . . . . 10.0 111.512 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -63.18 142.1 58.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.847 0.748 . . . . 10.0 109.309 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -137.72 42.04 2.32 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 10.0 108.744 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 73.71 -16.2 0.52 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.393 2.277 . . . . 10.0 114.699 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tttp . . . . . 0 C--O 1.245 0.822 0 C-N-CA 124.153 0.981 . . . . 10.0 109.424 178.312 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.932 -0.395 . . . . 10.0 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt -60.52 163.24 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 122.054 0.93 . . . . 10.0 111.42 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -128.17 161.47 29.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.108 2.563 . . . . 10.0 106.176 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -108.31 130.95 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.456 -2.053 . . . . 10.0 105.456 172.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.16 142.92 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -162.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.56 140.88 16.62 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.818 0.847 . . . . 10.0 109.833 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.49 153.74 5.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.211 1.404 . . . . 10.0 108.497 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.42 -27.44 28.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.207 1.938 . . . . 10.0 112.786 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -69.29 -30.4 68.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.825 0.676 . . . . 10.0 112.825 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.84 46.83 93.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.377 -0.689 . . . . 10.0 111.377 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -73.29 70.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.065 1.346 . . . . 10.0 111.152 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -52.61 121.28 6.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.737 1.215 . . . . 10.0 109.77 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -9.12 18.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.621 0.971 . . . . 10.0 113.621 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.34 -65.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.348 2.659 . . . . 10.0 114.986 -170.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 p -165.26 163.19 20.14 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.81 1.244 . . . . 10.0 110.723 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.23 174.06 15.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 10.0 108.607 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.32 133.68 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.726 -1.953 . . . . 10.0 105.726 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 tt -144.68 121.3 11.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.89 42.14 15.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.892 1.677 . . . . 10.0 112.664 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.53 0.79 74.26 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.216 0.912 . . . . 10.0 114.017 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.5 m -96.99 137.78 35.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -88.73 150.83 22.78 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -137.32 140.33 41.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.111 1.764 . . . . 10.0 106.277 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.1 158.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.519 1.128 . . . . 10.0 112.003 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.92 157.01 8.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.966 1.706 . . . . 10.0 112.495 171.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.67 -61.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.531 -1.223 . . . . 10.0 109.397 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 m -150.78 149.8 30.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.681 1.128 . . . . 10.0 111.025 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.65 156.73 44.25 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.908 0.883 . . . . 10.0 109.539 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.61 160.71 40.68 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.219 1.407 . . . . 10.0 108.725 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.51 120.08 34.2 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.12 81.81 6.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.333 -0.988 . . . . 10.0 108.333 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -53.23 -27.14 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.745 1.218 . . . . 10.0 113.342 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -64.23 -20.01 65.75 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.408 1.083 . . . . 10.0 112.952 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.0 -12.51 6.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.675 1.19 . . . . 10.0 111.911 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 41.96 32.84 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.748 0.69 . . . . 10.0 111.814 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 164.53 33.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.854 0.827 . . . . 10.0 110.574 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -78.57 150.03 32.88 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.17 153.78 24.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.585 -2.005 . . . . 10.0 105.585 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.71 162.92 34.92 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.283 -0.886 . . . . 10.0 113.088 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.6 mm -101.12 119.27 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.725 -3.435 . . . . 10.0 101.725 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.53 29.76 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -162.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.44 34.78 3.92 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.71 -1.219 . . . . 10.0 107.71 170.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.49 -56.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.317 0.962 . . . . 10.0 111.388 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -60.39 152.79 24.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.675 0.67 . . . . 10.0 111.128 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -136.36 29.29 3.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.355 1.062 . . . . 10.0 110.244 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.281 1.2 ptm180 56.38 -8.71 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.884 3.274 . . . . 10.0 117.531 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.047 0.939 . . . . 10.0 108.87 169.121 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.883 -0.414 . . . . 10.0 109.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.4 pt -60.2 156.58 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.103 0.954 . . . . 10.0 111.504 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -111.82 162.53 15.17 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.653 2.381 . . . . 10.0 106.259 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -123.43 135.2 53.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.117 -2.179 . . . . 10.0 105.117 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.64 148.84 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -165.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -139.48 127.46 22.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 170.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -161.12 151.66 14.99 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 119.47 1.032 . . . . 10.0 108.933 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.72 -27.7 26.36 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.958 1.772 . . . . 10.0 113.084 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -78.23 -25.09 46.78 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.473 0.916 . . . . 10.0 113.473 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.24 32.15 35.86 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.351 -1.249 . . . . 10.0 114.769 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -54.5 115.45 2.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.937 1.368 . . . . 10.0 111.434 -171.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -78.24 115.29 17.86 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.27 -11.58 23.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.77 -67.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.157 2.583 . . . . 10.0 114.608 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -165.47 162.88 19.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.852 1.261 . . . . 10.0 110.544 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -158.71 176.3 12.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.479 1.511 . . . . 10.0 108.751 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.31 130.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.782 -1.932 . . . . 10.0 105.782 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.18 138.12 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t0 45.94 51.21 10.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.152 1.781 . . . . 10.0 112.577 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.2 63.52 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.104 0.859 . . . . 10.0 113.487 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -132.98 143.37 49.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -90.71 150.63 21.56 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -137.07 140.27 41.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.14 156.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.46 1.104 . . . . 10.0 112.025 -167.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -57.85 154.77 11.5 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.266 1.826 . . . . 10.0 112.395 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -137.1 -61.6 0.65 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.449 -1.263 . . . . 10.0 109.277 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -161.37 154.88 21.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.706 1.593 . . . . 10.0 111.602 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -146.78 160.55 42.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.101 0.961 . . . . 10.0 109.378 166.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.16 158.26 43.74 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.318 1.447 . . . . 10.0 108.701 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -90.54 120.36 31.57 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -87.64 76.6 8.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -51.8 -28.3 15.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.031 1.332 . . . . 10.0 113.287 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -64.78 -17.38 64.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.668 1.187 . . . . 10.0 113.19 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -131.11 -15.63 3.29 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.457 1.103 . . . . 10.0 112.293 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 39.05 8.29 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.945 0.793 . . . . 10.0 112.515 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -148.54 163.64 36.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.042 0.921 . . . . 10.0 109.417 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -77.5 154.53 32.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.06 150.35 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.4 38.27 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.585 -0.817 . . . . 10.0 113.953 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.0 mt -114.5 118.66 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 101.636 -3.468 . . . . 10.0 101.636 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.3 134.54 20.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.969 -1.123 . . . . 10.0 107.969 -162.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -106.78 36.03 2.79 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.29 -46.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.43 1.014 . . . . 10.0 111.765 168.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -64.07 146.27 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.722 0.692 . . . . 10.0 109.879 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.94 48.3 1.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.905 0.882 . . . . 10.0 110.24 -165.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.64 52.61 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.003 1.321 . . . . 10.0 110.69 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.252 1.223 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 169.615 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.65 164.05 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 122.575 1.179 . . . . 10.0 112.386 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -120.51 165.33 15.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.751 2.82 . . . . 10.0 106.056 166.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.3 mt -127.18 137.92 53.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.51 148.12 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -168.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -144.21 115.34 7.92 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -153.69 149.59 21.41 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.698 0.799 . . . . 10.0 109.259 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.66 -26.99 32.74 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.982 1.788 . . . . 10.0 113.02 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -81.73 -19.13 42.07 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.04 45.85 26.49 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 119.204 0.911 . . . . 10.0 112.945 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -65.26 81.39 0.05 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.769 1.228 . . . . 10.0 112.195 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -57.95 121.49 10.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.294 1.438 . . . . 10.0 109.794 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.37 -10.19 19.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -173.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.25 -64.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.396 2.678 . . . . 10.0 115.012 -168.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -166.42 163.73 17.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.828 1.251 . . . . 10.0 110.818 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -158.49 178.09 10.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.84 1.656 . . . . 10.0 108.386 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.03 137.71 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 106.779 -1.563 . . . . 10.0 106.779 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 tp -149.33 127.18 11.81 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 44.87 46.35 8.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.08 1.752 . . . . 10.0 113.153 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.18 14.06 82.21 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.297 -0.724 . . . . 10.0 113.83 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.7 m -118.75 131.09 56.11 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -86.38 151.82 23.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.6 140.17 42.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.31 157.81 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 125.043 1.337 . . . . 10.0 111.695 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.61 155.32 4.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.225 1.81 . . . . 10.0 112.584 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -136.62 -64.89 0.57 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.444 -1.265 . . . . 10.0 109.083 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.0 m -152.38 151.01 30.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.376 1.444 . . . . 10.0 111.222 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -145.56 154.9 42.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.788 0.835 . . . . 10.0 109.66 169.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.0 156.81 38.09 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.77 1.228 . . . . 10.0 108.836 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -90.27 120.42 31.4 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -88.59 77.02 8.06 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.06 -28.79 18.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.86 1.264 . . . . 10.0 113.107 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -66.05 -17.6 64.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.475 1.11 . . . . 10.0 112.983 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -126.79 -17.35 4.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.339 1.056 . . . . 10.0 111.83 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.79 9.27 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.743 0.701 . . . . 10.0 112.349 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -148.65 163.46 37.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.282 1.041 . . . . 10.0 109.987 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -75.7 154.36 36.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.11 153.33 26.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.76 161.31 33.16 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.687 -0.633 . . . . 10.0 112.921 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.5 mt -103.67 124.25 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 101.778 -3.416 . . . . 10.0 101.778 166.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 131.6 18.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.468 -0.938 . . . . 10.0 108.468 -163.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -103.54 37.13 2.09 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -153.69 -49.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 119.283 0.947 . . . . 10.0 111.874 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -65.98 145.08 56.31 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.82 0.736 . . . . 10.0 110.203 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -144.84 43.47 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.695 1.598 . . . . 10.0 108.775 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.252 5.6 ptp180 46.01 31.57 1.16 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.91 2.084 . . . . 10.0 114.471 -168.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.252 1.2 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 164.077 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.612 0.244 . . . . 10.0 110.586 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt -60.06 154.04 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.527 0.679 . . . . 10.0 111.227 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -113.34 161.75 16.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.575 1.95 . . . . 10.0 106.761 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.96 137.19 52.28 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.464 -2.051 . . . . 10.0 105.464 169.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.89 147.63 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -141.47 126.23 18.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.481 1.512 . . . . 10.0 106.946 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -166.9 146.6 4.75 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.43 -16.43 47.61 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.973 1.782 . . . . 10.0 112.367 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -63.82 -41.16 97.92 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.647 0.658 . . . . 10.0 111.598 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.9 28.06 15.6 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.762 1.172 . . . . 10.0 114.629 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.07 105.33 1.03 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.525 1.163 . . . . 10.0 110.64 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -66.31 108.32 2.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.19 -12.0 42.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.423 0.897 . . . . 10.0 113.423 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.5 -70.06 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.165 2.586 . . . . 10.0 114.2 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 163.29 19.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.028 1.331 . . . . 10.0 110.37 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -157.72 174.06 15.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.215 1.406 . . . . 10.0 109.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -135.25 129.64 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.94 -1.874 . . . . 10.0 105.94 173.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.95 131.48 14.81 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.551 -1.648 . . . . 10.0 106.551 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.18 51.52 9.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.764 2.026 . . . . 10.0 112.743 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.77 21.96 63.72 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.528 -0.76 . . . . 10.0 113.378 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -127.7 142.82 51.22 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -91.72 151.93 20.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -138.9 140.33 38.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.122 -1.807 . . . . 10.0 106.122 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.23 158.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.742 1.156 . . . . 10.0 112.438 -166.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -57.23 155.29 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.029 1.732 . . . . 10.0 112.386 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -138.77 -62.51 0.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 117.358 -1.306 . . . . 10.0 109.106 167.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 m -154.46 149.15 26.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.201 1.364 . . . . 10.0 111.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -146.42 160.89 41.48 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.329 -0.857 . . . . 10.0 110.0 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.07 164.15 38.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.639 1.576 . . . . 10.0 108.716 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -96.34 121.82 38.55 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -90.88 87.1 6.5 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.09 -16.75 5.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.696 1.199 . . . . 10.0 113.362 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -25.86 68.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.182 0.901 . . . . 10.0 111.838 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -134.64 -11.7 2.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.181 0.992 . . . . 10.0 112.558 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.85 43.06 9.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 118.901 0.773 . . . . 10.0 111.952 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -146.02 163.03 36.51 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.657 0.783 . . . . 10.0 109.524 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -75.98 153.28 36.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 171.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -136.96 151.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.377 -2.083 . . . . 10.0 105.377 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 169.5 38.9 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.621 -0.799 . . . . 10.0 113.856 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.78 120.36 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 101.254 -3.61 . . . . 10.0 101.254 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.31 149.79 36.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -165.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.3 31.03 6.81 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.67 -47.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.767 0.827 . . . . 10.0 111.556 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -66.23 147.26 53.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.751 0.705 . . . . 10.0 110.464 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -149.21 33.66 0.73 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.992 1.317 . . . . 10.0 109.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.279 41.1 ptt180 44.57 43.42 6.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.512 1.925 . . . . 10.0 114.793 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? . . . . . 0 C--O 1.251 1.16 0 C-N-CA 127.73 2.412 . . . . 10.0 112.949 170.639 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.781 0.325 . . . . 10.0 110.651 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt -59.28 155.32 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.907 0.861 . . . . 10.0 111.425 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -109.32 165.02 11.94 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.893 2.077 . . . . 10.0 106.819 165.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.27 138.8 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.261 -2.126 . . . . 10.0 105.261 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.58 151.12 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -168.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.03 122.14 7.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.462 1.105 . . . . 10.0 108.264 171.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -154.25 151.61 24.63 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.791 1.236 . . . . 10.0 108.363 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.74 -25.07 40.18 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.894 1.729 . . . . 10.0 113.153 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -88.05 -15.87 35.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -172.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.47 36.1 37.77 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.203 -1.331 . . . . 10.0 113.954 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -53.16 98.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.128 1.371 . . . . 10.0 112.235 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.76 117.44 17.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.205 1.002 . . . . 10.0 108.927 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.35 -11.67 25.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.27 -64.78 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.162 2.585 . . . . 10.0 114.642 -167.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -166.59 162.99 16.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.836 1.254 . . . . 10.0 110.724 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -159.73 178.65 9.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 10.0 108.816 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -135.67 129.82 49.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -151.95 139.97 20.14 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t0 47.05 50.18 14.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.682 1.593 . . . . 10.0 112.434 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.25 64.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.14 0.876 . . . . 10.0 113.517 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -134.79 144.22 47.53 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 -173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -88.25 149.75 23.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -135.34 141.74 45.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.325 -1.732 . . . . 10.0 106.325 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 tt -152.25 156.92 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.213 . . . . 10.0 111.847 -168.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -58.0 153.7 13.93 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.577 1.551 . . . . 10.0 111.998 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -131.82 -70.18 0.58 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.345 -1.312 . . . . 10.0 108.318 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.2 m -153.47 149.46 27.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.312 1.414 . . . . 10.0 111.289 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -143.15 157.89 44.11 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.498 -0.751 . . . . 10.0 109.512 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -149.13 154.35 39.08 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.445 1.498 . . . . 10.0 108.352 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -88.82 119.85 29.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -85.07 82.24 8.52 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -55.83 -29.68 60.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.984 0.914 . . . . 10.0 112.269 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -25.39 68.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.867 1.267 . . . . 10.0 112.644 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -120.31 -18.07 8.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.851 0.86 . . . . 10.0 111.932 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.81 29.9 12.43 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.411 1.005 . . . . 10.0 113.003 168.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -153.53 163.74 39.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.882 1.341 . . . . 10.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -74.3 152.77 39.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -139.21 152.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.477 -2.046 . . . . 10.0 105.477 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.88 167.41 39.15 Favored Glycine 0 C--N 1.332 0.33 0 O-C-N 121.274 -0.891 . . . . 10.0 114.082 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -109.41 125.32 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 102.353 -3.202 . . . . 10.0 102.353 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.31 130.84 16.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -165.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -99.85 32.15 3.0 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 -48.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.69 1.132 . . . . 10.0 112.363 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -67.25 160.96 25.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.644 0.657 . . . . 10.0 110.569 -174.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.83 -48.17 0.42 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.363 -0.827 . . . . 10.0 112.338 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.03 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.99 0.814 . . . . 10.0 111.655 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.367 1.067 . . . . 10.0 110.36 -171.802 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt -56.23 165.25 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.426 1.09 . . . . 10.0 112.643 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.33 163.31 31.31 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.762 2.425 . . . . 10.0 106.512 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.89 135.43 54.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.809 -1.923 . . . . 10.0 105.809 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.07 145.4 27.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -144.74 119.19 9.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.16 -1.792 . . . . 10.0 106.16 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -168.11 153.16 6.52 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 125.292 1.437 . . . . 10.0 110.064 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.2 -27.08 17.1 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.466 2.111 . . . . 10.0 113.246 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -68.29 -29.99 68.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.954 0.797 . . . . 10.0 112.645 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.28 31.85 13.2 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.26 -1.3 . . . . 10.0 114.963 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 107.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.791 1.295 . . . . 10.0 111.546 -168.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.48 116.3 6.62 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.0 -8.49 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.413 0.894 . . . . 10.0 113.413 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.7 -69.26 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.313 2.645 . . . . 10.0 114.517 -171.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -164.86 162.54 20.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.867 1.267 . . . . 10.0 110.878 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -159.29 177.96 10.47 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.659 1.583 . . . . 10.0 109.061 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.14 129.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 105.943 -1.873 . . . . 10.0 105.943 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -154.97 142.97 20.12 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.362 1.465 . . . . 10.0 107.09 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.59 47.49 14.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.656 1.582 . . . . 10.0 112.644 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.45 23.72 62.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.238 0.923 . . . . 10.0 113.573 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.4 m -134.45 147.44 50.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.95 150.95 21.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -135.78 140.05 44.0 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 105.985 -1.857 . . . . 10.0 105.985 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -154.9 157.13 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.603 1.161 . . . . 10.0 111.384 -167.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -59.57 155.99 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.752 1.621 . . . . 10.0 112.19 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -136.83 -67.92 0.49 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.416 -1.278 . . . . 10.0 109.271 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.6 m -151.16 144.62 24.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.463 1.483 . . . . 10.0 111.259 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -148.75 151.48 34.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.915 0.886 . . . . 10.0 109.294 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.9 158.7 42.52 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.809 1.244 . . . . 10.0 108.997 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -91.18 119.3 31.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -88.33 81.43 7.27 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -53.85 -26.44 24.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.967 1.307 . . . . 10.0 113.437 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.2 m -63.0 -21.19 65.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.346 1.059 . . . . 10.0 112.901 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.64 -12.57 6.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.704 1.201 . . . . 10.0 111.916 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 42.33 28.31 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.78 166.45 26.61 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.624 0.77 . . . . 10.0 109.996 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -81.27 152.28 27.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.904 -0.776 . . . . 10.0 108.904 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -137.3 150.69 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.332 -2.099 . . . . 10.0 105.332 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.81 166.37 38.03 Favored Glycine 0 C--N 1.333 0.365 0 O-C-N 121.426 -0.796 . . . . 10.0 113.486 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -108.32 120.69 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 101.677 -3.453 . . . . 10.0 101.677 168.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.64 155.53 46.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -167.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -128.37 36.41 4.28 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 106.653 -1.61 . . . . 10.0 106.653 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.97 -45.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.63 1.105 . . . . 10.0 112.01 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -61.57 142.04 57.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.191 0.905 . . . . 10.0 109.533 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.53 54.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.968 1.307 . . . . 10.0 107.742 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.271 7.6 ptp180 52.11 -0.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.99 2.916 . . . . 10.0 116.614 -170.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.253 1.251 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 167.953 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 119.264 -0.398 . . . . 10.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.0 pt -58.09 155.61 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.831 0.824 . . . . 10.0 111.292 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.11 159.31 21.91 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.007 2.123 . . . . 10.0 106.36 166.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.85 128.12 56.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.672 -2.344 . . . . 10.0 104.672 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -139.21 147.73 24.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.23 -1.026 . . . . 10.0 108.23 -161.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -149.34 148.4 29.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.21 1.004 . . . . 10.0 108.524 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m 179.14 155.43 0.61 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 127.562 2.345 . . . . 10.0 108.17 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.41 -24.26 31.48 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.312 2.008 . . . . 10.0 113.254 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -68.08 -28.78 67.65 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.401 -0.809 . . . . 10.0 113.019 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.25 41.59 8.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.44 1.019 . . . . 10.0 114.348 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.23 91.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.159 1.384 . . . . 10.0 110.974 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.39 112.33 2.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.802 0.841 . . . . 10.0 108.892 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.65 -12.16 24.25 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.269 0.841 . . . . 10.0 113.269 -174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.07 -63.81 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.389 2.676 . . . . 10.0 114.567 -169.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -165.18 162.75 20.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.814 1.246 . . . . 10.0 110.569 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -158.01 177.5 11.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.687 1.595 . . . . 10.0 108.495 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 135.84 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.784 -1.561 . . . . 10.0 106.784 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.0 131.2 12.75 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 44.13 47.84 7.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.861 . . . . 10.0 113.086 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.34 18.14 76.6 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.352 -0.693 . . . . 10.0 113.707 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -125.18 136.17 53.32 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.36 152.97 21.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -137.55 140.43 41.04 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.337 -1.727 . . . . 10.0 106.337 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -154.68 159.31 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 119.591 1.087 . . . . 10.0 112.169 -167.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.03 156.4 9.42 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.69 1.596 . . . . 10.0 112.276 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -139.67 -63.26 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 117.265 -1.35 . . . . 10.0 109.445 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.9 m -151.7 149.52 29.18 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.092 1.314 . . . . 10.0 111.198 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -147.16 156.28 42.84 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.748 0.819 . . . . 10.0 109.719 168.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -155.13 160.7 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.955 1.302 . . . . 10.0 108.885 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -94.15 120.79 34.91 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.258 -1.386 . . . . 10.0 107.258 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.28 86.3 6.8 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.09 -0.708 . . . . 10.0 109.09 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -55.76 -15.94 3.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.483 1.113 . . . . 10.0 113.433 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -22.08 66.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.236 0.925 . . . . 10.0 112.161 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -139.4 -11.97 1.2 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.144 0.978 . . . . 10.0 112.826 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 45.29 7.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.15 0.886 . . . . 10.0 111.956 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.74 163.2 34.74 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.838 0.819 . . . . 10.0 109.629 172.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -76.49 153.17 35.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.25 153.05 23.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.911 2.084 . . . . 10.0 105.573 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.98 165.29 37.57 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 121.381 -0.825 . . . . 10.0 113.323 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.65 120.47 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 101.202 -3.629 . . . . 10.0 101.202 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.87 139.14 29.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 -164.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -109.36 30.08 6.95 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.64 -44.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.729 1.149 . . . . 10.0 113.041 171.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -61.97 146.07 51.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.819 1.191 . . . . 10.0 109.971 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -139.55 47.41 1.86 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.201 1.401 . . . . 10.0 108.413 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.286 0.0 OUTLIER 56.18 -12.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 130.189 3.396 . . . . 10.0 117.577 -173.309 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 tptm . . . . . 0 C--O 1.248 1.005 0 CA-C-O 116.909 -1.52 . . . . 10.0 107.786 -172.003 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 pt -62.68 152.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.779 0.799 . . . . 10.0 111.771 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.85 166.75 11.15 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.692 1.997 . . . . 10.0 107.092 158.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.97 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.17 146.09 25.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.014 -0.736 . . . . 10.0 109.014 -162.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.68 141.5 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.894 1.278 . . . . 10.0 108.09 169.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -173.03 154.12 2.64 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 126.853 2.061 . . . . 10.0 107.97 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.21 -25.95 30.66 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.227 1.951 . . . . 10.0 113.091 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -69.74 -28.39 65.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.696 -0.669 . . . . 10.0 112.58 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.05 48.23 58.83 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 118.638 0.654 . . . . 10.0 112.012 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -71.44 73.94 0.74 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.739 1.215 . . . . 10.0 111.176 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.21 120.09 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.074 1.35 . . . . 10.0 109.591 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.86 -7.92 21.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.06 -70.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.032 2.533 . . . . 10.0 114.48 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.7 p -159.61 164.82 33.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.512 1.051 . . . . 10.0 110.634 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -157.76 179.48 9.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.322 1.449 . . . . 10.0 108.975 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.71 130.79 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.3 144.03 21.66 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.75 46.85 11.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.52 . . . . 10.0 112.419 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.4 24.5 63.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.189 0.9 . . . . 10.0 113.636 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -133.75 147.43 51.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.066 1.346 . . . . 10.0 107.553 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -83.0 146.38 28.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -133.31 140.25 47.33 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.511 -1.662 . . . . 10.0 106.511 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -154.37 158.32 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.624 1.17 . . . . 10.0 111.874 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.99 156.58 5.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.055 1.742 . . . . 10.0 112.677 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -138.45 -62.2 0.57 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 117.257 -1.354 . . . . 10.0 109.334 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -151.9 150.25 29.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.127 1.33 . . . . 10.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -145.09 157.0 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.598 0.759 . . . . 10.0 109.556 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.08 160.8 41.27 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.941 1.296 . . . . 10.0 108.716 170.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -94.14 116.19 28.57 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.17 87.55 7.39 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -58.36 -15.4 10.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.607 1.163 . . . . 10.0 113.218 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.61 -25.11 67.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.428 1.013 . . . . 10.0 111.625 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.66 -12.63 4.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.626 1.17 . . . . 10.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 42.97 19.68 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.703 0.668 . . . . 10.0 111.506 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.46 163.84 34.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.026 0.913 . . . . 10.0 110.974 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -78.68 150.64 32.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -140.23 152.84 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.805 2.042 . . . . 10.0 105.616 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.39 163.64 36.7 Favored Glycine 0 C--N 1.334 0.427 0 O-C-N 121.242 -0.911 . . . . 10.0 113.485 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.96 123.99 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 101.828 -3.397 . . . . 10.0 101.828 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.27 29.18 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.736 -0.838 . . . . 10.0 108.736 -163.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -115.31 35.72 4.25 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.97 -49.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.892 0.769 . . . . 10.0 112.202 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -67.44 155.16 39.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.137 0.881 . . . . 10.0 110.65 -171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.35 36.56 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 10.0 110.207 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 78.8 -34.94 0.17 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.635 2.374 . . . . 10.0 112.198 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.0 mttp . . . . . 0 C--O 1.247 0.968 0 C-N-CA 126.691 1.996 . . . . 10.0 110.691 -178.414 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.884 0.374 . . . . 10.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.0 pt -59.65 157.98 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.912 0.863 . . . . 10.0 111.297 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -115.73 162.12 17.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.107 2.163 . . . . 10.0 106.585 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.72 136.62 53.24 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.4 -2.074 . . . . 10.0 105.4 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.9 146.89 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 -163.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.79 120.55 9.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.589 -1.634 . . . . 10.0 106.589 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m -158.99 150.99 17.27 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 119.739 1.154 . . . . 10.0 109.327 173.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.2 -27.19 35.36 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.035 1.823 . . . . 10.0 112.98 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -81.15 -17.43 49.84 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.792 1.034 . . . . 10.0 113.792 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.98 34.79 31.37 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.145 -1.364 . . . . 10.0 114.008 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -53.33 99.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.109 1.363 . . . . 10.0 112.408 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.8 117.26 15.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.501 1.12 . . . . 10.0 109.317 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.08 -11.81 27.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.98 -67.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.326 2.65 . . . . 10.0 114.2 -166.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -163.82 162.5 23.75 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.291 1.036 . . . . 10.0 110.366 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -158.55 176.4 12.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.04 1.336 . . . . 10.0 108.885 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -137.1 132.2 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -149.5 135.04 18.48 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.52 50.24 10.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.198 1.799 . . . . 10.0 112.757 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.19 69.17 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.822 0.725 . . . . 10.0 113.547 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -129.15 138.75 51.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.65 -1.611 . . . . 10.0 106.65 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -88.41 151.55 22.5 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.65 140.62 42.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.961 1.705 . . . . 10.0 106.518 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -152.58 155.02 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.153 1.381 . . . . 10.0 111.398 -163.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -57.59 156.02 8.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.565 1.546 . . . . 10.0 112.188 170.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -138.78 -64.99 0.5 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.538 -1.22 . . . . 10.0 109.465 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -152.15 149.75 29.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.203 1.365 . . . . 10.0 111.033 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 23.0 ttpt -149.97 143.61 25.32 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -150.84 154.76 37.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.739 1.216 . . . . 10.0 109.085 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -89.04 122.66 32.6 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.76 90.82 4.82 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.252 1.025 . . . . 10.0 108.88 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -57.4 -13.7 3.83 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.213 1.405 . . . . 10.0 113.399 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -62.71 -25.18 68.04 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.632 1.106 . . . . 10.0 111.876 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -131.59 -9.72 3.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.467 0.707 . . . . 10.0 111.959 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.58 8.69 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.469 -1.052 . . . . 10.0 110.469 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.32 163.17 34.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.317 1.047 . . . . 10.0 109.92 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.524 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 88.3 m95 -81.8 149.12 28.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -136.59 153.17 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.536 -2.024 . . . . 10.0 105.536 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.38 167.37 38.25 Favored Glycine 0 N--CA 1.45 -0.38 0 O-C-N 121.142 -0.974 . . . . 10.0 113.52 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.19 122.87 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 101.307 -3.59 . . . . 10.0 101.307 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.12 134.17 21.5 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -102.98 31.68 4.09 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 p -153.75 -47.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.913 1.233 . . . . 10.0 112.738 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -63.7 149.13 47.35 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.876 0.762 . . . . 10.0 110.696 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -137.53 34.8 2.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.64 1.176 . . . . 10.0 111.081 -165.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 58.13 43.27 20.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.28 1.432 . . . . 10.0 112.874 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.331 -1.729 . . . . 10.0 106.331 174.737 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 119.214 -0.422 . . . . 10.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp -56.29 156.74 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 122.231 1.015 . . . . 10.0 112.41 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -116.67 163.56 15.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.372 2.269 . . . . 10.0 106.577 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.65 133.41 52.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.66 149.66 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.897 -0.779 . . . . 10.0 108.897 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -144.43 127.6 16.65 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.519 -2.03 . . . . 10.0 105.519 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -169.66 153.43 5.04 Favored Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 125.372 1.469 . . . . 10.0 109.151 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.78 -24.88 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.335 2.024 . . . . 10.0 113.123 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -81.77 -18.72 43.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.698 0.999 . . . . 10.0 113.698 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.39 37.66 18.95 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.365 -1.242 . . . . 10.0 113.818 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -54.06 99.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.89 1.276 . . . . 10.0 112.094 -170.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.06 116.88 16.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.082 0.953 . . . . 10.0 108.736 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.32 -11.82 27.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.576 0.954 . . . . 10.0 113.576 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.41 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.153 2.581 . . . . 10.0 114.673 -166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 p -167.46 164.49 14.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.826 1.25 . . . . 10.0 110.899 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -158.53 175.98 12.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.843 1.657 . . . . 10.0 108.486 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.7 132.74 48.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.872 -1.899 . . . . 10.0 105.872 171.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.3 tp -146.5 132.37 19.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.2 -1.407 . . . . 10.0 107.2 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.71 49.3 11.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.854 1.662 . . . . 10.0 112.774 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.9 72.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.806 0.717 . . . . 10.0 113.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -127.48 136.4 51.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -86.27 150.65 24.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -136.17 140.8 43.88 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.53 156.62 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 10.0 111.742 -168.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.91 152.82 15.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.515 1.526 . . . . 10.0 111.763 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -130.38 -70.29 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.416 -1.278 . . . . 10.0 108.112 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.51 149.24 27.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.185 1.357 . . . . 10.0 111.0 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.59 155.93 46.43 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.619 -0.676 . . . . 10.0 109.577 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -148.54 153.85 38.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.557 1.543 . . . . 10.0 108.082 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -89.1 118.47 28.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.344 -1.354 . . . . 10.0 107.344 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -83.97 94.13 8.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.4 m -64.73 -25.5 67.96 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.383 0.673 . . . . 10.0 112.725 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -70.03 -41.97 73.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.672 0.669 . . . . 10.0 110.249 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -84.22 -25.88 29.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.412 0.685 . . . . 10.0 111.68 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.79 40.86 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.154 0.883 . . . . 10.0 111.545 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.35 168.24 23.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.551 1.175 . . . . 10.0 111.014 173.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.0 152.48 36.96 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.077 -0.712 . . . . 10.0 109.077 167.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.16 153.67 27.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.752 2.021 . . . . 10.0 105.758 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.08 162.71 35.44 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 121.249 -0.907 . . . . 10.0 113.74 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.06 124.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 102.49 -3.152 . . . . 10.0 102.49 168.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.36 129.47 17.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -167.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -100.08 33.71 2.54 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.169 -1.048 . . . . 10.0 108.169 171.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.56 -48.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.565 1.075 . . . . 10.0 112.048 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -66.55 159.47 27.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.805 0.73 . . . . 10.0 110.233 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.78 -46.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.652 0.781 . . . . 10.0 111.95 -174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.83 -44.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.786 -1.102 . . . . 10.0 110.328 -170.831 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.01 159.79 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.052 0.929 . . . . 10.0 111.646 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.9 165.14 17.9 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.971 2.508 . . . . 10.0 106.479 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.07 137.47 54.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.812 -1.921 . . . . 10.0 105.812 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.75 150.38 18.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 -168.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.51 14.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.511 1.124 . . . . 10.0 108.812 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.1 m -169.08 155.08 6.28 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.792 2.037 . . . . 10.0 107.943 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.01 -23.77 39.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.975 1.783 . . . . 10.0 112.754 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -71.25 -29.79 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.701 0.682 . . . . 10.0 112.361 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.1 42.23 71.26 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 118.973 -0.904 . . . . 10.0 112.513 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.18 98.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.017 0.927 . . . . 10.0 111.991 -163.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.96 121.53 17.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.455 0.702 . . . . 10.0 109.348 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.45 -8.94 17.79 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.18 -67.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.201 2.601 . . . . 10.0 114.814 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 p -165.04 162.7 20.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.158 1.383 . . . . 10.0 110.616 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -158.6 175.89 13.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.634 1.574 . . . . 10.0 108.602 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.99 132.31 47.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 105.786 -1.931 . . . . 10.0 105.786 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -149.57 134.46 17.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.161 -1.422 . . . . 10.0 107.161 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.33 49.94 10.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.108 1.763 . . . . 10.0 112.736 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.2 69.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.776 0.703 . . . . 10.0 113.508 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.2 m -128.86 140.21 51.8 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -90.34 150.38 21.91 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -136.24 139.12 42.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 tt -154.56 157.48 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.85 1.26 . . . . 10.0 111.975 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.55 154.29 4.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.943 1.697 . . . . 10.0 112.026 168.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -55.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.29 -1.338 . . . . 10.0 110.871 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.7 m -151.82 150.25 29.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.843 1.202 . . . . 10.0 110.794 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 25.6 ttpt -149.47 142.62 25.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -150.38 155.89 40.45 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.781 1.232 . . . . 10.0 109.197 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -93.2 122.2 35.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.465 -1.309 . . . . 10.0 107.465 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -96.81 89.99 5.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.94 -15.66 5.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.921 1.288 . . . . 10.0 113.386 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.48 -26.91 68.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.508 1.049 . . . . 10.0 111.632 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.79 -14.65 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.554 1.142 . . . . 10.0 111.635 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.13 13.24 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.556 -1.018 . . . . 10.0 110.556 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 166.09 26.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.661 0.784 . . . . 10.0 110.384 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 91.4 m95 -81.32 152.65 27.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.2 156.09 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.243 2.217 . . . . 10.0 105.267 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.34 169.35 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 O-C-N 120.905 -1.122 . . . . 10.0 113.386 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.77 113.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 101.442 -3.54 . . . . 10.0 101.442 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 133.35 28.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 -158.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -106.49 35.76 2.85 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.73 -48.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.679 1.127 . . . . 10.0 112.368 167.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -63.18 141.41 58.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.388 0.995 . . . . 10.0 109.299 -174.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -127.55 27.22 5.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 10.0 109.883 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.9 ttt-85 69.09 -38.49 0.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.364 2.666 . . . . 10.0 113.608 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt . . . . . 0 C--O 1.249 1.078 0 C-N-CA 125.782 1.633 . . . . 10.0 109.402 -175.016 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.7 164.11 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 122.332 1.063 . . . . 10.0 111.976 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -119.48 160.71 21.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.234 2.214 . . . . 10.0 106.247 162.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.57 132.95 54.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.8 146.52 26.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.081 -1.081 . . . . 10.0 108.081 -161.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -156.5 127.7 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.767 0.827 . . . . 10.0 109.324 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 m -160.89 155.15 19.43 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.074 1.75 . . . . 10.0 107.794 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 -26.46 35.14 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.161 1.907 . . . . 10.0 113.14 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -70.75 -31.84 68.79 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.69 0.677 . . . . 10.0 112.549 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.03 32.4 82.09 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.903 -0.943 . . . . 10.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -53.94 97.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.131 1.772 . . . . 10.0 112.116 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -68.09 122.64 18.68 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.17 -3.87 16.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 50.6 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.143 2.577 . . . . 10.0 115.001 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -163.09 162.02 25.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.229 1.411 . . . . 10.0 110.441 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.86 177.63 10.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.401 1.481 . . . . 10.0 109.075 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.36 129.37 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.025 -1.842 . . . . 10.0 106.025 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.02 144.01 19.73 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.29 47.27 13.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.436 1.494 . . . . 10.0 112.511 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.65 23.68 63.28 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.181 0.896 . . . . 10.0 113.566 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -135.2 148.53 49.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.288 1.435 . . . . 10.0 107.274 -172.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -92.39 150.17 20.97 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -135.63 140.07 44.27 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.271 -1.752 . . . . 10.0 106.271 -170.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -155.19 157.18 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.433 1.093 . . . . 10.0 111.869 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -58.73 156.39 11.13 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.133 1.773 . . . . 10.0 112.48 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -137.0 -65.24 0.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 117.316 -1.326 . . . . 10.0 109.104 167.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -150.96 149.94 30.21 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.966 1.257 . . . . 10.0 111.711 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 20.9 ptmt -144.62 152.12 40.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.677 1.191 . . . . 10.0 108.601 168.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.86 156.86 41.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.242 1.417 . . . . 10.0 108.715 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.86 119.97 33.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.256 -1.386 . . . . 10.0 107.256 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -90.18 88.21 7.16 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.22 -17.1 6.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.825 1.25 . . . . 10.0 113.349 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -25.92 68.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.278 0.944 . . . . 10.0 111.616 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -130.5 -12.37 3.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.653 1.181 . . . . 10.0 112.099 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.94 45.94 15.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.45 164.42 34.22 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.007 0.923 . . . . 10.0 110.297 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 84.9 m95 -82.21 150.24 27.47 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.19 154.04 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 105.289 -2.115 . . . . 10.0 105.289 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.49 172.43 42.39 Favored Glycine 0 N--CA 1.451 -0.348 0 O-C-N 120.977 -1.077 . . . . 10.0 113.528 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.5 mt -117.89 119.56 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 101.679 -3.452 . . . . 10.0 101.679 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 134.9 22.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -162.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -108.51 37.06 2.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.01 -45.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.162 0.892 . . . . 10.0 111.699 168.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -65.4 151.17 46.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.813 0.733 . . . . 10.0 110.628 -171.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.86 32.76 2.68 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.516 1.526 . . . . 10.0 109.886 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.252 0.7 OUTLIER 68.04 -23.19 0.13 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.781 2.833 . . . . 10.0 115.711 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt . . . . . 0 C--O 1.25 1.091 0 C-N-CA 124.246 1.018 . . . . 10.0 109.645 175.981 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 119.249 -0.405 . . . . 10.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.24 164.12 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.943 0.878 . . . . 10.0 111.394 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -137.34 162.4 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.515 2.326 . . . . 10.0 106.277 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -120.8 137.19 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.302 -1.74 . . . . 10.0 106.302 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.31 148.51 22.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -141.87 125.86 17.24 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -163.45 145.35 7.61 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 119.113 0.87 . . . . 10.0 108.809 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.58 -20.77 46.86 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.168 1.912 . . . . 10.0 112.317 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.0 -34.24 71.16 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.475 1.034 . . . . 10.0 111.542 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.1 27.98 71.39 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.787 -1.007 . . . . 10.0 114.519 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -52.27 108.82 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.697 1.599 . . . . 10.0 112.147 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.61 109.16 6.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 168.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.61 -2.31 51.63 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 49.32 -70.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.01 2.924 . . . . 10.0 115.983 -171.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -168.27 159.91 11.11 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.135 1.374 . . . . 10.0 110.211 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -159.32 176.08 12.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.543 1.137 . . . . 10.0 109.33 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.25 133.93 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.69 124.48 10.54 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -174.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t0 44.74 41.57 5.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.736 2.014 . . . . 10.0 112.833 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.7 48.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.425 1.012 . . . . 10.0 114.005 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -83.1 146.32 28.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 171.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -104.09 145.43 30.18 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.352 1.061 . . . . 10.0 108.466 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -136.31 144.49 44.73 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.384 1.074 . . . . 10.0 108.313 -168.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -160.23 159.78 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.857 1.263 . . . . 10.0 112.585 -168.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -58.07 157.44 8.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.009 1.724 . . . . 10.0 112.809 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -141.7 -63.13 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.271 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -151.13 144.66 24.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.911 1.232 . . . . 10.0 111.152 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -151.07 141.5 22.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -149.72 161.33 42.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.11 1.364 . . . . 10.0 109.628 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -92.9 123.48 36.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -92.67 78.05 4.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -52.65 -28.56 22.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.97 1.308 . . . . 10.0 113.323 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -63.41 -21.65 66.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.452 1.101 . . . . 10.0 112.93 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -125.14 -15.77 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.848 1.259 . . . . 10.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.82 37.84 21.6 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.762 0.71 . . . . 10.0 112.43 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.41 163.14 38.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.037 0.935 . . . . 10.0 109.299 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -76.12 153.65 36.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.02 150.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.657 1.983 . . . . 10.0 105.691 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.64 166.53 34.93 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 121.547 -0.721 . . . . 10.0 113.265 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.55 116.6 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 101.268 -3.605 . . . . 10.0 101.268 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.58 136.66 31.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 -163.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -103.81 30.72 4.91 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.457 -0.942 . . . . 10.0 108.457 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.99 -54.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-N 119.087 0.858 . . . . 10.0 111.108 167.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.69 143.93 45.11 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.59 0.632 . . . . 10.0 111.08 -165.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -133.58 27.2 4.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.598 1.159 . . . . 10.0 110.777 -166.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 62.24 14.21 6.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.092 1.757 . . . . 10.0 113.11 -171.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.364 -1.303 . . . . 10.0 107.595 169.611 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.928 -0.397 . . . . 10.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 pt -59.42 160.38 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.97 0.89 . . . . 10.0 111.523 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -128.34 166.01 19.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.826 2.45 . . . . 10.0 106.566 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -122.32 138.66 54.44 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -140.68 147.96 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.083 -1.08 . . . . 10.0 108.083 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.53 116.39 9.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.42 1.488 . . . . 10.0 107.166 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -154.7 150.31 21.44 Favored Pre-proline 0 N--CA 1.466 0.341 0 C-N-CA 123.768 0.827 . . . . 10.0 110.032 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.8 -28.41 25.08 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.905 1.736 . . . . 10.0 112.796 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -71.86 -29.43 64.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.67 29.82 26.3 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.503 -1.165 . . . . 10.0 115.395 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -61.05 107.19 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.681 1.241 . . . . 10.0 111.392 -172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -65.39 118.02 8.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.774 0.83 . . . . 10.0 109.143 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.28 -8.62 26.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.871 1.063 . . . . 10.0 113.871 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.5 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.976 2.51 . . . . 10.0 114.695 -170.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 p -162.24 165.55 26.65 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.692 1.197 . . . . 10.0 111.022 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -157.22 174.36 15.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.861 1.664 . . . . 10.0 108.585 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.12 133.47 47.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.787 -1.931 . . . . 10.0 105.787 172.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -143.93 121.2 11.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.079 -1.822 . . . . 10.0 106.079 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.6 t0 47.62 43.33 16.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.839 1.656 . . . . 10.0 112.721 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 4.68 78.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.105 0.859 . . . . 10.0 113.968 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 m -102.25 136.88 41.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -87.5 150.72 23.56 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -136.81 139.82 42.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.403 1.881 . . . . 10.0 106.098 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -153.32 156.84 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.645 1.178 . . . . 10.0 111.852 -168.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.78 155.08 13.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.032 1.733 . . . . 10.0 112.19 171.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -137.44 -61.39 0.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.261 -1.352 . . . . 10.0 110.597 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.5 m -152.55 149.94 29.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.505 1.502 . . . . 10.0 111.136 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -150.01 152.48 34.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.391 1.076 . . . . 10.0 109.295 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.93 157.32 40.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.795 1.238 . . . . 10.0 109.143 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -89.5 120.27 30.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -88.57 77.37 8.01 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.34 -29.21 22.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.894 1.278 . . . . 10.0 113.164 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -65.01 -19.34 65.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.476 1.11 . . . . 10.0 112.933 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.4 -17.56 5.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.602 1.161 . . . . 10.0 111.97 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.07 36.75 10.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.727 0.694 . . . . 10.0 112.48 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.2 163.26 38.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.219 1.009 . . . . 10.0 109.618 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -75.8 154.61 36.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.43 0.633 . . . . 10.0 109.71 170.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.9 t -138.03 154.29 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.559 -2.015 . . . . 10.0 105.559 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.81 166.42 36.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.259 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.8 mt -112.86 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 101.613 -3.477 . . . . 10.0 101.613 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 140.07 30.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -160.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.62 36.66 3.34 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.79 -44.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.304 0.956 . . . . 10.0 111.676 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -66.83 160.8 25.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.285 0.493 . . . . 10.0 110.776 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -141.44 -40.38 0.38 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.762 0.825 . . . . 10.0 112.395 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -172.0 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.405 1.082 . . . . 10.0 111.569 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 105.755 -1.943 . . . . 10.0 105.755 170.986 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -59.98 163.2 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 122.368 1.08 . . . . 10.0 111.954 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -126.31 164.02 21.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.748 2.419 . . . . 10.0 105.745 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.7 mt -123.55 137.01 54.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.61 150.83 19.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 -168.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -141.47 134.79 29.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.44 150.46 4.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.787 -0.819 . . . . 10.0 108.787 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.78 -25.24 39.78 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 121.805 1.67 . . . . 10.0 112.408 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -72.41 -32.16 66.12 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.592 0.633 . . . . 10.0 112.547 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.93 35.15 81.84 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.968 -0.907 . . . . 10.0 113.576 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -54.87 102.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.265 1.426 . . . . 10.0 111.96 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.18 116.1 10.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.51 -7.45 28.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.28 -72.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.053 2.541 . . . . 10.0 115.008 -170.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 164.19 19.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 10.0 110.729 -174.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -158.07 174.17 15.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.786 1.635 . . . . 10.0 108.558 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.33 133.77 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.788 -1.93 . . . . 10.0 105.788 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -144.07 120.72 11.14 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.44 43.2 15.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.912 1.685 . . . . 10.0 112.704 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.14 2.9 80.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.124 0.868 . . . . 10.0 114.047 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.5 m -99.95 136.49 39.78 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 173.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -87.71 150.61 23.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -137.15 139.94 41.5 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.188 -1.782 . . . . 10.0 106.188 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.16 156.75 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.825 1.25 . . . . 10.0 111.883 -168.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.84 155.56 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.008 1.723 . . . . 10.0 112.421 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -135.76 -66.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.403 -1.284 . . . . 10.0 109.009 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -150.97 151.33 31.94 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.887 1.221 . . . . 10.0 111.691 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -142.16 150.93 41.71 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.608 1.163 . . . . 10.0 108.649 168.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -151.41 154.85 37.43 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.028 1.331 . . . . 10.0 108.741 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -89.35 121.0 31.19 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.558 -1.275 . . . . 10.0 107.558 174.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.0 85.89 7.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.006 -1.479 . . . . 10.0 107.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -57.64 -27.44 62.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.805 0.842 . . . . 10.0 112.764 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -71.47 -26.35 62.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.558 0.743 . . . . 10.0 111.621 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.5 mmpt? -109.63 -17.64 13.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.857 0.863 . . . . 10.0 112.234 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.43 38.57 20.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.056 0.836 . . . . 10.0 112.331 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.64 164.36 37.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.515 1.157 . . . . 10.0 110.473 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 85.9 m95 -73.46 153.68 40.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 168.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.29 156.08 32.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.942 2.097 . . . . 10.0 105.366 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.87 162.89 33.39 Favored Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.452 -0.78 . . . . 10.0 112.865 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.2 mt -106.94 118.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 101.612 -3.477 . . . . 10.0 101.612 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.38 127.54 16.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -162.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -101.14 37.88 1.67 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.847 -1.168 . . . . 10.0 107.847 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.96 -48.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.407 1.003 . . . . 10.0 111.847 167.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -64.68 146.91 54.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.771 0.714 . . . . 10.0 110.379 -169.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.95 37.21 1.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.453 1.501 . . . . 10.0 109.535 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 56.07 26.94 10.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.692 1.597 . . . . 10.0 112.702 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.248 0.982 0 N-CA-C 107.308 -1.367 . . . . 10.0 107.308 167.836 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.0 pt -60.67 160.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 122.08 0.943 . . . . 10.0 111.466 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -119.55 165.27 14.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.863 2.465 . . . . 10.0 106.523 163.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.09 135.77 54.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.031 -2.211 . . . . 10.0 105.031 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -138.38 142.89 34.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 -167.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -145.28 101.48 3.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -152.15 149.87 24.24 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 118.828 0.74 . . . . 10.0 109.871 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.06 -27.75 19.98 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.082 1.855 . . . . 10.0 113.366 -173.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -72.09 -25.28 61.69 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.17 35.47 26.8 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.792 -1.004 . . . . 10.0 115.099 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -58.7 98.99 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.114 1.366 . . . . 10.0 111.514 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.32 110.72 4.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.682 0.793 . . . . 10.0 108.862 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.98 -12.19 31.33 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.52 -66.05 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.14 2.576 . . . . 10.0 114.606 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 p -164.52 161.74 21.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.943 1.297 . . . . 10.0 110.745 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.4 177.73 10.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.452 1.501 . . . . 10.0 109.099 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.41 129.82 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 106.042 -1.836 . . . . 10.0 106.042 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.7 tp -155.67 143.72 19.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.11 47.7 12.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.585 1.554 . . . . 10.0 112.512 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.81 63.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.116 0.865 . . . . 10.0 113.612 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -134.94 147.85 49.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.32 1.448 . . . . 10.0 107.19 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -91.1 150.24 21.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.816 -0.809 . . . . 10.0 108.816 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -135.24 140.37 45.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.413 -1.699 . . . . 10.0 106.413 -171.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.5 158.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.424 1.09 . . . . 10.0 112.002 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.04 157.32 8.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.223 1.809 . . . . 10.0 112.458 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -139.17 -61.94 0.55 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 117.608 -1.187 . . . . 10.0 109.529 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 m -152.58 149.3 28.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.889 1.222 . . . . 10.0 111.215 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -148.11 156.07 42.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.872 0.869 . . . . 10.0 109.696 169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -155.5 161.01 41.01 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.033 1.333 . . . . 10.0 108.877 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.87 118.93 31.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.227 -1.397 . . . . 10.0 107.227 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.59 80.34 8.04 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -53.02 -26.71 16.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.944 1.297 . . . . 10.0 113.451 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 m -63.0 -21.2 65.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.453 1.101 . . . . 10.0 112.983 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.57 -12.44 6.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.696 1.198 . . . . 10.0 112.065 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.47 41.8 29.15 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.62 0.645 . . . . 10.0 111.739 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.2 164.91 30.77 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.926 0.863 . . . . 10.0 110.555 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -79.52 149.48 31.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.5 t -135.8 149.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.576 -2.009 . . . . 10.0 105.576 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.44 165.98 36.98 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.58 -0.7 . . . . 10.0 113.204 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.9 mt -110.73 120.21 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 101.489 -3.522 . . . . 10.0 101.489 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.76 139.02 26.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 -162.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -111.88 35.56 3.65 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 170.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.51 -44.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.485 1.039 . . . . 10.0 112.003 168.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -66.1 152.76 44.01 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.293 0.951 . . . . 10.0 110.816 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.81 38.15 0.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.967 1.307 . . . . 10.0 109.76 -167.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 65.86 -33.12 0.17 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.018 2.527 . . . . 10.0 114.491 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 tptt . . . . . 0 C--O 1.248 1.016 0 C-N-CA 124.83 1.252 . . . . 10.0 109.853 176.64 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.506 0.193 . . . . 10.0 110.961 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.2 165.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.566 0.698 . . . . 10.0 111.452 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -130.91 161.38 32.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.552 1.941 . . . . 10.0 106.832 167.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.76 134.78 51.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.579 -2.008 . . . . 10.0 105.579 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -140.48 148.25 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 -163.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -152.94 137.66 16.97 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.661 0.785 . . . . 10.0 109.911 171.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 m -161.03 153.04 16.65 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.043 1.337 . . . . 10.0 108.204 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.86 -28.17 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.885 1.723 . . . . 10.0 112.812 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -75.97 -16.56 59.97 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.86 1.059 . . . . 10.0 113.86 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.08 44.51 33.11 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.298 0.954 . . . . 10.0 112.787 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -65.81 78.04 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.848 1.259 . . . . 10.0 112.21 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -55.82 126.57 26.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.134 1.374 . . . . 10.0 109.712 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.57 -4.75 14.67 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.124 1.157 . . . . 10.0 114.124 -170.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.19 -68.4 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.271 2.628 . . . . 10.0 115.492 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.8 p -165.55 162.57 19.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.98 1.312 . . . . 10.0 110.508 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -158.74 174.49 14.95 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.296 1.438 . . . . 10.0 108.712 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.7 132.64 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.797 -1.927 . . . . 10.0 105.797 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.87 127.31 13.16 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.02 42.33 9.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.617 1.967 . . . . 10.0 112.695 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 1.28 57.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.27 0.938 . . . . 10.0 114.119 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -95.19 140.66 29.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.605 -1.628 . . . . 10.0 106.605 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.85 151.15 21.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -137.9 140.23 40.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.276 1.831 . . . . 10.0 106.358 -171.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 tt -153.39 159.83 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 119.617 1.099 . . . . 10.0 112.257 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.23 156.96 9.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.026 1.73 . . . . 10.0 112.371 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -138.17 -64.54 0.53 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 117.519 -1.229 . . . . 10.0 109.498 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -151.92 149.9 29.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.112 1.323 . . . . 10.0 111.112 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -147.56 157.24 43.48 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.789 0.836 . . . . 10.0 110.129 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -155.26 160.18 40.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.453 1.501 . . . . 10.0 108.774 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -92.76 122.05 34.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -89.58 79.48 6.85 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.755 -1.202 . . . . 10.0 107.755 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -52.13 -28.47 18.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.666 1.186 . . . . 10.0 113.235 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m -66.75 -19.98 65.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.353 1.061 . . . . 10.0 112.874 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -124.15 -17.04 6.31 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.635 1.174 . . . . 10.0 112.079 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.79 37.42 16.51 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.917 0.781 . . . . 10.0 112.508 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.46 163.06 37.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.316 1.058 . . . . 10.0 109.729 173.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.92 153.26 36.79 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 t -139.82 154.24 23.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.413 1.885 . . . . 10.0 105.972 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.19 165.17 37.04 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-O 121.998 0.777 . . . . 10.0 112.877 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.92 125.47 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 101.57 -3.492 . . . . 10.0 101.57 169.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.42 153.9 44.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.331 -0.618 . . . . 10.0 109.331 -166.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -124.72 31.47 5.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.827 -1.175 . . . . 10.0 107.827 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.61 -45.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 119.366 0.984 . . . . 10.0 112.156 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -64.61 148.77 50.2 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 0.752 . . . . 10.0 110.184 -170.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -140.78 39.07 1.82 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.261 1.024 . . . . 10.0 110.738 -168.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 58.53 43.34 19.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.411 1.484 . . . . 10.0 113.248 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.244 0.798 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 174.176 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.544 0.211 . . . . 10.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt -58.76 151.93 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.559 0.695 . . . . 10.0 110.979 171.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -110.69 162.93 14.25 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.242 1.817 . . . . 10.0 106.56 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.92 136.12 53.46 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.22 -2.141 . . . . 10.0 105.22 168.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.72 144.54 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 -164.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -145.54 106.81 4.18 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.147 1.379 . . . . 10.0 107.467 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -152.64 144.04 16.17 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 119.421 1.009 . . . . 10.0 110.027 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.8 -36.05 89.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.119 2.546 . . . . 10.0 114.6 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -73.83 -25.12 59.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.498 0.925 . . . . 10.0 113.498 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.0 28.8 26.1 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.603 -1.11 . . . . 10.0 115.644 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -52.01 112.44 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.244 1.417 . . . . 10.0 111.772 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -73.0 102.45 3.49 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.691 0.796 . . . . 10.0 108.974 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.12 -13.2 57.58 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.82 1.044 . . . . 10.0 113.82 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.85 -69.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.123 2.569 . . . . 10.0 114.481 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -165.16 164.16 20.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.848 1.259 . . . . 10.0 110.589 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.0 176.68 12.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.729 1.612 . . . . 10.0 108.669 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.75 135.92 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.04 128.79 12.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 45.64 44.25 10.09 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.104 1.762 . . . . 10.0 113.022 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.68 79.61 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.262 -0.744 . . . . 10.0 113.858 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -112.22 135.6 52.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -90.14 152.39 21.14 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.582 -0.896 . . . . 10.0 108.582 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -138.22 140.18 39.61 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 -171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.9 tt -153.89 157.24 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.562 1.074 . . . . 10.0 112.24 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.71 154.91 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.705 1.602 . . . . 10.0 112.223 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -135.28 -66.52 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.314 -1.326 . . . . 10.0 109.092 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 m -151.35 151.31 31.57 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.378 1.445 . . . . 10.0 111.352 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -145.54 153.17 40.82 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 10.0 109.698 170.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -153.63 157.77 40.13 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.296 1.439 . . . . 10.0 108.865 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -91.7 123.97 35.49 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -93.63 86.3 5.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.653 0.74 . . . . 10.0 109.115 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -56.09 -17.1 6.16 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.673 1.189 . . . . 10.0 113.443 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.67 70.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.202 0.91 . . . . 10.0 111.633 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.46 -13.08 3.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.275 1.03 . . . . 10.0 112.308 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.7 43.82 8.16 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.775 0.716 . . . . 10.0 111.759 171.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -145.86 162.78 36.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.773 0.787 . . . . 10.0 109.883 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 80.2 m95 -75.51 152.89 37.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.385 0.612 . . . . 10.0 109.369 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.4 t -135.16 153.19 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 162.04 33.96 Favored Glycine 0 N--CA 1.45 -0.433 0 O-C-N 121.575 -0.703 . . . . 10.0 112.983 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -102.0 121.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 101.641 -3.466 . . . . 10.0 101.641 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 137.18 25.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.336 -0.987 . . . . 10.0 108.336 -165.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -108.69 33.38 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.897 -1.149 . . . . 10.0 107.897 172.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.59 -44.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.341 0.973 . . . . 10.0 112.313 170.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -66.07 153.07 43.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.991 0.814 . . . . 10.0 111.492 -168.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -148.35 34.53 0.8 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.496 1.518 . . . . 10.0 109.801 -167.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 69.83 -25.84 0.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.848 2.459 . . . . 10.0 114.406 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm . . . . . 0 C--O 1.247 0.958 0 C-N-CA 124.289 1.036 . . . . 10.0 109.999 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 119.523 -0.275 . . . . 10.0 110.512 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 pt -57.71 156.89 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.673 0.749 . . . . 10.0 110.968 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -122.22 159.21 27.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.316 2.246 . . . . 10.0 106.053 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.94 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.6 -2.0 . . . . 10.0 105.6 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.46 141.95 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -163.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -147.73 102.37 3.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.098 1.359 . . . . 10.0 107.912 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -153.19 150.13 23.17 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.687 0.676 . . . . 10.0 109.683 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.49 -26.58 28.72 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.28 1.987 . . . . 10.0 113.22 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -70.04 -33.18 71.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.756 0.707 . . . . 10.0 112.389 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.9 30.01 74.05 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.766 -1.019 . . . . 10.0 114.076 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -50.46 106.5 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.57 1.548 . . . . 10.0 112.06 -174.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -75.12 102.98 5.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -10.83 58.38 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.602 0.964 . . . . 10.0 113.602 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.05 -70.94 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.165 2.586 . . . . 10.0 114.489 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -163.92 162.78 23.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.969 1.308 . . . . 10.0 110.708 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -158.73 177.5 11.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.528 1.531 . . . . 10.0 109.026 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.16 129.83 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 tp -155.46 143.66 20.1 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.331 1.453 . . . . 10.0 107.271 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.61 47.41 11.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.487 1.515 . . . . 10.0 112.532 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.81 63.33 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.165 0.888 . . . . 10.0 113.698 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -134.93 148.44 50.05 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.337 1.455 . . . . 10.0 107.258 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -90.87 150.49 21.52 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -136.51 140.54 43.08 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.273 -1.751 . . . . 10.0 106.273 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.77 159.23 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.59 1.086 . . . . 10.0 112.286 -165.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -55.36 154.51 6.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.018 1.727 . . . . 10.0 112.621 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -136.09 -59.18 0.75 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-O 117.578 -1.201 . . . . 10.0 109.133 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -161.57 159.89 28.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.282 1.401 . . . . 10.0 112.354 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -141.24 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.231 1.412 . . . . 10.0 108.643 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -150.71 158.6 44.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.99 1.316 . . . . 10.0 108.233 162.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -91.57 123.22 34.82 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.095 -1.446 . . . . 10.0 107.095 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -95.64 88.78 5.12 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -56.75 -15.72 5.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.894 1.278 . . . . 10.0 113.383 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -64.17 -24.58 67.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.361 0.982 . . . . 10.0 111.855 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -130.23 -12.42 4.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.579 1.152 . . . . 10.0 112.016 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 46.32 16.87 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.34 167.44 22.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.556 0.743 . . . . 10.0 110.48 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.83 150.05 28.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.44 152.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.501 -2.037 . . . . 10.0 105.501 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.2 37.57 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 121.358 -0.839 . . . . 10.0 112.914 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.92 126.45 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 102.107 -3.294 . . . . 10.0 102.107 167.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 136.17 23.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -104.17 31.49 4.55 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.79 -50.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.505 1.048 . . . . 10.0 111.705 169.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -67.54 148.27 51.69 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.831 0.741 . . . . 10.0 110.453 -170.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.09 47.4 0.77 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.848 1.259 . . . . 10.0 109.734 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 62.41 10.78 4.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.363 1.865 . . . . 10.0 113.977 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.248 1.019 0 C-N-CA 124.111 0.964 . . . . 10.0 108.576 174.285 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 119.471 -0.299 . . . . 10.0 110.842 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 pt -60.17 159.15 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.832 0.825 . . . . 10.0 111.312 174.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 159.32 27.25 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.247 2.219 . . . . 10.0 106.574 168.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -111.66 133.96 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.196 -2.15 . . . . 10.0 105.196 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.91 149.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -167.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.33 137.92 16.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 109.31 173.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -169.79 150.55 3.89 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 125.18 1.392 . . . . 10.0 107.603 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.27 -26.63 43.99 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.747 2.298 . . . . 10.0 113.194 166.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -63.83 -39.67 94.79 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.636 0.774 . . . . 10.0 112.226 -175.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.45 33.8 17.94 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.302 0.953 . . . . 10.0 114.001 -175.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -60.57 105.67 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.411 1.084 . . . . 10.0 111.08 -168.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.48 108.45 4.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.024 -0.732 . . . . 10.0 109.024 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.09 -10.63 38.29 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 -174.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.96 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.14 2.576 . . . . 10.0 114.582 -171.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -164.6 162.98 21.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.995 1.318 . . . . 10.0 110.314 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -157.75 176.97 11.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.527 1.531 . . . . 10.0 108.63 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.34 135.93 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 174.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -152.56 131.47 12.52 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.494 -1.298 . . . . 10.0 107.494 -174.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.0 t0 44.49 47.72 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.494 1.918 . . . . 10.0 113.021 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.29 75.85 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.797 0.713 . . . . 10.0 113.625 175.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.8 m -124.67 135.82 53.38 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.14 153.18 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 175.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.96 140.49 40.26 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.465 -1.68 . . . . 10.0 106.465 -172.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.08 157.23 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 119.379 0.991 . . . . 10.0 112.217 -167.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -57.1 154.27 10.23 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.781 1.633 . . . . 10.0 112.373 170.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -138.75 -55.82 0.62 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 117.516 -1.23 . . . . 10.0 109.914 165.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -159.82 153.36 22.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.519 1.509 . . . . 10.0 111.613 173.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -145.26 160.67 41.13 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.413 1.085 . . . . 10.0 108.615 161.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -152.51 162.48 41.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.701 1.6 . . . . 10.0 108.591 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -95.85 123.59 39.5 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -96.5 90.9 5.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.835 0.854 . . . . 10.0 108.718 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.71 -15.4 7.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.756 1.222 . . . . 10.0 113.416 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.78 -26.14 68.5 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.381 0.991 . . . . 10.0 111.576 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -129.95 -10.82 4.32 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.371 1.068 . . . . 10.0 112.114 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.7 46.36 18.68 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.794 -0.923 . . . . 10.0 110.794 175.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.96 164.78 31.85 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.953 0.901 . . . . 10.0 110.201 177.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -81.39 153.17 27.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.81 151.44 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 127.161 2.184 . . . . 10.0 105.194 176.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.93 173.22 39.95 Favored Glycine 0 C--N 1.334 0.418 0 O-C-N 120.904 -1.122 . . . . 10.0 113.973 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 54.1 mt -124.85 113.51 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 101.618 -3.475 . . . . 10.0 101.618 178.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.81 139.43 32.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.792 -1.188 . . . . 10.0 107.792 -158.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -108.99 30.75 6.26 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 173.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.67 -45.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.174 0.897 . . . . 10.0 112.1 171.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -65.99 154.05 40.48 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.985 0.811 . . . . 10.0 111.164 -169.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.47 31.59 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 10.0 110.103 -166.079 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 67.4 -23.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 127.983 2.513 . . . . 10.0 114.403 -175.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm . . . . . 0 C--O 1.251 1.17 0 C-N-CA 124.253 1.021 . . . . 10.0 110.187 178.708 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 121.933 0.873 . . . . 10.0 112.219 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -127.92 162.79 25.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.831 2.452 . . . . 10.0 106.994 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.9 mt -117.06 134.32 54.9 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.446 -2.057 . . . . 10.0 105.446 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -139.78 147.2 24.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -164.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -145.3 126.11 14.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.193 1.397 . . . . 10.0 107.253 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -168.12 153.3 6.57 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.601 1.16 . . . . 10.0 110.377 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.24 -24.72 27.16 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.395 2.063 . . . . 10.0 113.292 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -76.28 -19.26 58.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.99 30.53 23.11 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.565 1.079 . . . . 10.0 114.668 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -52.75 105.71 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 10.0 111.887 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -74.53 105.52 5.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.833 0.853 . . . . 10.0 109.123 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.6 -10.26 56.12 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.862 1.06 . . . . 10.0 113.862 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.06 -72.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.277 2.631 . . . . 10.0 114.884 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.6 p -165.48 161.96 19.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.174 1.39 . . . . 10.0 110.32 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -158.99 175.3 13.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.233 1.413 . . . . 10.0 109.092 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.67 130.76 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 105.685 -1.968 . . . . 10.0 105.685 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -152.2 137.87 17.86 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.03 -1.47 . . . . 10.0 107.03 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.68 50.13 10.88 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.193 1.797 . . . . 10.0 112.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.79 23.24 63.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.104 0.859 . . . . 10.0 113.382 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -130.7 145.07 51.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.672 -1.603 . . . . 10.0 106.672 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.26 151.0 19.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.801 -0.814 . . . . 10.0 108.801 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -138.2 139.24 39.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 tt -155.11 158.18 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.371 1.068 . . . . 10.0 112.015 -168.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.19 156.94 3.76 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.328 1.851 . . . . 10.0 112.545 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -140.45 -61.52 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.533 -1.222 . . . . 10.0 109.569 168.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -154.23 147.28 24.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.045 1.293 . . . . 10.0 111.21 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.28 160.89 41.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.256 -0.903 . . . . 10.0 110.088 162.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.95 162.64 41.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.54 1.536 . . . . 10.0 108.819 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -94.01 123.16 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -93.62 82.1 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.412 -0.959 . . . . 10.0 108.412 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -54.35 -25.67 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.808 1.243 . . . . 10.0 113.452 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m -63.93 -20.17 65.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.436 1.094 . . . . 10.0 112.847 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -126.81 -16.56 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.143 1.377 . . . . 10.0 111.558 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.68 40.11 38.7 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.507 -0.637 . . . . 10.0 111.507 174.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.92 166.85 23.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.759 0.779 . . . . 10.0 110.097 172.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -80.28 152.19 29.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.671 -0.862 . . . . 10.0 108.671 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.2 t -137.56 151.4 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.507 -2.035 . . . . 10.0 105.507 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 170.24 38.48 Favored Glycine 0 N--CA 1.45 -0.369 0 O-C-N 121.353 -0.842 . . . . 10.0 113.246 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -116.84 122.0 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 101.653 -3.462 . . . . 10.0 101.653 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.48 44.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 -164.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -127.09 36.78 4.38 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.13 -45.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.722 0.692 . . . . 10.0 111.512 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.1 t90 . . . . . 0 CA--C 1.532 0.257 0 CA-C-N 118.847 0.748 . . . . 10.0 109.309 -174.564 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 122.054 0.93 . . . . 10.0 111.42 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -128.17 161.47 29.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.108 2.563 . . . . 10.0 106.176 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -108.31 130.95 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.456 -2.053 . . . . 10.0 105.456 172.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.16 142.92 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -162.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.56 140.88 16.62 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.818 0.847 . . . . 10.0 109.833 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.49 153.74 5.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.211 1.404 . . . . 10.0 108.497 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.42 -27.44 28.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.207 1.938 . . . . 10.0 112.786 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -69.29 -30.4 68.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.825 0.676 . . . . 10.0 112.825 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.84 46.83 93.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.377 -0.689 . . . . 10.0 111.377 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -73.29 70.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.065 1.346 . . . . 10.0 111.152 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -52.61 121.28 6.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.737 1.215 . . . . 10.0 109.77 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -9.12 18.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.621 0.971 . . . . 10.0 113.621 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.34 -65.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.348 2.659 . . . . 10.0 114.986 -170.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 p -165.26 163.19 20.14 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.81 1.244 . . . . 10.0 110.723 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.23 174.06 15.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 10.0 108.607 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.32 133.68 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.726 -1.953 . . . . 10.0 105.726 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 tt -144.68 121.3 11.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.89 42.14 15.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.892 1.677 . . . . 10.0 112.664 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.53 0.79 74.26 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.216 0.912 . . . . 10.0 114.017 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.5 m -96.99 137.78 35.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -88.73 150.83 22.78 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -137.32 140.33 41.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.111 1.764 . . . . 10.0 106.277 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.1 158.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.519 1.128 . . . . 10.0 112.003 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.92 157.01 8.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.966 1.706 . . . . 10.0 112.495 171.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.67 -61.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.531 -1.223 . . . . 10.0 109.397 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 m -150.78 149.8 30.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.681 1.128 . . . . 10.0 111.025 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.65 156.73 44.25 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.908 0.883 . . . . 10.0 109.539 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.61 160.71 40.68 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.219 1.407 . . . . 10.0 108.725 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.51 120.08 34.2 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.12 81.81 6.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.333 -0.988 . . . . 10.0 108.333 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -53.23 -27.14 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.745 1.218 . . . . 10.0 113.342 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -64.23 -20.01 65.75 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.408 1.083 . . . . 10.0 112.952 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.0 -12.51 6.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.675 1.19 . . . . 10.0 111.911 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 41.96 32.84 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.748 0.69 . . . . 10.0 111.814 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 164.53 33.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.854 0.827 . . . . 10.0 110.574 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -78.57 150.03 32.88 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.17 153.78 24.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.585 -2.005 . . . . 10.0 105.585 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.71 162.92 34.92 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.283 -0.886 . . . . 10.0 113.088 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.6 mm -101.12 119.27 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.725 -3.435 . . . . 10.0 101.725 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.53 29.76 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -162.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.44 34.78 3.92 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.71 -1.219 . . . . 10.0 107.71 170.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.49 -56.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.317 0.962 . . . . 10.0 111.388 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.9 t90 . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 118.675 0.67 . . . . 10.0 111.128 -165.219 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.4 pt . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 122.103 0.954 . . . . 10.0 111.504 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -111.82 162.53 15.17 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.653 2.381 . . . . 10.0 106.259 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -123.43 135.2 53.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.117 -2.179 . . . . 10.0 105.117 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.64 148.84 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -165.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -139.48 127.46 22.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 170.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -161.12 151.66 14.99 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 119.47 1.032 . . . . 10.0 108.933 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.72 -27.7 26.36 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.958 1.772 . . . . 10.0 113.084 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -78.23 -25.09 46.78 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.473 0.916 . . . . 10.0 113.473 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.24 32.15 35.86 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.351 -1.249 . . . . 10.0 114.769 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -54.5 115.45 2.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.937 1.368 . . . . 10.0 111.434 -171.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -78.24 115.29 17.86 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.27 -11.58 23.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.77 -67.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.157 2.583 . . . . 10.0 114.608 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -165.47 162.88 19.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.852 1.261 . . . . 10.0 110.544 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -158.71 176.3 12.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.479 1.511 . . . . 10.0 108.751 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.31 130.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.782 -1.932 . . . . 10.0 105.782 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.18 138.12 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t0 45.94 51.21 10.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.152 1.781 . . . . 10.0 112.577 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.2 63.52 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.104 0.859 . . . . 10.0 113.487 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -132.98 143.37 49.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -90.71 150.63 21.56 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -137.07 140.27 41.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.14 156.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.46 1.104 . . . . 10.0 112.025 -167.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -57.85 154.77 11.5 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.266 1.826 . . . . 10.0 112.395 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -137.1 -61.6 0.65 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.449 -1.263 . . . . 10.0 109.277 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -161.37 154.88 21.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.706 1.593 . . . . 10.0 111.602 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -146.78 160.55 42.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.101 0.961 . . . . 10.0 109.378 166.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.16 158.26 43.74 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.318 1.447 . . . . 10.0 108.701 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -90.54 120.36 31.57 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -87.64 76.6 8.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -51.8 -28.3 15.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.031 1.332 . . . . 10.0 113.287 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -64.78 -17.38 64.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.668 1.187 . . . . 10.0 113.19 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -131.11 -15.63 3.29 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.457 1.103 . . . . 10.0 112.293 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 39.05 8.29 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.945 0.793 . . . . 10.0 112.515 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -148.54 163.64 36.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.042 0.921 . . . . 10.0 109.417 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -77.5 154.53 32.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.06 150.35 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.4 38.27 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.585 -0.817 . . . . 10.0 113.953 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.0 mt -114.5 118.66 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 101.636 -3.468 . . . . 10.0 101.636 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.3 134.54 20.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.969 -1.123 . . . . 10.0 107.969 -162.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -106.78 36.03 2.79 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.29 -46.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.43 1.014 . . . . 10.0 111.765 168.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 118.722 0.692 . . . . 10.0 109.879 -175.546 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 122.575 1.179 . . . . 10.0 112.386 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -120.51 165.33 15.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.751 2.82 . . . . 10.0 106.056 166.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.3 mt -127.18 137.92 53.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.51 148.12 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -168.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -144.21 115.34 7.92 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -153.69 149.59 21.41 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.698 0.799 . . . . 10.0 109.259 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.66 -26.99 32.74 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.982 1.788 . . . . 10.0 113.02 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -81.73 -19.13 42.07 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.04 45.85 26.49 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 119.204 0.911 . . . . 10.0 112.945 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -65.26 81.39 0.05 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.769 1.228 . . . . 10.0 112.195 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -57.95 121.49 10.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.294 1.438 . . . . 10.0 109.794 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.37 -10.19 19.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -173.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.25 -64.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.396 2.678 . . . . 10.0 115.012 -168.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -166.42 163.73 17.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.828 1.251 . . . . 10.0 110.818 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -158.49 178.09 10.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.84 1.656 . . . . 10.0 108.386 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.03 137.71 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 106.779 -1.563 . . . . 10.0 106.779 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 tp -149.33 127.18 11.81 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 44.87 46.35 8.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.08 1.752 . . . . 10.0 113.153 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.18 14.06 82.21 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.297 -0.724 . . . . 10.0 113.83 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.7 m -118.75 131.09 56.11 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -86.38 151.82 23.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.6 140.17 42.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.31 157.81 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 125.043 1.337 . . . . 10.0 111.695 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.61 155.32 4.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.225 1.81 . . . . 10.0 112.584 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -136.62 -64.89 0.57 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.444 -1.265 . . . . 10.0 109.083 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.0 m -152.38 151.01 30.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.376 1.444 . . . . 10.0 111.222 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -145.56 154.9 42.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.788 0.835 . . . . 10.0 109.66 169.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.0 156.81 38.09 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.77 1.228 . . . . 10.0 108.836 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -90.27 120.42 31.4 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -88.59 77.02 8.06 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.06 -28.79 18.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.86 1.264 . . . . 10.0 113.107 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -66.05 -17.6 64.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.475 1.11 . . . . 10.0 112.983 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -126.79 -17.35 4.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.339 1.056 . . . . 10.0 111.83 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.79 9.27 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.743 0.701 . . . . 10.0 112.349 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -148.65 163.46 37.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.282 1.041 . . . . 10.0 109.987 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -75.7 154.36 36.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.11 153.33 26.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.76 161.31 33.16 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.687 -0.633 . . . . 10.0 112.921 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.5 mt -103.67 124.25 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 101.778 -3.416 . . . . 10.0 101.778 166.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 131.6 18.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.468 -0.938 . . . . 10.0 108.468 -163.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -103.54 37.13 2.09 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -153.69 -49.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 119.283 0.947 . . . . 10.0 111.874 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 . . . . . 0 CA--C 1.535 0.376 0 CA-C-N 118.82 0.736 . . . . 10.0 110.203 -170.89 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.527 0.679 . . . . 10.0 111.227 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -113.34 161.75 16.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.575 1.95 . . . . 10.0 106.761 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.96 137.19 52.28 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.464 -2.051 . . . . 10.0 105.464 169.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.89 147.63 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -141.47 126.23 18.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.481 1.512 . . . . 10.0 106.946 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -166.9 146.6 4.75 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.43 -16.43 47.61 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.973 1.782 . . . . 10.0 112.367 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -63.82 -41.16 97.92 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.647 0.658 . . . . 10.0 111.598 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.9 28.06 15.6 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.762 1.172 . . . . 10.0 114.629 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.07 105.33 1.03 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.525 1.163 . . . . 10.0 110.64 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -66.31 108.32 2.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.19 -12.0 42.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.423 0.897 . . . . 10.0 113.423 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.5 -70.06 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.165 2.586 . . . . 10.0 114.2 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 163.29 19.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.028 1.331 . . . . 10.0 110.37 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -157.72 174.06 15.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.215 1.406 . . . . 10.0 109.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -135.25 129.64 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.94 -1.874 . . . . 10.0 105.94 173.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.95 131.48 14.81 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.551 -1.648 . . . . 10.0 106.551 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.18 51.52 9.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.764 2.026 . . . . 10.0 112.743 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.77 21.96 63.72 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.528 -0.76 . . . . 10.0 113.378 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -127.7 142.82 51.22 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -91.72 151.93 20.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -138.9 140.33 38.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.122 -1.807 . . . . 10.0 106.122 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.23 158.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.742 1.156 . . . . 10.0 112.438 -166.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -57.23 155.29 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.029 1.732 . . . . 10.0 112.386 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -138.77 -62.51 0.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 117.358 -1.306 . . . . 10.0 109.106 167.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 m -154.46 149.15 26.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.201 1.364 . . . . 10.0 111.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -146.42 160.89 41.48 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.329 -0.857 . . . . 10.0 110.0 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.07 164.15 38.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.639 1.576 . . . . 10.0 108.716 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -96.34 121.82 38.55 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -90.88 87.1 6.5 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.09 -16.75 5.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.696 1.199 . . . . 10.0 113.362 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -25.86 68.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.182 0.901 . . . . 10.0 111.838 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -134.64 -11.7 2.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.181 0.992 . . . . 10.0 112.558 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.85 43.06 9.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 118.901 0.773 . . . . 10.0 111.952 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -146.02 163.03 36.51 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.657 0.783 . . . . 10.0 109.524 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -75.98 153.28 36.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 171.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -136.96 151.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.377 -2.083 . . . . 10.0 105.377 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 169.5 38.9 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.621 -0.799 . . . . 10.0 113.856 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.78 120.36 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 101.254 -3.61 . . . . 10.0 101.254 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.31 149.79 36.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -165.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.3 31.03 6.81 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.67 -47.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.767 0.827 . . . . 10.0 111.556 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.1 t90 . . . . . 0 CA--C 1.532 0.278 0 CA-C-N 118.751 0.705 . . . . 10.0 110.464 -171.737 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 121.907 0.861 . . . . 10.0 111.425 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -109.32 165.02 11.94 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.893 2.077 . . . . 10.0 106.819 165.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.27 138.8 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.261 -2.126 . . . . 10.0 105.261 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.58 151.12 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -168.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.03 122.14 7.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.462 1.105 . . . . 10.0 108.264 171.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -154.25 151.61 24.63 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.791 1.236 . . . . 10.0 108.363 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.74 -25.07 40.18 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.894 1.729 . . . . 10.0 113.153 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -88.05 -15.87 35.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -172.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.47 36.1 37.77 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.203 -1.331 . . . . 10.0 113.954 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -53.16 98.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.128 1.371 . . . . 10.0 112.235 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.76 117.44 17.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.205 1.002 . . . . 10.0 108.927 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.35 -11.67 25.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.27 -64.78 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.162 2.585 . . . . 10.0 114.642 -167.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -166.59 162.99 16.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.836 1.254 . . . . 10.0 110.724 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -159.73 178.65 9.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 10.0 108.816 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -135.67 129.82 49.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -151.95 139.97 20.14 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t0 47.05 50.18 14.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.682 1.593 . . . . 10.0 112.434 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.25 64.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.14 0.876 . . . . 10.0 113.517 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -134.79 144.22 47.53 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 -173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -88.25 149.75 23.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -135.34 141.74 45.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.325 -1.732 . . . . 10.0 106.325 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 tt -152.25 156.92 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.213 . . . . 10.0 111.847 -168.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -58.0 153.7 13.93 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.577 1.551 . . . . 10.0 111.998 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -131.82 -70.18 0.58 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.345 -1.312 . . . . 10.0 108.318 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.2 m -153.47 149.46 27.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.312 1.414 . . . . 10.0 111.289 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -143.15 157.89 44.11 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.498 -0.751 . . . . 10.0 109.512 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -149.13 154.35 39.08 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.445 1.498 . . . . 10.0 108.352 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -88.82 119.85 29.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -85.07 82.24 8.52 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -55.83 -29.68 60.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.984 0.914 . . . . 10.0 112.269 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -25.39 68.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.867 1.267 . . . . 10.0 112.644 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -120.31 -18.07 8.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.851 0.86 . . . . 10.0 111.932 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.81 29.9 12.43 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.411 1.005 . . . . 10.0 113.003 168.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -153.53 163.74 39.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.882 1.341 . . . . 10.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -74.3 152.77 39.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -139.21 152.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.477 -2.046 . . . . 10.0 105.477 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.88 167.41 39.15 Favored Glycine 0 C--N 1.332 0.33 0 O-C-N 121.274 -0.891 . . . . 10.0 114.082 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -109.41 125.32 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 102.353 -3.202 . . . . 10.0 102.353 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.31 130.84 16.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -165.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -99.85 32.15 3.0 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 -48.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.69 1.132 . . . . 10.0 112.363 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t90 . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 118.644 0.657 . . . . 10.0 110.569 -174.1 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 122.105 0.955 . . . . 10.0 112.643 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.33 163.31 31.31 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.762 2.425 . . . . 10.0 106.512 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.89 135.43 54.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.809 -1.923 . . . . 10.0 105.809 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.07 145.4 27.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -144.74 119.19 9.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.16 -1.792 . . . . 10.0 106.16 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -168.11 153.16 6.52 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 125.292 1.437 . . . . 10.0 110.064 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.2 -27.08 17.1 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.466 2.111 . . . . 10.0 113.246 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -68.29 -29.99 68.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.954 0.797 . . . . 10.0 112.645 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.28 31.85 13.2 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.26 -1.3 . . . . 10.0 114.963 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 107.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.791 1.295 . . . . 10.0 111.546 -168.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.48 116.3 6.62 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.0 -8.49 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.413 0.894 . . . . 10.0 113.413 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.7 -69.26 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.313 2.645 . . . . 10.0 114.517 -171.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -164.86 162.54 20.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.867 1.267 . . . . 10.0 110.878 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -159.29 177.96 10.47 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.659 1.583 . . . . 10.0 109.061 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.14 129.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 105.943 -1.873 . . . . 10.0 105.943 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -154.97 142.97 20.12 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.362 1.465 . . . . 10.0 107.09 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.59 47.49 14.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.656 1.582 . . . . 10.0 112.644 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.45 23.72 62.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.238 0.923 . . . . 10.0 113.573 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.4 m -134.45 147.44 50.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.95 150.95 21.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -135.78 140.05 44.0 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 105.985 -1.857 . . . . 10.0 105.985 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -154.9 157.13 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.603 1.161 . . . . 10.0 111.384 -167.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -59.57 155.99 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.752 1.621 . . . . 10.0 112.19 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -136.83 -67.92 0.49 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.416 -1.278 . . . . 10.0 109.271 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.6 m -151.16 144.62 24.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.463 1.483 . . . . 10.0 111.259 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -148.75 151.48 34.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.915 0.886 . . . . 10.0 109.294 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.9 158.7 42.52 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.809 1.244 . . . . 10.0 108.997 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -91.18 119.3 31.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -88.33 81.43 7.27 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -53.85 -26.44 24.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.967 1.307 . . . . 10.0 113.437 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.2 m -63.0 -21.19 65.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.346 1.059 . . . . 10.0 112.901 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.64 -12.57 6.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.704 1.201 . . . . 10.0 111.916 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 42.33 28.31 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.78 166.45 26.61 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.624 0.77 . . . . 10.0 109.996 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -81.27 152.28 27.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.904 -0.776 . . . . 10.0 108.904 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -137.3 150.69 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.332 -2.099 . . . . 10.0 105.332 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.81 166.37 38.03 Favored Glycine 0 C--N 1.333 0.365 0 O-C-N 121.426 -0.796 . . . . 10.0 113.486 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -108.32 120.69 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 101.677 -3.453 . . . . 10.0 101.677 168.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.64 155.53 46.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -167.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -128.37 36.41 4.28 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 106.653 -1.61 . . . . 10.0 106.653 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.97 -45.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.63 1.105 . . . . 10.0 112.01 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.2 t90 . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 119.191 0.905 . . . . 10.0 109.533 -175.535 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.0 pt . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.831 0.824 . . . . 10.0 111.292 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.11 159.31 21.91 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.007 2.123 . . . . 10.0 106.36 166.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.85 128.12 56.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.672 -2.344 . . . . 10.0 104.672 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -139.21 147.73 24.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.23 -1.026 . . . . 10.0 108.23 -161.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -149.34 148.4 29.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.21 1.004 . . . . 10.0 108.524 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m 179.14 155.43 0.61 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 127.562 2.345 . . . . 10.0 108.17 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.41 -24.26 31.48 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.312 2.008 . . . . 10.0 113.254 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -68.08 -28.78 67.65 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.401 -0.809 . . . . 10.0 113.019 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.25 41.59 8.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.44 1.019 . . . . 10.0 114.348 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.23 91.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.159 1.384 . . . . 10.0 110.974 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.39 112.33 2.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.802 0.841 . . . . 10.0 108.892 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.65 -12.16 24.25 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.269 0.841 . . . . 10.0 113.269 -174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.07 -63.81 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.389 2.676 . . . . 10.0 114.567 -169.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -165.18 162.75 20.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.814 1.246 . . . . 10.0 110.569 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -158.01 177.5 11.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.687 1.595 . . . . 10.0 108.495 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 135.84 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.784 -1.561 . . . . 10.0 106.784 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.0 131.2 12.75 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 44.13 47.84 7.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.861 . . . . 10.0 113.086 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.34 18.14 76.6 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.352 -0.693 . . . . 10.0 113.707 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -125.18 136.17 53.32 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.36 152.97 21.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -137.55 140.43 41.04 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.337 -1.727 . . . . 10.0 106.337 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -154.68 159.31 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 119.591 1.087 . . . . 10.0 112.169 -167.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.03 156.4 9.42 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.69 1.596 . . . . 10.0 112.276 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -139.67 -63.26 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 117.265 -1.35 . . . . 10.0 109.445 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.9 m -151.7 149.52 29.18 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.092 1.314 . . . . 10.0 111.198 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -147.16 156.28 42.84 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.748 0.819 . . . . 10.0 109.719 168.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -155.13 160.7 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.955 1.302 . . . . 10.0 108.885 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -94.15 120.79 34.91 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.258 -1.386 . . . . 10.0 107.258 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.28 86.3 6.8 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.09 -0.708 . . . . 10.0 109.09 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -55.76 -15.94 3.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.483 1.113 . . . . 10.0 113.433 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -22.08 66.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.236 0.925 . . . . 10.0 112.161 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -139.4 -11.97 1.2 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.144 0.978 . . . . 10.0 112.826 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 45.29 7.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.15 0.886 . . . . 10.0 111.956 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.74 163.2 34.74 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.838 0.819 . . . . 10.0 109.629 172.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -76.49 153.17 35.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.25 153.05 23.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.911 2.084 . . . . 10.0 105.573 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.98 165.29 37.57 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 121.381 -0.825 . . . . 10.0 113.323 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.65 120.47 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 101.202 -3.629 . . . . 10.0 101.202 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.87 139.14 29.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 -164.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -109.36 30.08 6.95 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.64 -44.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.729 1.149 . . . . 10.0 113.041 171.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.7 t90 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 119.819 1.191 . . . . 10.0 109.971 -173.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 121.779 0.799 . . . . 10.0 111.771 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.85 166.75 11.15 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.692 1.997 . . . . 10.0 107.092 158.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.97 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.17 146.09 25.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.014 -0.736 . . . . 10.0 109.014 -162.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.68 141.5 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.894 1.278 . . . . 10.0 108.09 169.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -173.03 154.12 2.64 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 126.853 2.061 . . . . 10.0 107.97 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.21 -25.95 30.66 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.227 1.951 . . . . 10.0 113.091 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -69.74 -28.39 65.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.696 -0.669 . . . . 10.0 112.58 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.05 48.23 58.83 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 118.638 0.654 . . . . 10.0 112.012 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -71.44 73.94 0.74 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.739 1.215 . . . . 10.0 111.176 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.21 120.09 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.074 1.35 . . . . 10.0 109.591 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.86 -7.92 21.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.06 -70.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.032 2.533 . . . . 10.0 114.48 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.7 p -159.61 164.82 33.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.512 1.051 . . . . 10.0 110.634 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -157.76 179.48 9.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.322 1.449 . . . . 10.0 108.975 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.71 130.79 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.3 144.03 21.66 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.75 46.85 11.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.52 . . . . 10.0 112.419 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.4 24.5 63.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.189 0.9 . . . . 10.0 113.636 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -133.75 147.43 51.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.066 1.346 . . . . 10.0 107.553 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -83.0 146.38 28.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -133.31 140.25 47.33 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.511 -1.662 . . . . 10.0 106.511 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -154.37 158.32 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.624 1.17 . . . . 10.0 111.874 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.99 156.58 5.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.055 1.742 . . . . 10.0 112.677 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -138.45 -62.2 0.57 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 117.257 -1.354 . . . . 10.0 109.334 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -151.9 150.25 29.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.127 1.33 . . . . 10.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -145.09 157.0 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.598 0.759 . . . . 10.0 109.556 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.08 160.8 41.27 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.941 1.296 . . . . 10.0 108.716 170.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -94.14 116.19 28.57 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.17 87.55 7.39 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -58.36 -15.4 10.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.607 1.163 . . . . 10.0 113.218 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.61 -25.11 67.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.428 1.013 . . . . 10.0 111.625 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.66 -12.63 4.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.626 1.17 . . . . 10.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 42.97 19.68 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.703 0.668 . . . . 10.0 111.506 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.46 163.84 34.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.026 0.913 . . . . 10.0 110.974 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -78.68 150.64 32.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -140.23 152.84 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.805 2.042 . . . . 10.0 105.616 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.39 163.64 36.7 Favored Glycine 0 C--N 1.334 0.427 0 O-C-N 121.242 -0.911 . . . . 10.0 113.485 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.96 123.99 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 101.828 -3.397 . . . . 10.0 101.828 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.27 29.18 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.736 -0.838 . . . . 10.0 108.736 -163.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -115.31 35.72 4.25 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.97 -49.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.892 0.769 . . . . 10.0 112.202 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 . . . . . 0 CA--C 1.536 0.409 0 CA-C-N 119.137 0.881 . . . . 10.0 110.65 -171.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.912 0.863 . . . . 10.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -115.73 162.12 17.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.107 2.163 . . . . 10.0 106.585 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.72 136.62 53.24 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.4 -2.074 . . . . 10.0 105.4 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.9 146.89 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 -163.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.79 120.55 9.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.589 -1.634 . . . . 10.0 106.589 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m -158.99 150.99 17.27 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 119.739 1.154 . . . . 10.0 109.327 173.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.2 -27.19 35.36 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.035 1.823 . . . . 10.0 112.98 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -81.15 -17.43 49.84 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.792 1.034 . . . . 10.0 113.792 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.98 34.79 31.37 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.145 -1.364 . . . . 10.0 114.008 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -53.33 99.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.109 1.363 . . . . 10.0 112.408 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.8 117.26 15.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.501 1.12 . . . . 10.0 109.317 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.08 -11.81 27.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.98 -67.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.326 2.65 . . . . 10.0 114.2 -166.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -163.82 162.5 23.75 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.291 1.036 . . . . 10.0 110.366 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -158.55 176.4 12.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.04 1.336 . . . . 10.0 108.885 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -137.1 132.2 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -149.5 135.04 18.48 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.52 50.24 10.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.198 1.799 . . . . 10.0 112.757 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.19 69.17 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.822 0.725 . . . . 10.0 113.547 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -129.15 138.75 51.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.65 -1.611 . . . . 10.0 106.65 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -88.41 151.55 22.5 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.65 140.62 42.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.961 1.705 . . . . 10.0 106.518 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -152.58 155.02 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.153 1.381 . . . . 10.0 111.398 -163.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -57.59 156.02 8.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.565 1.546 . . . . 10.0 112.188 170.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -138.78 -64.99 0.5 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.538 -1.22 . . . . 10.0 109.465 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -152.15 149.75 29.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.203 1.365 . . . . 10.0 111.033 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 23.0 ttpt -149.97 143.61 25.32 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -150.84 154.76 37.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.739 1.216 . . . . 10.0 109.085 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -89.04 122.66 32.6 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.76 90.82 4.82 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.252 1.025 . . . . 10.0 108.88 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -57.4 -13.7 3.83 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.213 1.405 . . . . 10.0 113.399 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -62.71 -25.18 68.04 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.632 1.106 . . . . 10.0 111.876 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -131.59 -9.72 3.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.467 0.707 . . . . 10.0 111.959 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.58 8.69 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.469 -1.052 . . . . 10.0 110.469 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.32 163.17 34.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.317 1.047 . . . . 10.0 109.92 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.524 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 88.3 m95 -81.8 149.12 28.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -136.59 153.17 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.536 -2.024 . . . . 10.0 105.536 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.38 167.37 38.25 Favored Glycine 0 N--CA 1.45 -0.38 0 O-C-N 121.142 -0.974 . . . . 10.0 113.52 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.19 122.87 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 101.307 -3.59 . . . . 10.0 101.307 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.12 134.17 21.5 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -102.98 31.68 4.09 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 p -153.75 -47.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.913 1.233 . . . . 10.0 112.738 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 118.876 0.762 . . . . 10.0 110.696 -169.335 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.231 1.015 . . . . 10.0 112.41 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -116.67 163.56 15.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.372 2.269 . . . . 10.0 106.577 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.65 133.41 52.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.66 149.66 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.897 -0.779 . . . . 10.0 108.897 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -144.43 127.6 16.65 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.519 -2.03 . . . . 10.0 105.519 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -169.66 153.43 5.04 Favored Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 125.372 1.469 . . . . 10.0 109.151 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.78 -24.88 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.335 2.024 . . . . 10.0 113.123 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -81.77 -18.72 43.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.698 0.999 . . . . 10.0 113.698 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.39 37.66 18.95 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.365 -1.242 . . . . 10.0 113.818 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -54.06 99.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.89 1.276 . . . . 10.0 112.094 -170.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.06 116.88 16.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.082 0.953 . . . . 10.0 108.736 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.32 -11.82 27.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.576 0.954 . . . . 10.0 113.576 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.41 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.153 2.581 . . . . 10.0 114.673 -166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 p -167.46 164.49 14.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.826 1.25 . . . . 10.0 110.899 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -158.53 175.98 12.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.843 1.657 . . . . 10.0 108.486 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.7 132.74 48.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.872 -1.899 . . . . 10.0 105.872 171.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.3 tp -146.5 132.37 19.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.2 -1.407 . . . . 10.0 107.2 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.71 49.3 11.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.854 1.662 . . . . 10.0 112.774 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.9 72.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.806 0.717 . . . . 10.0 113.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -127.48 136.4 51.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -86.27 150.65 24.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -136.17 140.8 43.88 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.53 156.62 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 10.0 111.742 -168.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.91 152.82 15.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.515 1.526 . . . . 10.0 111.763 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -130.38 -70.29 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.416 -1.278 . . . . 10.0 108.112 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.51 149.24 27.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.185 1.357 . . . . 10.0 111.0 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.59 155.93 46.43 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.619 -0.676 . . . . 10.0 109.577 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -148.54 153.85 38.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.557 1.543 . . . . 10.0 108.082 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -89.1 118.47 28.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.344 -1.354 . . . . 10.0 107.344 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -83.97 94.13 8.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.4 m -64.73 -25.5 67.96 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.383 0.673 . . . . 10.0 112.725 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -70.03 -41.97 73.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.672 0.669 . . . . 10.0 110.249 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -84.22 -25.88 29.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.412 0.685 . . . . 10.0 111.68 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.79 40.86 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.154 0.883 . . . . 10.0 111.545 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.35 168.24 23.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.551 1.175 . . . . 10.0 111.014 173.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.0 152.48 36.96 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.077 -0.712 . . . . 10.0 109.077 167.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.16 153.67 27.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.752 2.021 . . . . 10.0 105.758 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.08 162.71 35.44 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 121.249 -0.907 . . . . 10.0 113.74 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.06 124.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 102.49 -3.152 . . . . 10.0 102.49 168.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.36 129.47 17.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -167.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -100.08 33.71 2.54 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.169 -1.048 . . . . 10.0 108.169 171.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.56 -48.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.565 1.075 . . . . 10.0 112.048 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t90 . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 118.805 0.73 . . . . 10.0 110.233 -175.678 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 pt . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 122.052 0.929 . . . . 10.0 111.646 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.9 165.14 17.9 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.971 2.508 . . . . 10.0 106.479 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.07 137.47 54.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.812 -1.921 . . . . 10.0 105.812 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.75 150.38 18.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 -168.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.51 14.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.511 1.124 . . . . 10.0 108.812 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.1 m -169.08 155.08 6.28 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.792 2.037 . . . . 10.0 107.943 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.01 -23.77 39.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.975 1.783 . . . . 10.0 112.754 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -71.25 -29.79 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.701 0.682 . . . . 10.0 112.361 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.1 42.23 71.26 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 118.973 -0.904 . . . . 10.0 112.513 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.18 98.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.017 0.927 . . . . 10.0 111.991 -163.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.96 121.53 17.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.455 0.702 . . . . 10.0 109.348 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.45 -8.94 17.79 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.18 -67.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.201 2.601 . . . . 10.0 114.814 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 p -165.04 162.7 20.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.158 1.383 . . . . 10.0 110.616 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -158.6 175.89 13.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.634 1.574 . . . . 10.0 108.602 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.99 132.31 47.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 105.786 -1.931 . . . . 10.0 105.786 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -149.57 134.46 17.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.161 -1.422 . . . . 10.0 107.161 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.33 49.94 10.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.108 1.763 . . . . 10.0 112.736 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.2 69.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.776 0.703 . . . . 10.0 113.508 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.2 m -128.86 140.21 51.8 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -90.34 150.38 21.91 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -136.24 139.12 42.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 tt -154.56 157.48 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.85 1.26 . . . . 10.0 111.975 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.55 154.29 4.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.943 1.697 . . . . 10.0 112.026 168.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -55.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.29 -1.338 . . . . 10.0 110.871 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.7 m -151.82 150.25 29.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.843 1.202 . . . . 10.0 110.794 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 25.6 ttpt -149.47 142.62 25.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -150.38 155.89 40.45 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.781 1.232 . . . . 10.0 109.197 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -93.2 122.2 35.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.465 -1.309 . . . . 10.0 107.465 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -96.81 89.99 5.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.94 -15.66 5.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.921 1.288 . . . . 10.0 113.386 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.48 -26.91 68.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.508 1.049 . . . . 10.0 111.632 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.79 -14.65 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.554 1.142 . . . . 10.0 111.635 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.13 13.24 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.556 -1.018 . . . . 10.0 110.556 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 166.09 26.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.661 0.784 . . . . 10.0 110.384 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 91.4 m95 -81.32 152.65 27.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.2 156.09 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.243 2.217 . . . . 10.0 105.267 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.34 169.35 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 O-C-N 120.905 -1.122 . . . . 10.0 113.386 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.77 113.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 101.442 -3.54 . . . . 10.0 101.442 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 133.35 28.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 -158.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -106.49 35.76 2.85 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.73 -48.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.679 1.127 . . . . 10.0 112.368 167.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 CA--C 1.536 0.427 0 CA-C-N 119.388 0.995 . . . . 10.0 109.299 -174.022 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 122.332 1.063 . . . . 10.0 111.976 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -119.48 160.71 21.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.234 2.214 . . . . 10.0 106.247 162.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.57 132.95 54.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.8 146.52 26.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.081 -1.081 . . . . 10.0 108.081 -161.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -156.5 127.7 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.767 0.827 . . . . 10.0 109.324 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 m -160.89 155.15 19.43 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.074 1.75 . . . . 10.0 107.794 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 -26.46 35.14 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.161 1.907 . . . . 10.0 113.14 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -70.75 -31.84 68.79 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.69 0.677 . . . . 10.0 112.549 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.03 32.4 82.09 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.903 -0.943 . . . . 10.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -53.94 97.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.131 1.772 . . . . 10.0 112.116 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -68.09 122.64 18.68 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.17 -3.87 16.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 50.6 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.143 2.577 . . . . 10.0 115.001 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -163.09 162.02 25.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.229 1.411 . . . . 10.0 110.441 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.86 177.63 10.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.401 1.481 . . . . 10.0 109.075 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.36 129.37 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.025 -1.842 . . . . 10.0 106.025 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.02 144.01 19.73 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.29 47.27 13.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.436 1.494 . . . . 10.0 112.511 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.65 23.68 63.28 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.181 0.896 . . . . 10.0 113.566 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -135.2 148.53 49.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.288 1.435 . . . . 10.0 107.274 -172.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -92.39 150.17 20.97 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -135.63 140.07 44.27 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.271 -1.752 . . . . 10.0 106.271 -170.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -155.19 157.18 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.433 1.093 . . . . 10.0 111.869 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -58.73 156.39 11.13 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.133 1.773 . . . . 10.0 112.48 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -137.0 -65.24 0.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 117.316 -1.326 . . . . 10.0 109.104 167.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -150.96 149.94 30.21 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.966 1.257 . . . . 10.0 111.711 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 20.9 ptmt -144.62 152.12 40.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.677 1.191 . . . . 10.0 108.601 168.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.86 156.86 41.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.242 1.417 . . . . 10.0 108.715 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.86 119.97 33.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.256 -1.386 . . . . 10.0 107.256 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -90.18 88.21 7.16 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.22 -17.1 6.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.825 1.25 . . . . 10.0 113.349 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -25.92 68.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.278 0.944 . . . . 10.0 111.616 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -130.5 -12.37 3.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.653 1.181 . . . . 10.0 112.099 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.94 45.94 15.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.45 164.42 34.22 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.007 0.923 . . . . 10.0 110.297 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 84.9 m95 -82.21 150.24 27.47 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.19 154.04 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 105.289 -2.115 . . . . 10.0 105.289 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.49 172.43 42.39 Favored Glycine 0 N--CA 1.451 -0.348 0 O-C-N 120.977 -1.077 . . . . 10.0 113.528 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.5 mt -117.89 119.56 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 101.679 -3.452 . . . . 10.0 101.679 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 134.9 22.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -162.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -108.51 37.06 2.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.01 -45.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.162 0.892 . . . . 10.0 111.699 168.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 t90 . . . . . 0 CA--C 1.536 0.414 0 CA-C-N 118.813 0.733 . . . . 10.0 110.628 -171.4 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.943 0.878 . . . . 10.0 111.394 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -137.34 162.4 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.515 2.326 . . . . 10.0 106.277 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -120.8 137.19 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.302 -1.74 . . . . 10.0 106.302 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.31 148.51 22.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -141.87 125.86 17.24 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -163.45 145.35 7.61 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 119.113 0.87 . . . . 10.0 108.809 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.58 -20.77 46.86 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.168 1.912 . . . . 10.0 112.317 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.0 -34.24 71.16 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.475 1.034 . . . . 10.0 111.542 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.1 27.98 71.39 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.787 -1.007 . . . . 10.0 114.519 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -52.27 108.82 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.697 1.599 . . . . 10.0 112.147 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.61 109.16 6.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 168.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.61 -2.31 51.63 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 49.32 -70.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.01 2.924 . . . . 10.0 115.983 -171.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -168.27 159.91 11.11 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.135 1.374 . . . . 10.0 110.211 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -159.32 176.08 12.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.543 1.137 . . . . 10.0 109.33 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.25 133.93 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.69 124.48 10.54 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -174.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t0 44.74 41.57 5.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.736 2.014 . . . . 10.0 112.833 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.7 48.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.425 1.012 . . . . 10.0 114.005 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -83.1 146.32 28.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 171.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -104.09 145.43 30.18 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.352 1.061 . . . . 10.0 108.466 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -136.31 144.49 44.73 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.384 1.074 . . . . 10.0 108.313 -168.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -160.23 159.78 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.857 1.263 . . . . 10.0 112.585 -168.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -58.07 157.44 8.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.009 1.724 . . . . 10.0 112.809 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -141.7 -63.13 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.271 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -151.13 144.66 24.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.911 1.232 . . . . 10.0 111.152 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -151.07 141.5 22.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -149.72 161.33 42.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.11 1.364 . . . . 10.0 109.628 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -92.9 123.48 36.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -92.67 78.05 4.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -52.65 -28.56 22.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.97 1.308 . . . . 10.0 113.323 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -63.41 -21.65 66.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.452 1.101 . . . . 10.0 112.93 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -125.14 -15.77 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.848 1.259 . . . . 10.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.82 37.84 21.6 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.762 0.71 . . . . 10.0 112.43 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.41 163.14 38.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.037 0.935 . . . . 10.0 109.299 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -76.12 153.65 36.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.02 150.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.657 1.983 . . . . 10.0 105.691 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.64 166.53 34.93 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 121.547 -0.721 . . . . 10.0 113.265 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.55 116.6 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 101.268 -3.605 . . . . 10.0 101.268 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.58 136.66 31.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 -163.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -103.81 30.72 4.91 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.457 -0.942 . . . . 10.0 108.457 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.99 -54.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-N 119.087 0.858 . . . . 10.0 111.108 167.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.4 t90 . . . . . 0 C--N 1.342 0.239 0 CA-C-N 118.59 0.632 . . . . 10.0 111.08 -165.391 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.97 0.89 . . . . 10.0 111.523 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -128.34 166.01 19.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.826 2.45 . . . . 10.0 106.566 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -122.32 138.66 54.44 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -140.68 147.96 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.083 -1.08 . . . . 10.0 108.083 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.53 116.39 9.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.42 1.488 . . . . 10.0 107.166 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -154.7 150.31 21.44 Favored Pre-proline 0 N--CA 1.466 0.341 0 C-N-CA 123.768 0.827 . . . . 10.0 110.032 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.8 -28.41 25.08 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.905 1.736 . . . . 10.0 112.796 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -71.86 -29.43 64.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.67 29.82 26.3 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.503 -1.165 . . . . 10.0 115.395 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -61.05 107.19 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.681 1.241 . . . . 10.0 111.392 -172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -65.39 118.02 8.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.774 0.83 . . . . 10.0 109.143 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.28 -8.62 26.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.871 1.063 . . . . 10.0 113.871 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.5 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.976 2.51 . . . . 10.0 114.695 -170.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 p -162.24 165.55 26.65 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.692 1.197 . . . . 10.0 111.022 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -157.22 174.36 15.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.861 1.664 . . . . 10.0 108.585 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.12 133.47 47.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.787 -1.931 . . . . 10.0 105.787 172.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -143.93 121.2 11.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.079 -1.822 . . . . 10.0 106.079 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.6 t0 47.62 43.33 16.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.839 1.656 . . . . 10.0 112.721 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 4.68 78.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.105 0.859 . . . . 10.0 113.968 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 m -102.25 136.88 41.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -87.5 150.72 23.56 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -136.81 139.82 42.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.403 1.881 . . . . 10.0 106.098 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -153.32 156.84 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.645 1.178 . . . . 10.0 111.852 -168.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.78 155.08 13.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.032 1.733 . . . . 10.0 112.19 171.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -137.44 -61.39 0.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.261 -1.352 . . . . 10.0 110.597 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.5 m -152.55 149.94 29.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.505 1.502 . . . . 10.0 111.136 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -150.01 152.48 34.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.391 1.076 . . . . 10.0 109.295 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.93 157.32 40.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.795 1.238 . . . . 10.0 109.143 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -89.5 120.27 30.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -88.57 77.37 8.01 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.34 -29.21 22.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.894 1.278 . . . . 10.0 113.164 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -65.01 -19.34 65.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.476 1.11 . . . . 10.0 112.933 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.4 -17.56 5.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.602 1.161 . . . . 10.0 111.97 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.07 36.75 10.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.727 0.694 . . . . 10.0 112.48 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.2 163.26 38.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.219 1.009 . . . . 10.0 109.618 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -75.8 154.61 36.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.43 0.633 . . . . 10.0 109.71 170.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.9 t -138.03 154.29 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.559 -2.015 . . . . 10.0 105.559 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.81 166.42 36.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.259 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.8 mt -112.86 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 101.613 -3.477 . . . . 10.0 101.613 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 140.07 30.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -160.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.62 36.66 3.34 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.79 -44.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.304 0.956 . . . . 10.0 111.676 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.1 t90 . . . . . 0 CA--C 1.536 0.425 0 CA-C-N 118.285 0.493 . . . . 10.0 110.776 -174.377 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 122.368 1.08 . . . . 10.0 111.954 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -126.31 164.02 21.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.748 2.419 . . . . 10.0 105.745 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.7 mt -123.55 137.01 54.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.61 150.83 19.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 -168.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -141.47 134.79 29.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.44 150.46 4.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.787 -0.819 . . . . 10.0 108.787 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.78 -25.24 39.78 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 121.805 1.67 . . . . 10.0 112.408 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -72.41 -32.16 66.12 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.592 0.633 . . . . 10.0 112.547 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.93 35.15 81.84 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.968 -0.907 . . . . 10.0 113.576 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -54.87 102.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.265 1.426 . . . . 10.0 111.96 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.18 116.1 10.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.51 -7.45 28.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.28 -72.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.053 2.541 . . . . 10.0 115.008 -170.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 164.19 19.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 10.0 110.729 -174.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -158.07 174.17 15.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.786 1.635 . . . . 10.0 108.558 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.33 133.77 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.788 -1.93 . . . . 10.0 105.788 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -144.07 120.72 11.14 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.44 43.2 15.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.912 1.685 . . . . 10.0 112.704 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.14 2.9 80.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.124 0.868 . . . . 10.0 114.047 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.5 m -99.95 136.49 39.78 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 173.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -87.71 150.61 23.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -137.15 139.94 41.5 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.188 -1.782 . . . . 10.0 106.188 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.16 156.75 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.825 1.25 . . . . 10.0 111.883 -168.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.84 155.56 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.008 1.723 . . . . 10.0 112.421 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -135.76 -66.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.403 -1.284 . . . . 10.0 109.009 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -150.97 151.33 31.94 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.887 1.221 . . . . 10.0 111.691 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -142.16 150.93 41.71 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.608 1.163 . . . . 10.0 108.649 168.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -151.41 154.85 37.43 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.028 1.331 . . . . 10.0 108.741 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -89.35 121.0 31.19 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.558 -1.275 . . . . 10.0 107.558 174.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.0 85.89 7.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.006 -1.479 . . . . 10.0 107.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -57.64 -27.44 62.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.805 0.842 . . . . 10.0 112.764 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -71.47 -26.35 62.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.558 0.743 . . . . 10.0 111.621 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.5 mmpt? -109.63 -17.64 13.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.857 0.863 . . . . 10.0 112.234 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.43 38.57 20.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.056 0.836 . . . . 10.0 112.331 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.64 164.36 37.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.515 1.157 . . . . 10.0 110.473 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 85.9 m95 -73.46 153.68 40.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 168.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.29 156.08 32.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.942 2.097 . . . . 10.0 105.366 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.87 162.89 33.39 Favored Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.452 -0.78 . . . . 10.0 112.865 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.2 mt -106.94 118.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 101.612 -3.477 . . . . 10.0 101.612 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.38 127.54 16.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -162.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -101.14 37.88 1.67 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.847 -1.168 . . . . 10.0 107.847 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.96 -48.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.407 1.003 . . . . 10.0 111.847 167.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.0 t90 . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 118.771 0.714 . . . . 10.0 110.379 -169.744 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.0 pt . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 122.08 0.943 . . . . 10.0 111.466 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -119.55 165.27 14.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.863 2.465 . . . . 10.0 106.523 163.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.09 135.77 54.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.031 -2.211 . . . . 10.0 105.031 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -138.38 142.89 34.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 -167.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -145.28 101.48 3.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -152.15 149.87 24.24 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 118.828 0.74 . . . . 10.0 109.871 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.06 -27.75 19.98 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.082 1.855 . . . . 10.0 113.366 -173.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -72.09 -25.28 61.69 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.17 35.47 26.8 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.792 -1.004 . . . . 10.0 115.099 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -58.7 98.99 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.114 1.366 . . . . 10.0 111.514 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.32 110.72 4.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.682 0.793 . . . . 10.0 108.862 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.98 -12.19 31.33 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.52 -66.05 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.14 2.576 . . . . 10.0 114.606 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 p -164.52 161.74 21.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.943 1.297 . . . . 10.0 110.745 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.4 177.73 10.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.452 1.501 . . . . 10.0 109.099 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.41 129.82 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 106.042 -1.836 . . . . 10.0 106.042 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.7 tp -155.67 143.72 19.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.11 47.7 12.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.585 1.554 . . . . 10.0 112.512 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.81 63.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.116 0.865 . . . . 10.0 113.612 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -134.94 147.85 49.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.32 1.448 . . . . 10.0 107.19 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -91.1 150.24 21.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.816 -0.809 . . . . 10.0 108.816 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -135.24 140.37 45.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.413 -1.699 . . . . 10.0 106.413 -171.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.5 158.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.424 1.09 . . . . 10.0 112.002 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.04 157.32 8.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.223 1.809 . . . . 10.0 112.458 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -139.17 -61.94 0.55 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 117.608 -1.187 . . . . 10.0 109.529 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 m -152.58 149.3 28.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.889 1.222 . . . . 10.0 111.215 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -148.11 156.07 42.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.872 0.869 . . . . 10.0 109.696 169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -155.5 161.01 41.01 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.033 1.333 . . . . 10.0 108.877 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.87 118.93 31.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.227 -1.397 . . . . 10.0 107.227 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.59 80.34 8.04 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -53.02 -26.71 16.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.944 1.297 . . . . 10.0 113.451 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 m -63.0 -21.2 65.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.453 1.101 . . . . 10.0 112.983 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.57 -12.44 6.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.696 1.198 . . . . 10.0 112.065 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.47 41.8 29.15 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.62 0.645 . . . . 10.0 111.739 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.2 164.91 30.77 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.926 0.863 . . . . 10.0 110.555 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -79.52 149.48 31.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.5 t -135.8 149.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.576 -2.009 . . . . 10.0 105.576 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.44 165.98 36.98 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.58 -0.7 . . . . 10.0 113.204 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.9 mt -110.73 120.21 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 101.489 -3.522 . . . . 10.0 101.489 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.76 139.02 26.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 -162.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -111.88 35.56 3.65 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 170.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.51 -44.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.485 1.039 . . . . 10.0 112.003 168.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 . . . . . 0 CA--C 1.536 0.406 0 CA-C-N 119.293 0.951 . . . . 10.0 110.816 -172.181 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.566 0.698 . . . . 10.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -130.91 161.38 32.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.552 1.941 . . . . 10.0 106.832 167.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.76 134.78 51.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.579 -2.008 . . . . 10.0 105.579 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -140.48 148.25 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 -163.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -152.94 137.66 16.97 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.661 0.785 . . . . 10.0 109.911 171.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 m -161.03 153.04 16.65 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.043 1.337 . . . . 10.0 108.204 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.86 -28.17 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.885 1.723 . . . . 10.0 112.812 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -75.97 -16.56 59.97 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.86 1.059 . . . . 10.0 113.86 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.08 44.51 33.11 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.298 0.954 . . . . 10.0 112.787 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -65.81 78.04 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.848 1.259 . . . . 10.0 112.21 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -55.82 126.57 26.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.134 1.374 . . . . 10.0 109.712 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.57 -4.75 14.67 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.124 1.157 . . . . 10.0 114.124 -170.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.19 -68.4 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.271 2.628 . . . . 10.0 115.492 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.8 p -165.55 162.57 19.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.98 1.312 . . . . 10.0 110.508 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -158.74 174.49 14.95 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.296 1.438 . . . . 10.0 108.712 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.7 132.64 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.797 -1.927 . . . . 10.0 105.797 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.87 127.31 13.16 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.02 42.33 9.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.617 1.967 . . . . 10.0 112.695 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 1.28 57.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.27 0.938 . . . . 10.0 114.119 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -95.19 140.66 29.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.605 -1.628 . . . . 10.0 106.605 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.85 151.15 21.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -137.9 140.23 40.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.276 1.831 . . . . 10.0 106.358 -171.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 tt -153.39 159.83 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 119.617 1.099 . . . . 10.0 112.257 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.23 156.96 9.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.026 1.73 . . . . 10.0 112.371 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -138.17 -64.54 0.53 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 117.519 -1.229 . . . . 10.0 109.498 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -151.92 149.9 29.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.112 1.323 . . . . 10.0 111.112 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -147.56 157.24 43.48 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.789 0.836 . . . . 10.0 110.129 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -155.26 160.18 40.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.453 1.501 . . . . 10.0 108.774 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -92.76 122.05 34.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -89.58 79.48 6.85 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.755 -1.202 . . . . 10.0 107.755 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -52.13 -28.47 18.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.666 1.186 . . . . 10.0 113.235 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m -66.75 -19.98 65.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.353 1.061 . . . . 10.0 112.874 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -124.15 -17.04 6.31 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.635 1.174 . . . . 10.0 112.079 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.79 37.42 16.51 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.917 0.781 . . . . 10.0 112.508 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.46 163.06 37.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.316 1.058 . . . . 10.0 109.729 173.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.92 153.26 36.79 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 t -139.82 154.24 23.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.413 1.885 . . . . 10.0 105.972 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.19 165.17 37.04 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-O 121.998 0.777 . . . . 10.0 112.877 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.92 125.47 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 101.57 -3.492 . . . . 10.0 101.57 169.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.42 153.9 44.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.331 -0.618 . . . . 10.0 109.331 -166.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -124.72 31.47 5.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.827 -1.175 . . . . 10.0 107.827 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.61 -45.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 119.366 0.984 . . . . 10.0 112.156 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.2 t90 . . . . . 0 CA--C 1.534 0.336 0 CA-C-N 118.855 0.752 . . . . 10.0 110.184 -170.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt . . . . . 0 CA--C 1.535 0.375 0 CA-C-O 121.559 0.695 . . . . 10.0 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -110.69 162.93 14.25 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.242 1.817 . . . . 10.0 106.56 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.92 136.12 53.46 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.22 -2.141 . . . . 10.0 105.22 168.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.72 144.54 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 -164.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -145.54 106.81 4.18 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.147 1.379 . . . . 10.0 107.467 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -152.64 144.04 16.17 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 119.421 1.009 . . . . 10.0 110.027 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.8 -36.05 89.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.119 2.546 . . . . 10.0 114.6 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -73.83 -25.12 59.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.498 0.925 . . . . 10.0 113.498 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.0 28.8 26.1 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.603 -1.11 . . . . 10.0 115.644 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -52.01 112.44 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.244 1.417 . . . . 10.0 111.772 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -73.0 102.45 3.49 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.691 0.796 . . . . 10.0 108.974 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.12 -13.2 57.58 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.82 1.044 . . . . 10.0 113.82 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.85 -69.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.123 2.569 . . . . 10.0 114.481 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -165.16 164.16 20.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.848 1.259 . . . . 10.0 110.589 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.0 176.68 12.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.729 1.612 . . . . 10.0 108.669 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.75 135.92 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.04 128.79 12.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 45.64 44.25 10.09 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.104 1.762 . . . . 10.0 113.022 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.68 79.61 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.262 -0.744 . . . . 10.0 113.858 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -112.22 135.6 52.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -90.14 152.39 21.14 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.582 -0.896 . . . . 10.0 108.582 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -138.22 140.18 39.61 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 -171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.9 tt -153.89 157.24 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.562 1.074 . . . . 10.0 112.24 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.71 154.91 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.705 1.602 . . . . 10.0 112.223 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -135.28 -66.52 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.314 -1.326 . . . . 10.0 109.092 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 m -151.35 151.31 31.57 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.378 1.445 . . . . 10.0 111.352 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -145.54 153.17 40.82 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 10.0 109.698 170.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -153.63 157.77 40.13 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.296 1.439 . . . . 10.0 108.865 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -91.7 123.97 35.49 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -93.63 86.3 5.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.653 0.74 . . . . 10.0 109.115 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -56.09 -17.1 6.16 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.673 1.189 . . . . 10.0 113.443 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.67 70.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.202 0.91 . . . . 10.0 111.633 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.46 -13.08 3.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.275 1.03 . . . . 10.0 112.308 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.7 43.82 8.16 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.775 0.716 . . . . 10.0 111.759 171.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -145.86 162.78 36.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.773 0.787 . . . . 10.0 109.883 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 80.2 m95 -75.51 152.89 37.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.385 0.612 . . . . 10.0 109.369 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.4 t -135.16 153.19 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 162.04 33.96 Favored Glycine 0 N--CA 1.45 -0.433 0 O-C-N 121.575 -0.703 . . . . 10.0 112.983 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -102.0 121.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 101.641 -3.466 . . . . 10.0 101.641 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 137.18 25.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.336 -0.987 . . . . 10.0 108.336 -165.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -108.69 33.38 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.897 -1.149 . . . . 10.0 107.897 172.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.59 -44.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.341 0.973 . . . . 10.0 112.313 170.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 118.991 0.814 . . . . 10.0 111.492 -168.145 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.673 0.749 . . . . 10.0 110.968 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -122.22 159.21 27.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.316 2.246 . . . . 10.0 106.053 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.94 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.6 -2.0 . . . . 10.0 105.6 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.46 141.95 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -163.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -147.73 102.37 3.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.098 1.359 . . . . 10.0 107.912 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -153.19 150.13 23.17 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.687 0.676 . . . . 10.0 109.683 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.49 -26.58 28.72 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.28 1.987 . . . . 10.0 113.22 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -70.04 -33.18 71.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.756 0.707 . . . . 10.0 112.389 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.9 30.01 74.05 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.766 -1.019 . . . . 10.0 114.076 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -50.46 106.5 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.57 1.548 . . . . 10.0 112.06 -174.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -75.12 102.98 5.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -10.83 58.38 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.602 0.964 . . . . 10.0 113.602 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.05 -70.94 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.165 2.586 . . . . 10.0 114.489 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -163.92 162.78 23.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.969 1.308 . . . . 10.0 110.708 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -158.73 177.5 11.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.528 1.531 . . . . 10.0 109.026 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.16 129.83 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 tp -155.46 143.66 20.1 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.331 1.453 . . . . 10.0 107.271 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.61 47.41 11.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.487 1.515 . . . . 10.0 112.532 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.81 63.33 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.165 0.888 . . . . 10.0 113.698 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -134.93 148.44 50.05 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.337 1.455 . . . . 10.0 107.258 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -90.87 150.49 21.52 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -136.51 140.54 43.08 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.273 -1.751 . . . . 10.0 106.273 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.77 159.23 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.59 1.086 . . . . 10.0 112.286 -165.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -55.36 154.51 6.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.018 1.727 . . . . 10.0 112.621 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -136.09 -59.18 0.75 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-O 117.578 -1.201 . . . . 10.0 109.133 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -161.57 159.89 28.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.282 1.401 . . . . 10.0 112.354 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -141.24 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.231 1.412 . . . . 10.0 108.643 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -150.71 158.6 44.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.99 1.316 . . . . 10.0 108.233 162.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -91.57 123.22 34.82 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.095 -1.446 . . . . 10.0 107.095 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -95.64 88.78 5.12 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -56.75 -15.72 5.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.894 1.278 . . . . 10.0 113.383 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -64.17 -24.58 67.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.361 0.982 . . . . 10.0 111.855 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -130.23 -12.42 4.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.579 1.152 . . . . 10.0 112.016 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 46.32 16.87 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.34 167.44 22.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.556 0.743 . . . . 10.0 110.48 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.83 150.05 28.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.44 152.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.501 -2.037 . . . . 10.0 105.501 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.2 37.57 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 121.358 -0.839 . . . . 10.0 112.914 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.92 126.45 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 102.107 -3.294 . . . . 10.0 102.107 167.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 136.17 23.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -104.17 31.49 4.55 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.79 -50.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.505 1.048 . . . . 10.0 111.705 169.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.5 t90 . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 118.831 0.741 . . . . 10.0 110.453 -170.541 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 121.832 0.825 . . . . 10.0 111.312 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 159.32 27.25 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.247 2.219 . . . . 10.0 106.574 168.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -111.66 133.96 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.196 -2.15 . . . . 10.0 105.196 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.91 149.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -167.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.33 137.92 16.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 109.31 173.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -169.79 150.55 3.89 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 125.18 1.392 . . . . 10.0 107.603 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.27 -26.63 43.99 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.747 2.298 . . . . 10.0 113.194 166.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -63.83 -39.67 94.79 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.636 0.774 . . . . 10.0 112.226 -175.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.45 33.8 17.94 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.302 0.953 . . . . 10.0 114.001 -175.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -60.57 105.67 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.411 1.084 . . . . 10.0 111.08 -168.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.48 108.45 4.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.024 -0.732 . . . . 10.0 109.024 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.09 -10.63 38.29 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 -174.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.96 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.14 2.576 . . . . 10.0 114.582 -171.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -164.6 162.98 21.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.995 1.318 . . . . 10.0 110.314 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -157.75 176.97 11.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.527 1.531 . . . . 10.0 108.63 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.34 135.93 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 174.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -152.56 131.47 12.52 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.494 -1.298 . . . . 10.0 107.494 -174.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.0 t0 44.49 47.72 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.494 1.918 . . . . 10.0 113.021 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.29 75.85 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.797 0.713 . . . . 10.0 113.625 175.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.8 m -124.67 135.82 53.38 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.14 153.18 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 175.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.96 140.49 40.26 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.465 -1.68 . . . . 10.0 106.465 -172.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.08 157.23 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 119.379 0.991 . . . . 10.0 112.217 -167.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -57.1 154.27 10.23 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.781 1.633 . . . . 10.0 112.373 170.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -138.75 -55.82 0.62 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 117.516 -1.23 . . . . 10.0 109.914 165.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -159.82 153.36 22.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.519 1.509 . . . . 10.0 111.613 173.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -145.26 160.67 41.13 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.413 1.085 . . . . 10.0 108.615 161.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -152.51 162.48 41.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.701 1.6 . . . . 10.0 108.591 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -95.85 123.59 39.5 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -96.5 90.9 5.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.835 0.854 . . . . 10.0 108.718 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.71 -15.4 7.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.756 1.222 . . . . 10.0 113.416 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.78 -26.14 68.5 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.381 0.991 . . . . 10.0 111.576 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -129.95 -10.82 4.32 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.371 1.068 . . . . 10.0 112.114 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.7 46.36 18.68 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.794 -0.923 . . . . 10.0 110.794 175.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.96 164.78 31.85 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.953 0.901 . . . . 10.0 110.201 177.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -81.39 153.17 27.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.81 151.44 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 127.161 2.184 . . . . 10.0 105.194 176.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.93 173.22 39.95 Favored Glycine 0 C--N 1.334 0.418 0 O-C-N 120.904 -1.122 . . . . 10.0 113.973 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 54.1 mt -124.85 113.51 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 101.618 -3.475 . . . . 10.0 101.618 178.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.81 139.43 32.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.792 -1.188 . . . . 10.0 107.792 -158.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -108.99 30.75 6.26 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 173.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.67 -45.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.174 0.897 . . . . 10.0 112.1 171.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.7 t90 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 118.985 0.811 . . . . 10.0 111.164 -169.801 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.7 pt -60.61 164.48 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.933 0.873 . . . . 10.0 112.219 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -127.92 162.79 25.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.831 2.452 . . . . 10.0 106.994 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.9 mt -117.06 134.32 54.9 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.446 -2.057 . . . . 10.0 105.446 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -139.78 147.2 24.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -164.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -145.3 126.11 14.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.193 1.397 . . . . 10.0 107.253 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -168.12 153.3 6.57 Favored Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 124.601 1.16 . . . . 10.0 110.377 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.24 -24.72 27.16 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.395 2.063 . . . . 10.0 113.292 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -76.28 -19.26 58.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.99 30.53 23.11 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.565 1.079 . . . . 10.0 114.668 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -52.75 105.71 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 10.0 111.887 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -74.53 105.52 5.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.833 0.853 . . . . 10.0 109.123 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.6 -10.26 56.12 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.862 1.06 . . . . 10.0 113.862 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.06 -72.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.277 2.631 . . . . 10.0 114.884 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.6 p -165.48 161.96 19.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.174 1.39 . . . . 10.0 110.32 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -158.99 175.3 13.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.233 1.413 . . . . 10.0 109.092 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.67 130.76 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 105.685 -1.968 . . . . 10.0 105.685 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -152.2 137.87 17.86 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.03 -1.47 . . . . 10.0 107.03 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.68 50.13 10.88 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.193 1.797 . . . . 10.0 112.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.79 23.24 63.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.104 0.859 . . . . 10.0 113.382 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -130.7 145.07 51.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.672 -1.603 . . . . 10.0 106.672 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.26 151.0 19.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.801 -0.814 . . . . 10.0 108.801 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -138.2 139.24 39.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 tt -155.11 158.18 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.371 1.068 . . . . 10.0 112.015 -168.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.19 156.94 3.76 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.328 1.851 . . . . 10.0 112.545 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -140.45 -61.52 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.533 -1.222 . . . . 10.0 109.569 168.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -154.23 147.28 24.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.045 1.293 . . . . 10.0 111.21 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.28 160.89 41.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.256 -0.903 . . . . 10.0 110.088 162.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.95 162.64 41.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.54 1.536 . . . . 10.0 108.819 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -94.01 123.16 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -93.62 82.1 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.412 -0.959 . . . . 10.0 108.412 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -54.35 -25.67 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.808 1.243 . . . . 10.0 113.452 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 m -63.93 -20.17 65.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.436 1.094 . . . . 10.0 112.847 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -126.81 -16.56 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.143 1.377 . . . . 10.0 111.558 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.68 40.11 38.7 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.507 -0.637 . . . . 10.0 111.507 174.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.92 166.85 23.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.759 0.779 . . . . 10.0 110.097 172.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -80.28 152.19 29.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.671 -0.862 . . . . 10.0 108.671 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.2 t -137.56 151.4 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.507 -2.035 . . . . 10.0 105.507 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 170.24 38.48 Favored Glycine 0 N--CA 1.45 -0.369 0 O-C-N 121.353 -0.842 . . . . 10.0 113.246 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -116.84 122.0 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 101.653 -3.462 . . . . 10.0 101.653 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.48 44.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 -164.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -127.09 36.78 4.38 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.13 -45.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.722 0.692 . . . . 10.0 111.512 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -63.18 142.1 58.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.847 0.748 . . . . 10.0 109.309 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -137.72 42.04 2.32 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 10.0 108.744 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 73.71 -16.2 0.52 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.393 2.277 . . . . 10.0 114.699 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tttp . . . . . 0 C--O 1.245 0.822 0 C-N-CA 124.153 0.981 . . . . 10.0 109.424 178.312 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.932 -0.395 . . . . 10.0 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt -60.52 163.24 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 122.054 0.93 . . . . 10.0 111.42 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -128.17 161.47 29.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.108 2.563 . . . . 10.0 106.176 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -108.31 130.95 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.456 -2.053 . . . . 10.0 105.456 172.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.16 142.92 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -162.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.56 140.88 16.62 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.818 0.847 . . . . 10.0 109.833 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.49 153.74 5.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.211 1.404 . . . . 10.0 108.497 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.42 -27.44 28.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.207 1.938 . . . . 10.0 112.786 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -69.29 -30.4 68.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.825 0.676 . . . . 10.0 112.825 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.84 46.83 93.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.377 -0.689 . . . . 10.0 111.377 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -73.29 70.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.065 1.346 . . . . 10.0 111.152 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -52.61 121.28 6.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.737 1.215 . . . . 10.0 109.77 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -9.12 18.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.621 0.971 . . . . 10.0 113.621 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.34 -65.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.348 2.659 . . . . 10.0 114.986 -170.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 p -165.26 163.19 20.14 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.81 1.244 . . . . 10.0 110.723 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.23 174.06 15.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 10.0 108.607 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.32 133.68 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.726 -1.953 . . . . 10.0 105.726 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 tt -144.68 121.3 11.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.89 42.14 15.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.892 1.677 . . . . 10.0 112.664 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.53 0.79 74.26 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.216 0.912 . . . . 10.0 114.017 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.5 m -96.99 137.78 35.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -88.73 150.83 22.78 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -137.32 140.33 41.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.111 1.764 . . . . 10.0 106.277 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.1 158.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.519 1.128 . . . . 10.0 112.003 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.92 157.01 8.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.966 1.706 . . . . 10.0 112.495 171.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.67 -61.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.531 -1.223 . . . . 10.0 109.397 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 m -150.78 149.8 30.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.681 1.128 . . . . 10.0 111.025 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.65 156.73 44.25 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.908 0.883 . . . . 10.0 109.539 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.61 160.71 40.68 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.219 1.407 . . . . 10.0 108.725 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.51 120.08 34.2 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.12 81.81 6.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.333 -0.988 . . . . 10.0 108.333 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -53.23 -27.14 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.745 1.218 . . . . 10.0 113.342 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -64.23 -20.01 65.75 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.408 1.083 . . . . 10.0 112.952 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.0 -12.51 6.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.675 1.19 . . . . 10.0 111.911 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.76 41.96 32.84 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.748 0.69 . . . . 10.0 111.814 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 164.53 33.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.854 0.827 . . . . 10.0 110.574 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -78.57 150.03 32.88 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 170.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.17 153.78 24.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.585 -2.005 . . . . 10.0 105.585 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.71 162.92 34.92 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.283 -0.886 . . . . 10.0 113.088 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.6 mm -101.12 119.27 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.725 -3.435 . . . . 10.0 101.725 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.53 29.76 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -162.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.44 34.78 3.92 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.71 -1.219 . . . . 10.0 107.71 170.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.49 -56.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.317 0.962 . . . . 10.0 111.388 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -60.39 152.79 24.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.675 0.67 . . . . 10.0 111.128 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -136.36 29.29 3.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.355 1.062 . . . . 10.0 110.244 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.281 1.2 ptm180 56.38 -8.71 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.884 3.274 . . . . 10.0 117.531 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.047 0.939 . . . . 10.0 108.87 169.121 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.883 -0.414 . . . . 10.0 109.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.4 pt -60.2 156.58 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.103 0.954 . . . . 10.0 111.504 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -111.82 162.53 15.17 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.653 2.381 . . . . 10.0 106.259 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -123.43 135.2 53.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.117 -2.179 . . . . 10.0 105.117 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.64 148.84 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -165.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -139.48 127.46 22.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 170.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -161.12 151.66 14.99 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 119.47 1.032 . . . . 10.0 108.933 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.72 -27.7 26.36 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.958 1.772 . . . . 10.0 113.084 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -78.23 -25.09 46.78 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.473 0.916 . . . . 10.0 113.473 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.24 32.15 35.86 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.351 -1.249 . . . . 10.0 114.769 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -54.5 115.45 2.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.937 1.368 . . . . 10.0 111.434 -171.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -78.24 115.29 17.86 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.27 -11.58 23.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.77 -67.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.157 2.583 . . . . 10.0 114.608 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -165.47 162.88 19.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.852 1.261 . . . . 10.0 110.544 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -158.71 176.3 12.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.479 1.511 . . . . 10.0 108.751 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.31 130.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.782 -1.932 . . . . 10.0 105.782 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.18 138.12 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t0 45.94 51.21 10.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.152 1.781 . . . . 10.0 112.577 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.2 63.52 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.104 0.859 . . . . 10.0 113.487 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -132.98 143.37 49.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -90.71 150.63 21.56 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -137.07 140.27 41.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.14 156.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.46 1.104 . . . . 10.0 112.025 -167.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -57.85 154.77 11.5 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.266 1.826 . . . . 10.0 112.395 171.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -137.1 -61.6 0.65 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.449 -1.263 . . . . 10.0 109.277 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -161.37 154.88 21.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.706 1.593 . . . . 10.0 111.602 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -146.78 160.55 42.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.101 0.961 . . . . 10.0 109.378 166.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.16 158.26 43.74 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.318 1.447 . . . . 10.0 108.701 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -90.54 120.36 31.57 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -87.64 76.6 8.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -51.8 -28.3 15.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.031 1.332 . . . . 10.0 113.287 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -64.78 -17.38 64.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.668 1.187 . . . . 10.0 113.19 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -131.11 -15.63 3.29 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.457 1.103 . . . . 10.0 112.293 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 39.05 8.29 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.945 0.793 . . . . 10.0 112.515 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -148.54 163.64 36.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.042 0.921 . . . . 10.0 109.417 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -77.5 154.53 32.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.06 150.35 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.4 38.27 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.585 -0.817 . . . . 10.0 113.953 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.0 mt -114.5 118.66 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 101.636 -3.468 . . . . 10.0 101.636 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.3 134.54 20.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.969 -1.123 . . . . 10.0 107.969 -162.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -106.78 36.03 2.79 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.29 -46.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.43 1.014 . . . . 10.0 111.765 168.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -64.07 146.27 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.722 0.692 . . . . 10.0 109.879 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -145.94 48.3 1.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.905 0.882 . . . . 10.0 110.24 -165.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.64 52.61 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.003 1.321 . . . . 10.0 110.69 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.252 1.223 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 169.615 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.65 164.05 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 122.575 1.179 . . . . 10.0 112.386 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -120.51 165.33 15.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.751 2.82 . . . . 10.0 106.056 166.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.3 mt -127.18 137.92 53.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.51 148.12 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -168.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -144.21 115.34 7.92 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -153.69 149.59 21.41 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.698 0.799 . . . . 10.0 109.259 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.66 -26.99 32.74 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.982 1.788 . . . . 10.0 113.02 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -81.73 -19.13 42.07 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.04 45.85 26.49 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 119.204 0.911 . . . . 10.0 112.945 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -65.26 81.39 0.05 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.769 1.228 . . . . 10.0 112.195 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -57.95 121.49 10.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.294 1.438 . . . . 10.0 109.794 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.37 -10.19 19.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -173.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.25 -64.05 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.396 2.678 . . . . 10.0 115.012 -168.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -166.42 163.73 17.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.828 1.251 . . . . 10.0 110.818 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -158.49 178.09 10.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.84 1.656 . . . . 10.0 108.386 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.03 137.71 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 106.779 -1.563 . . . . 10.0 106.779 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 tp -149.33 127.18 11.81 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 44.87 46.35 8.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.08 1.752 . . . . 10.0 113.153 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.18 14.06 82.21 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.297 -0.724 . . . . 10.0 113.83 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.7 m -118.75 131.09 56.11 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -86.38 151.82 23.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.6 140.17 42.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.31 157.81 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 125.043 1.337 . . . . 10.0 111.695 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.61 155.32 4.19 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.225 1.81 . . . . 10.0 112.584 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -136.62 -64.89 0.57 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.444 -1.265 . . . . 10.0 109.083 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.0 m -152.38 151.01 30.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.376 1.444 . . . . 10.0 111.222 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -145.56 154.9 42.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.788 0.835 . . . . 10.0 109.66 169.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.0 156.81 38.09 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.77 1.228 . . . . 10.0 108.836 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -90.27 120.42 31.4 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -88.59 77.02 8.06 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.06 -28.79 18.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.86 1.264 . . . . 10.0 113.107 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 m -66.05 -17.6 64.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.475 1.11 . . . . 10.0 112.983 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -126.79 -17.35 4.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.339 1.056 . . . . 10.0 111.83 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.79 9.27 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.743 0.701 . . . . 10.0 112.349 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -148.65 163.46 37.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.282 1.041 . . . . 10.0 109.987 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -75.7 154.36 36.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.11 153.33 26.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.76 161.31 33.16 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.687 -0.633 . . . . 10.0 112.921 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.5 mt -103.67 124.25 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 101.778 -3.416 . . . . 10.0 101.778 166.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 131.6 18.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.468 -0.938 . . . . 10.0 108.468 -163.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -103.54 37.13 2.09 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -153.69 -49.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 119.283 0.947 . . . . 10.0 111.874 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -65.98 145.08 56.31 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.82 0.736 . . . . 10.0 110.203 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -144.84 43.47 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.695 1.598 . . . . 10.0 108.775 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.252 5.6 ptp180 46.01 31.57 1.16 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.91 2.084 . . . . 10.0 114.471 -168.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.252 1.2 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 164.077 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.612 0.244 . . . . 10.0 110.586 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 pt -60.06 154.04 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.527 0.679 . . . . 10.0 111.227 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -113.34 161.75 16.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.575 1.95 . . . . 10.0 106.761 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.96 137.19 52.28 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.464 -2.051 . . . . 10.0 105.464 169.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.89 147.63 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -141.47 126.23 18.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.481 1.512 . . . . 10.0 106.946 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -166.9 146.6 4.75 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.43 -16.43 47.61 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.973 1.782 . . . . 10.0 112.367 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -63.82 -41.16 97.92 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.647 0.658 . . . . 10.0 111.598 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.9 28.06 15.6 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.762 1.172 . . . . 10.0 114.629 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.07 105.33 1.03 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.525 1.163 . . . . 10.0 110.64 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -66.31 108.32 2.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.19 -12.0 42.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.423 0.897 . . . . 10.0 113.423 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.5 -70.06 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.165 2.586 . . . . 10.0 114.2 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 163.29 19.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.028 1.331 . . . . 10.0 110.37 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -157.72 174.06 15.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.215 1.406 . . . . 10.0 109.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -135.25 129.64 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.94 -1.874 . . . . 10.0 105.94 173.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.95 131.48 14.81 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.551 -1.648 . . . . 10.0 106.551 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.18 51.52 9.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.764 2.026 . . . . 10.0 112.743 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.77 21.96 63.72 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.528 -0.76 . . . . 10.0 113.378 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -127.7 142.82 51.22 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -91.72 151.93 20.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -138.9 140.33 38.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.122 -1.807 . . . . 10.0 106.122 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.23 158.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.742 1.156 . . . . 10.0 112.438 -166.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -57.23 155.29 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.029 1.732 . . . . 10.0 112.386 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -138.77 -62.51 0.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 117.358 -1.306 . . . . 10.0 109.106 167.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 m -154.46 149.15 26.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.201 1.364 . . . . 10.0 111.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -146.42 160.89 41.48 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.329 -0.857 . . . . 10.0 110.0 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.07 164.15 38.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.639 1.576 . . . . 10.0 108.716 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -96.34 121.82 38.55 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -90.88 87.1 6.5 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.09 -16.75 5.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.696 1.199 . . . . 10.0 113.362 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -25.86 68.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.182 0.901 . . . . 10.0 111.838 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -134.64 -11.7 2.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.181 0.992 . . . . 10.0 112.558 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.85 43.06 9.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 118.901 0.773 . . . . 10.0 111.952 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -146.02 163.03 36.51 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.657 0.783 . . . . 10.0 109.524 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -75.98 153.28 36.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 171.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -136.96 151.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.377 -2.083 . . . . 10.0 105.377 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 169.5 38.9 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.621 -0.799 . . . . 10.0 113.856 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.78 120.36 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 101.254 -3.61 . . . . 10.0 101.254 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.31 149.79 36.79 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -165.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.3 31.03 6.81 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.67 -47.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.767 0.827 . . . . 10.0 111.556 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -66.23 147.26 53.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.751 0.705 . . . . 10.0 110.464 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -149.21 33.66 0.73 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.992 1.317 . . . . 10.0 109.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.279 41.1 ptt180 44.57 43.42 6.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.512 1.925 . . . . 10.0 114.793 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? . . . . . 0 C--O 1.251 1.16 0 C-N-CA 127.73 2.412 . . . . 10.0 112.949 170.639 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.781 0.325 . . . . 10.0 110.651 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt -59.28 155.32 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.907 0.861 . . . . 10.0 111.425 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -109.32 165.02 11.94 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.893 2.077 . . . . 10.0 106.819 165.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.27 138.8 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.261 -2.126 . . . . 10.0 105.261 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.58 151.12 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -168.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.03 122.14 7.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.462 1.105 . . . . 10.0 108.264 171.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -154.25 151.61 24.63 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.791 1.236 . . . . 10.0 108.363 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.74 -25.07 40.18 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.894 1.729 . . . . 10.0 113.153 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -88.05 -15.87 35.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -172.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.47 36.1 37.77 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.203 -1.331 . . . . 10.0 113.954 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -53.16 98.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.128 1.371 . . . . 10.0 112.235 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.76 117.44 17.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.205 1.002 . . . . 10.0 108.927 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.35 -11.67 25.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.27 -64.78 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.162 2.585 . . . . 10.0 114.642 -167.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -166.59 162.99 16.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.836 1.254 . . . . 10.0 110.724 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -159.73 178.65 9.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 10.0 108.816 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -135.67 129.82 49.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -151.95 139.97 20.14 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t0 47.05 50.18 14.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.682 1.593 . . . . 10.0 112.434 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.25 64.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.14 0.876 . . . . 10.0 113.517 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -134.79 144.22 47.53 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 -173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -88.25 149.75 23.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -135.34 141.74 45.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.325 -1.732 . . . . 10.0 106.325 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 tt -152.25 156.92 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.213 . . . . 10.0 111.847 -168.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -58.0 153.7 13.93 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.577 1.551 . . . . 10.0 111.998 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -131.82 -70.18 0.58 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.345 -1.312 . . . . 10.0 108.318 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.2 m -153.47 149.46 27.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.312 1.414 . . . . 10.0 111.289 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -143.15 157.89 44.11 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.498 -0.751 . . . . 10.0 109.512 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -149.13 154.35 39.08 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.445 1.498 . . . . 10.0 108.352 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -88.82 119.85 29.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -85.07 82.24 8.52 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -55.83 -29.68 60.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.984 0.914 . . . . 10.0 112.269 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -25.39 68.1 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.867 1.267 . . . . 10.0 112.644 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -120.31 -18.07 8.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.851 0.86 . . . . 10.0 111.932 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.81 29.9 12.43 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.411 1.005 . . . . 10.0 113.003 168.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -153.53 163.74 39.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.882 1.341 . . . . 10.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -74.3 152.77 39.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -139.21 152.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.477 -2.046 . . . . 10.0 105.477 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.88 167.41 39.15 Favored Glycine 0 C--N 1.332 0.33 0 O-C-N 121.274 -0.891 . . . . 10.0 114.082 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.7 mt -109.41 125.32 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 102.353 -3.202 . . . . 10.0 102.353 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.31 130.84 16.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -165.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -99.85 32.15 3.0 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 -48.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.69 1.132 . . . . 10.0 112.363 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -67.25 160.96 25.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.644 0.657 . . . . 10.0 110.569 -174.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.83 -48.17 0.42 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.363 -0.827 . . . . 10.0 112.338 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.03 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.99 0.814 . . . . 10.0 111.655 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.367 1.067 . . . . 10.0 110.36 -171.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt -56.23 165.25 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.426 1.09 . . . . 10.0 112.643 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.33 163.31 31.31 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.762 2.425 . . . . 10.0 106.512 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.89 135.43 54.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.809 -1.923 . . . . 10.0 105.809 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.07 145.4 27.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -144.74 119.19 9.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.16 -1.792 . . . . 10.0 106.16 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -168.11 153.16 6.52 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 125.292 1.437 . . . . 10.0 110.064 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.2 -27.08 17.1 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.466 2.111 . . . . 10.0 113.246 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -68.29 -29.99 68.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.954 0.797 . . . . 10.0 112.645 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.28 31.85 13.2 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.26 -1.3 . . . . 10.0 114.963 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 107.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.791 1.295 . . . . 10.0 111.546 -168.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.48 116.3 6.62 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.0 -8.49 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.413 0.894 . . . . 10.0 113.413 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.7 -69.26 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.313 2.645 . . . . 10.0 114.517 -171.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -164.86 162.54 20.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.867 1.267 . . . . 10.0 110.878 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -159.29 177.96 10.47 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.659 1.583 . . . . 10.0 109.061 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.14 129.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 105.943 -1.873 . . . . 10.0 105.943 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -154.97 142.97 20.12 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.362 1.465 . . . . 10.0 107.09 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.59 47.49 14.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.656 1.582 . . . . 10.0 112.644 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.45 23.72 62.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.238 0.923 . . . . 10.0 113.573 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.4 m -134.45 147.44 50.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.95 150.95 21.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -135.78 140.05 44.0 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 105.985 -1.857 . . . . 10.0 105.985 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -154.9 157.13 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.603 1.161 . . . . 10.0 111.384 -167.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -59.57 155.99 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.752 1.621 . . . . 10.0 112.19 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -136.83 -67.92 0.49 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.416 -1.278 . . . . 10.0 109.271 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.6 m -151.16 144.62 24.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.463 1.483 . . . . 10.0 111.259 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -148.75 151.48 34.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.915 0.886 . . . . 10.0 109.294 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.9 158.7 42.52 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.809 1.244 . . . . 10.0 108.997 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -91.18 119.3 31.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -88.33 81.43 7.27 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -53.85 -26.44 24.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.967 1.307 . . . . 10.0 113.437 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.2 m -63.0 -21.19 65.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.346 1.059 . . . . 10.0 112.901 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.64 -12.57 6.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.704 1.201 . . . . 10.0 111.916 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.34 42.33 28.31 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.78 166.45 26.61 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.624 0.77 . . . . 10.0 109.996 173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -81.27 152.28 27.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.904 -0.776 . . . . 10.0 108.904 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -137.3 150.69 26.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.332 -2.099 . . . . 10.0 105.332 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.81 166.37 38.03 Favored Glycine 0 C--N 1.333 0.365 0 O-C-N 121.426 -0.796 . . . . 10.0 113.486 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -108.32 120.69 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 101.677 -3.453 . . . . 10.0 101.677 168.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.64 155.53 46.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -167.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -128.37 36.41 4.28 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 106.653 -1.61 . . . . 10.0 106.653 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.97 -45.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.63 1.105 . . . . 10.0 112.01 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -61.57 142.04 57.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.191 0.905 . . . . 10.0 109.533 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.53 54.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.968 1.307 . . . . 10.0 107.742 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.271 7.6 ptp180 52.11 -0.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 128.99 2.916 . . . . 10.0 116.614 -170.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.253 1.251 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 167.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 119.264 -0.398 . . . . 10.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.0 pt -58.09 155.61 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.831 0.824 . . . . 10.0 111.292 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.11 159.31 21.91 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.007 2.123 . . . . 10.0 106.36 166.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.85 128.12 56.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.672 -2.344 . . . . 10.0 104.672 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -139.21 147.73 24.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.23 -1.026 . . . . 10.0 108.23 -161.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -149.34 148.4 29.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.21 1.004 . . . . 10.0 108.524 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m 179.14 155.43 0.61 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 127.562 2.345 . . . . 10.0 108.17 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.41 -24.26 31.48 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.312 2.008 . . . . 10.0 113.254 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -68.08 -28.78 67.65 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.401 -0.809 . . . . 10.0 113.019 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.25 41.59 8.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.44 1.019 . . . . 10.0 114.348 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.23 91.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.159 1.384 . . . . 10.0 110.974 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.39 112.33 2.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.802 0.841 . . . . 10.0 108.892 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.65 -12.16 24.25 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.269 0.841 . . . . 10.0 113.269 -174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.07 -63.81 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.389 2.676 . . . . 10.0 114.567 -169.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -165.18 162.75 20.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.814 1.246 . . . . 10.0 110.569 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -158.01 177.5 11.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.687 1.595 . . . . 10.0 108.495 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.66 135.84 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.784 -1.561 . . . . 10.0 106.784 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.0 131.2 12.75 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 44.13 47.84 7.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.861 . . . . 10.0 113.086 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.34 18.14 76.6 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.352 -0.693 . . . . 10.0 113.707 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -125.18 136.17 53.32 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.36 152.97 21.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -137.55 140.43 41.04 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.337 -1.727 . . . . 10.0 106.337 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -154.68 159.31 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 119.591 1.087 . . . . 10.0 112.169 -167.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.03 156.4 9.42 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.69 1.596 . . . . 10.0 112.276 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -139.67 -63.26 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 117.265 -1.35 . . . . 10.0 109.445 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.9 m -151.7 149.52 29.18 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.092 1.314 . . . . 10.0 111.198 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -147.16 156.28 42.84 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.748 0.819 . . . . 10.0 109.719 168.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -155.13 160.7 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.955 1.302 . . . . 10.0 108.885 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -94.15 120.79 34.91 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.258 -1.386 . . . . 10.0 107.258 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.28 86.3 6.8 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.09 -0.708 . . . . 10.0 109.09 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -55.76 -15.94 3.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.483 1.113 . . . . 10.0 113.433 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -22.08 66.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.236 0.925 . . . . 10.0 112.161 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -139.4 -11.97 1.2 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.144 0.978 . . . . 10.0 112.826 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 45.29 7.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.15 0.886 . . . . 10.0 111.956 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.74 163.2 34.74 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.838 0.819 . . . . 10.0 109.629 172.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -76.49 153.17 35.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.25 153.05 23.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.911 2.084 . . . . 10.0 105.573 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.98 165.29 37.57 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 121.381 -0.825 . . . . 10.0 113.323 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.65 120.47 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 101.202 -3.629 . . . . 10.0 101.202 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.87 139.14 29.08 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 -164.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -109.36 30.08 6.95 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.64 -44.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.729 1.149 . . . . 10.0 113.041 171.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -61.97 146.07 51.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.819 1.191 . . . . 10.0 109.971 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -139.55 47.41 1.86 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.201 1.401 . . . . 10.0 108.413 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.286 0.0 OUTLIER 56.18 -12.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 130.189 3.396 . . . . 10.0 117.577 -173.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 tptm . . . . . 0 C--O 1.248 1.005 0 CA-C-O 116.909 -1.52 . . . . 10.0 107.786 -172.003 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 pt -62.68 152.82 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.779 0.799 . . . . 10.0 111.771 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.85 166.75 11.15 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.692 1.997 . . . . 10.0 107.092 158.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.97 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.17 146.09 25.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.014 -0.736 . . . . 10.0 109.014 -162.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.68 141.5 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.894 1.278 . . . . 10.0 108.09 169.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -173.03 154.12 2.64 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 126.853 2.061 . . . . 10.0 107.97 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.21 -25.95 30.66 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.227 1.951 . . . . 10.0 113.091 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -69.74 -28.39 65.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.696 -0.669 . . . . 10.0 112.58 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.05 48.23 58.83 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 118.638 0.654 . . . . 10.0 112.012 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -71.44 73.94 0.74 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.739 1.215 . . . . 10.0 111.176 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -54.21 120.09 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.074 1.35 . . . . 10.0 109.591 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.86 -7.92 21.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.06 -70.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.032 2.533 . . . . 10.0 114.48 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.7 p -159.61 164.82 33.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.512 1.051 . . . . 10.0 110.634 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -157.76 179.48 9.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.322 1.449 . . . . 10.0 108.975 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.71 130.79 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.3 144.03 21.66 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.75 46.85 11.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.52 . . . . 10.0 112.419 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.4 24.5 63.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.189 0.9 . . . . 10.0 113.636 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -133.75 147.43 51.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.066 1.346 . . . . 10.0 107.553 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -83.0 146.38 28.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -133.31 140.25 47.33 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.511 -1.662 . . . . 10.0 106.511 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -154.37 158.32 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.624 1.17 . . . . 10.0 111.874 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.99 156.58 5.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.055 1.742 . . . . 10.0 112.677 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -138.45 -62.2 0.57 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 117.257 -1.354 . . . . 10.0 109.334 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -151.9 150.25 29.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.127 1.33 . . . . 10.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -145.09 157.0 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.598 0.759 . . . . 10.0 109.556 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.08 160.8 41.27 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.941 1.296 . . . . 10.0 108.716 170.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -94.14 116.19 28.57 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.17 87.55 7.39 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -58.36 -15.4 10.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.607 1.163 . . . . 10.0 113.218 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.61 -25.11 67.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.428 1.013 . . . . 10.0 111.625 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.66 -12.63 4.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.626 1.17 . . . . 10.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.75 42.97 19.68 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.703 0.668 . . . . 10.0 111.506 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.46 163.84 34.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.026 0.913 . . . . 10.0 110.974 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -78.68 150.64 32.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -140.23 152.84 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.805 2.042 . . . . 10.0 105.616 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.39 163.64 36.7 Favored Glycine 0 C--N 1.334 0.427 0 O-C-N 121.242 -0.911 . . . . 10.0 113.485 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.96 123.99 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 101.828 -3.397 . . . . 10.0 101.828 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.27 29.18 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.736 -0.838 . . . . 10.0 108.736 -163.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -115.31 35.72 4.25 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.97 -49.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.892 0.769 . . . . 10.0 112.202 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -67.44 155.16 39.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.137 0.881 . . . . 10.0 110.65 -171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.35 36.56 0.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 10.0 110.207 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 78.8 -34.94 0.17 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.635 2.374 . . . . 10.0 112.198 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.0 mttp . . . . . 0 C--O 1.247 0.968 0 C-N-CA 126.691 1.996 . . . . 10.0 110.691 -178.414 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.884 0.374 . . . . 10.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.0 pt -59.65 157.98 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.912 0.863 . . . . 10.0 111.297 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -115.73 162.12 17.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.107 2.163 . . . . 10.0 106.585 167.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.72 136.62 53.24 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.4 -2.074 . . . . 10.0 105.4 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.9 146.89 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 -163.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.79 120.55 9.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.589 -1.634 . . . . 10.0 106.589 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m -158.99 150.99 17.27 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 119.739 1.154 . . . . 10.0 109.327 173.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.2 -27.19 35.36 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.035 1.823 . . . . 10.0 112.98 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -81.15 -17.43 49.84 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.792 1.034 . . . . 10.0 113.792 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.98 34.79 31.37 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.145 -1.364 . . . . 10.0 114.008 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -53.33 99.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.109 1.363 . . . . 10.0 112.408 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.8 117.26 15.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.501 1.12 . . . . 10.0 109.317 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.08 -11.81 27.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.98 -67.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.326 2.65 . . . . 10.0 114.2 -166.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -163.82 162.5 23.75 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.291 1.036 . . . . 10.0 110.366 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -158.55 176.4 12.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.04 1.336 . . . . 10.0 108.885 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -137.1 132.2 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -149.5 135.04 18.48 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.52 50.24 10.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.198 1.799 . . . . 10.0 112.757 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.19 69.17 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.822 0.725 . . . . 10.0 113.547 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -129.15 138.75 51.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.65 -1.611 . . . . 10.0 106.65 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -88.41 151.55 22.5 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -136.65 140.62 42.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.961 1.705 . . . . 10.0 106.518 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -152.58 155.02 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.153 1.381 . . . . 10.0 111.398 -163.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -57.59 156.02 8.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.565 1.546 . . . . 10.0 112.188 170.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -138.78 -64.99 0.5 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.538 -1.22 . . . . 10.0 109.465 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.7 m -152.15 149.75 29.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.203 1.365 . . . . 10.0 111.033 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 23.0 ttpt -149.97 143.61 25.32 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -150.84 154.76 37.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.739 1.216 . . . . 10.0 109.085 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -89.04 122.66 32.6 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.76 90.82 4.82 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.252 1.025 . . . . 10.0 108.88 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -57.4 -13.7 3.83 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.213 1.405 . . . . 10.0 113.399 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -62.71 -25.18 68.04 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.632 1.106 . . . . 10.0 111.876 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -131.59 -9.72 3.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.467 0.707 . . . . 10.0 111.959 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 48.58 8.69 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.469 -1.052 . . . . 10.0 110.469 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.32 163.17 34.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.317 1.047 . . . . 10.0 109.92 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.524 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 88.3 m95 -81.8 149.12 28.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -136.59 153.17 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.536 -2.024 . . . . 10.0 105.536 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.38 167.37 38.25 Favored Glycine 0 N--CA 1.45 -0.38 0 O-C-N 121.142 -0.974 . . . . 10.0 113.52 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.19 122.87 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 101.307 -3.59 . . . . 10.0 101.307 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.12 134.17 21.5 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -102.98 31.68 4.09 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 p -153.75 -47.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.913 1.233 . . . . 10.0 112.738 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -63.7 149.13 47.35 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.876 0.762 . . . . 10.0 110.696 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -137.53 34.8 2.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.64 1.176 . . . . 10.0 111.081 -165.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 58.13 43.27 20.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.28 1.432 . . . . 10.0 112.874 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.331 -1.729 . . . . 10.0 106.331 174.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 119.214 -0.422 . . . . 10.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp -56.29 156.74 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 122.231 1.015 . . . . 10.0 112.41 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -116.67 163.56 15.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.372 2.269 . . . . 10.0 106.577 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.65 133.41 52.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.66 149.66 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.897 -0.779 . . . . 10.0 108.897 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -144.43 127.6 16.65 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.519 -2.03 . . . . 10.0 105.519 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -169.66 153.43 5.04 Favored Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 125.372 1.469 . . . . 10.0 109.151 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.78 -24.88 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.335 2.024 . . . . 10.0 113.123 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -81.77 -18.72 43.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.698 0.999 . . . . 10.0 113.698 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.39 37.66 18.95 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.365 -1.242 . . . . 10.0 113.818 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -54.06 99.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.89 1.276 . . . . 10.0 112.094 -170.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.06 116.88 16.29 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.082 0.953 . . . . 10.0 108.736 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.32 -11.82 27.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.576 0.954 . . . . 10.0 113.576 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.41 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.153 2.581 . . . . 10.0 114.673 -166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 p -167.46 164.49 14.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.826 1.25 . . . . 10.0 110.899 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -158.53 175.98 12.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.843 1.657 . . . . 10.0 108.486 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.7 132.74 48.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.872 -1.899 . . . . 10.0 105.872 171.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.3 tp -146.5 132.37 19.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.2 -1.407 . . . . 10.0 107.2 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.71 49.3 11.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.854 1.662 . . . . 10.0 112.774 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.9 72.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.806 0.717 . . . . 10.0 113.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -127.48 136.4 51.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -86.27 150.65 24.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -136.17 140.8 43.88 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 -174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.53 156.62 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.882 1.273 . . . . 10.0 111.742 -168.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -57.91 152.82 15.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.515 1.526 . . . . 10.0 111.763 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -130.38 -70.29 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.416 -1.278 . . . . 10.0 108.112 169.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.51 149.24 27.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.185 1.357 . . . . 10.0 111.0 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.59 155.93 46.43 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.619 -0.676 . . . . 10.0 109.577 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -148.54 153.85 38.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.557 1.543 . . . . 10.0 108.082 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -89.1 118.47 28.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.344 -1.354 . . . . 10.0 107.344 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -83.97 94.13 8.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.741 -1.578 . . . . 10.0 106.741 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.4 m -64.73 -25.5 67.96 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.383 0.673 . . . . 10.0 112.725 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -70.03 -41.97 73.56 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.672 0.669 . . . . 10.0 110.249 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -84.22 -25.88 29.14 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.412 0.685 . . . . 10.0 111.68 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.79 40.86 20.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.154 0.883 . . . . 10.0 111.545 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.35 168.24 23.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.551 1.175 . . . . 10.0 111.014 173.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -76.0 152.48 36.96 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.077 -0.712 . . . . 10.0 109.077 167.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.16 153.67 27.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.752 2.021 . . . . 10.0 105.758 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.08 162.71 35.44 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 121.249 -0.907 . . . . 10.0 113.74 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.06 124.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 102.49 -3.152 . . . . 10.0 102.49 168.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.36 129.47 17.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -167.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -100.08 33.71 2.54 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.169 -1.048 . . . . 10.0 108.169 171.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.56 -48.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.565 1.075 . . . . 10.0 112.048 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -66.55 159.47 27.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.805 0.73 . . . . 10.0 110.233 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -142.78 -46.8 0.32 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.652 0.781 . . . . 10.0 111.95 -174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.83 -44.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.786 -1.102 . . . . 10.0 110.328 -170.831 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 pt -60.01 159.79 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.052 0.929 . . . . 10.0 111.646 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.9 165.14 17.9 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.971 2.508 . . . . 10.0 106.479 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.07 137.47 54.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.812 -1.921 . . . . 10.0 105.812 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.75 150.38 18.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 -168.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.51 14.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.511 1.124 . . . . 10.0 108.812 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.1 m -169.08 155.08 6.28 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.792 2.037 . . . . 10.0 107.943 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.01 -23.77 39.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.975 1.783 . . . . 10.0 112.754 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -71.25 -29.79 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.701 0.682 . . . . 10.0 112.361 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.1 42.23 71.26 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 118.973 -0.904 . . . . 10.0 112.513 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.18 98.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.017 0.927 . . . . 10.0 111.991 -163.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.96 121.53 17.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.455 0.702 . . . . 10.0 109.348 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.45 -8.94 17.79 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.18 -67.98 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.201 2.601 . . . . 10.0 114.814 -168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 p -165.04 162.7 20.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.158 1.383 . . . . 10.0 110.616 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -158.6 175.89 13.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.634 1.574 . . . . 10.0 108.602 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.99 132.31 47.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 105.786 -1.931 . . . . 10.0 105.786 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -149.57 134.46 17.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.161 -1.422 . . . . 10.0 107.161 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t0 45.33 49.94 10.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.108 1.763 . . . . 10.0 112.736 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.2 69.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.776 0.703 . . . . 10.0 113.508 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.2 m -128.86 140.21 51.8 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.684 -1.598 . . . . 10.0 106.684 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -90.34 150.38 21.91 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -136.24 139.12 42.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 tt -154.56 157.48 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.85 1.26 . . . . 10.0 111.975 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.55 154.29 4.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.943 1.697 . . . . 10.0 112.026 168.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -55.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.29 -1.338 . . . . 10.0 110.871 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 62.7 m -151.82 150.25 29.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.843 1.202 . . . . 10.0 110.794 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HE3' ' CE3' ' A' ' 37' ' ' TRP . 25.6 ttpt -149.47 142.62 25.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -150.38 155.89 40.45 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.781 1.232 . . . . 10.0 109.197 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -93.2 122.2 35.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.465 -1.309 . . . . 10.0 107.465 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -96.81 89.99 5.09 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.94 -15.66 5.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.921 1.288 . . . . 10.0 113.386 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.48 -26.91 68.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.508 1.049 . . . . 10.0 111.632 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.79 -14.65 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.554 1.142 . . . . 10.0 111.635 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.13 13.24 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.556 -1.018 . . . . 10.0 110.556 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.92 166.09 26.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.661 0.784 . . . . 10.0 110.384 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' CE3' ' HE3' ' A' ' 28' ' ' LYS . 91.4 m95 -81.32 152.65 27.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.2 156.09 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.243 2.217 . . . . 10.0 105.267 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.34 169.35 39.12 Favored Glycine 0 N--CA 1.452 -0.295 0 O-C-N 120.905 -1.122 . . . . 10.0 113.386 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.77 113.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 101.442 -3.54 . . . . 10.0 101.442 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 133.35 28.86 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 -158.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -106.49 35.76 2.85 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.73 -48.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.679 1.127 . . . . 10.0 112.368 167.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -63.18 141.41 58.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.388 0.995 . . . . 10.0 109.299 -174.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -127.55 27.22 5.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 10.0 109.883 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.9 ttt-85 69.09 -38.49 0.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.364 2.666 . . . . 10.0 113.608 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt . . . . . 0 C--O 1.249 1.078 0 C-N-CA 125.782 1.633 . . . . 10.0 109.402 -175.016 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.7 164.11 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 122.332 1.063 . . . . 10.0 111.976 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -119.48 160.71 21.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.234 2.214 . . . . 10.0 106.247 162.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.57 132.95 54.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.8 146.52 26.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.081 -1.081 . . . . 10.0 108.081 -161.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -156.5 127.7 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.767 0.827 . . . . 10.0 109.324 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 m -160.89 155.15 19.43 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.074 1.75 . . . . 10.0 107.794 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 -26.46 35.14 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.161 1.907 . . . . 10.0 113.14 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -70.75 -31.84 68.79 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.69 0.677 . . . . 10.0 112.549 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.03 32.4 82.09 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.903 -0.943 . . . . 10.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -53.94 97.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.131 1.772 . . . . 10.0 112.116 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -68.09 122.64 18.68 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.17 -3.87 16.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 50.6 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.143 2.577 . . . . 10.0 115.001 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 p -163.09 162.02 25.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.229 1.411 . . . . 10.0 110.441 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.86 177.63 10.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.401 1.481 . . . . 10.0 109.075 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.36 129.37 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.025 -1.842 . . . . 10.0 106.025 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.02 144.01 19.73 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.29 47.27 13.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.436 1.494 . . . . 10.0 112.511 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.65 23.68 63.28 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.181 0.896 . . . . 10.0 113.566 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.9 m -135.2 148.53 49.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.288 1.435 . . . . 10.0 107.274 -172.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -92.39 150.17 20.97 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -135.63 140.07 44.27 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.271 -1.752 . . . . 10.0 106.271 -170.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.8 tt -155.19 157.18 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.433 1.093 . . . . 10.0 111.869 -168.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -58.73 156.39 11.13 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.133 1.773 . . . . 10.0 112.48 172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -137.0 -65.24 0.55 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 117.316 -1.326 . . . . 10.0 109.104 167.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -150.96 149.94 30.21 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.966 1.257 . . . . 10.0 111.711 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 20.9 ptmt -144.62 152.12 40.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.677 1.191 . . . . 10.0 108.601 168.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.86 156.86 41.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.242 1.417 . . . . 10.0 108.715 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.86 119.97 33.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.256 -1.386 . . . . 10.0 107.256 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -90.18 88.21 7.16 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -56.22 -17.1 6.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.825 1.25 . . . . 10.0 113.349 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -25.92 68.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.278 0.944 . . . . 10.0 111.616 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -130.5 -12.37 3.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.653 1.181 . . . . 10.0 112.099 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.94 45.94 15.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.45 164.42 34.22 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.007 0.923 . . . . 10.0 110.297 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 84.9 m95 -82.21 150.24 27.47 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.19 154.04 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 105.289 -2.115 . . . . 10.0 105.289 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.49 172.43 42.39 Favored Glycine 0 N--CA 1.451 -0.348 0 O-C-N 120.977 -1.077 . . . . 10.0 113.528 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.5 mt -117.89 119.56 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 101.679 -3.452 . . . . 10.0 101.679 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 134.9 22.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -162.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -108.51 37.06 2.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.01 -45.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.162 0.892 . . . . 10.0 111.699 168.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -65.4 151.17 46.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.813 0.733 . . . . 10.0 110.628 -171.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.86 32.76 2.68 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.516 1.526 . . . . 10.0 109.886 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.252 0.7 OUTLIER 68.04 -23.19 0.13 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.781 2.833 . . . . 10.0 115.711 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt . . . . . 0 C--O 1.25 1.091 0 C-N-CA 124.246 1.018 . . . . 10.0 109.645 175.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 119.249 -0.405 . . . . 10.0 111.129 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.24 164.12 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.943 0.878 . . . . 10.0 111.394 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -137.34 162.4 33.67 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.515 2.326 . . . . 10.0 106.277 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -120.8 137.19 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.302 -1.74 . . . . 10.0 106.302 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.31 148.51 22.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -141.87 125.86 17.24 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -163.45 145.35 7.61 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 119.113 0.87 . . . . 10.0 108.809 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.58 -20.77 46.86 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.168 1.912 . . . . 10.0 112.317 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.0 -34.24 71.16 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.475 1.034 . . . . 10.0 111.542 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.1 27.98 71.39 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.787 -1.007 . . . . 10.0 114.519 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -52.27 108.82 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.697 1.599 . . . . 10.0 112.147 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.61 109.16 6.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 168.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.61 -2.31 51.63 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 49.32 -70.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.01 2.924 . . . . 10.0 115.983 -171.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -168.27 159.91 11.11 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.135 1.374 . . . . 10.0 110.211 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -159.32 176.08 12.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.543 1.137 . . . . 10.0 109.33 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.25 133.93 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.69 124.48 10.54 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -174.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t0 44.74 41.57 5.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.736 2.014 . . . . 10.0 112.833 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.7 48.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.425 1.012 . . . . 10.0 114.005 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.4 m -83.1 146.32 28.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 171.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -104.09 145.43 30.18 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.352 1.061 . . . . 10.0 108.466 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -136.31 144.49 44.73 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.384 1.074 . . . . 10.0 108.313 -168.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -160.23 159.78 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.857 1.263 . . . . 10.0 112.585 -168.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -58.07 157.44 8.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.009 1.724 . . . . 10.0 112.809 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -141.7 -63.13 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.271 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -151.13 144.66 24.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.911 1.232 . . . . 10.0 111.152 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -151.07 141.5 22.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -149.72 161.33 42.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.11 1.364 . . . . 10.0 109.628 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -92.9 123.48 36.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -92.67 78.05 4.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -52.65 -28.56 22.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.97 1.308 . . . . 10.0 113.323 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -63.41 -21.65 66.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.452 1.101 . . . . 10.0 112.93 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -125.14 -15.77 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.848 1.259 . . . . 10.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.82 37.84 21.6 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.762 0.71 . . . . 10.0 112.43 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.41 163.14 38.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.037 0.935 . . . . 10.0 109.299 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -76.12 153.65 36.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.02 150.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.657 1.983 . . . . 10.0 105.691 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.64 166.53 34.93 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 121.547 -0.721 . . . . 10.0 113.265 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.55 116.6 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 101.268 -3.605 . . . . 10.0 101.268 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.58 136.66 31.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 -163.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -103.81 30.72 4.91 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.457 -0.942 . . . . 10.0 108.457 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.99 -54.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.337 0 CA-C-N 119.087 0.858 . . . . 10.0 111.108 167.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.69 143.93 45.11 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.59 0.632 . . . . 10.0 111.08 -165.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -133.58 27.2 4.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.598 1.159 . . . . 10.0 110.777 -166.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 62.24 14.21 6.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.092 1.757 . . . . 10.0 113.11 -171.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.364 -1.303 . . . . 10.0 107.595 169.611 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.928 -0.397 . . . . 10.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 pt -59.42 160.38 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.97 0.89 . . . . 10.0 111.523 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -128.34 166.01 19.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.826 2.45 . . . . 10.0 106.566 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -122.32 138.66 54.44 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 t -140.68 147.96 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.083 -1.08 . . . . 10.0 108.083 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.53 116.39 9.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.42 1.488 . . . . 10.0 107.166 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -154.7 150.31 21.44 Favored Pre-proline 0 N--CA 1.466 0.341 0 C-N-CA 123.768 0.827 . . . . 10.0 110.032 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.8 -28.41 25.08 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 121.905 1.736 . . . . 10.0 112.796 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -71.86 -29.43 64.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.67 29.82 26.3 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.503 -1.165 . . . . 10.0 115.395 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -61.05 107.19 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.681 1.241 . . . . 10.0 111.392 -172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -65.39 118.02 8.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.774 0.83 . . . . 10.0 109.143 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.28 -8.62 26.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.871 1.063 . . . . 10.0 113.871 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.5 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.976 2.51 . . . . 10.0 114.695 -170.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 p -162.24 165.55 26.65 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.692 1.197 . . . . 10.0 111.022 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -157.22 174.36 15.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.861 1.664 . . . . 10.0 108.585 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.12 133.47 47.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.787 -1.931 . . . . 10.0 105.787 172.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -143.93 121.2 11.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.079 -1.822 . . . . 10.0 106.079 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.6 t0 47.62 43.33 16.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.839 1.656 . . . . 10.0 112.721 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 4.68 78.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.105 0.859 . . . . 10.0 113.968 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 m -102.25 136.88 41.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -87.5 150.72 23.56 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -136.81 139.82 42.04 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.403 1.881 . . . . 10.0 106.098 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -153.32 156.84 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.645 1.178 . . . . 10.0 111.852 -168.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.78 155.08 13.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.032 1.733 . . . . 10.0 112.19 171.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -137.44 -61.39 0.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 117.261 -1.352 . . . . 10.0 110.597 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.5 m -152.55 149.94 29.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.505 1.502 . . . . 10.0 111.136 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -150.01 152.48 34.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.391 1.076 . . . . 10.0 109.295 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.93 157.32 40.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.795 1.238 . . . . 10.0 109.143 177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -89.5 120.27 30.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -88.57 77.37 8.01 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -52.34 -29.21 22.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.894 1.278 . . . . 10.0 113.164 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -65.01 -19.34 65.95 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.476 1.11 . . . . 10.0 112.933 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -125.4 -17.56 5.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.602 1.161 . . . . 10.0 111.97 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.07 36.75 10.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.727 0.694 . . . . 10.0 112.48 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.2 163.26 38.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.219 1.009 . . . . 10.0 109.618 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -75.8 154.61 36.12 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.43 0.633 . . . . 10.0 109.71 170.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.9 t -138.03 154.29 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.559 -2.015 . . . . 10.0 105.559 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.81 166.42 36.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.259 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.8 mt -112.86 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 101.613 -3.477 . . . . 10.0 101.613 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 140.07 30.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -160.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.62 36.66 3.34 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.79 -44.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.304 0.956 . . . . 10.0 111.676 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -66.83 160.8 25.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.285 0.493 . . . . 10.0 110.776 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -141.44 -40.38 0.38 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.762 0.825 . . . . 10.0 112.395 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -172.0 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.405 1.082 . . . . 10.0 111.569 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.251 1.141 0 N-CA-C 105.755 -1.943 . . . . 10.0 105.755 170.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -59.98 163.2 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 122.368 1.08 . . . . 10.0 111.954 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -126.31 164.02 21.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.748 2.419 . . . . 10.0 105.745 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.7 mt -123.55 137.01 54.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.61 150.83 19.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 -168.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -141.47 134.79 29.53 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.44 150.46 4.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.787 -0.819 . . . . 10.0 108.787 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.78 -25.24 39.78 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 121.805 1.67 . . . . 10.0 112.408 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -72.41 -32.16 66.12 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.592 0.633 . . . . 10.0 112.547 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.93 35.15 81.84 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.968 -0.907 . . . . 10.0 113.576 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -54.87 102.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.265 1.426 . . . . 10.0 111.96 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.18 116.1 10.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.51 -7.45 28.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.28 -72.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.053 2.541 . . . . 10.0 115.008 -170.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -165.38 164.19 19.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 10.0 110.729 -174.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -158.07 174.17 15.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.786 1.635 . . . . 10.0 108.558 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.33 133.77 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.788 -1.93 . . . . 10.0 105.788 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -144.07 120.72 11.14 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t0 47.44 43.2 15.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.912 1.685 . . . . 10.0 112.704 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.14 2.9 80.3 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.124 0.868 . . . . 10.0 114.047 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.5 m -99.95 136.49 39.78 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 173.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -87.71 150.61 23.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.008 -0.738 . . . . 10.0 109.008 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -137.15 139.94 41.5 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.188 -1.782 . . . . 10.0 106.188 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.16 156.75 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.825 1.25 . . . . 10.0 111.883 -168.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.84 155.56 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.008 1.723 . . . . 10.0 112.421 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -135.76 -66.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.403 -1.284 . . . . 10.0 109.009 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -150.97 151.33 31.94 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.887 1.221 . . . . 10.0 111.691 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -142.16 150.93 41.71 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.608 1.163 . . . . 10.0 108.649 168.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -151.41 154.85 37.43 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.028 1.331 . . . . 10.0 108.741 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -89.35 121.0 31.19 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.558 -1.275 . . . . 10.0 107.558 174.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.0 85.89 7.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.006 -1.479 . . . . 10.0 107.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 m -57.64 -27.44 62.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.805 0.842 . . . . 10.0 112.764 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -71.47 -26.35 62.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.558 0.743 . . . . 10.0 111.621 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.5 mmpt? -109.63 -17.64 13.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.857 0.863 . . . . 10.0 112.234 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.43 38.57 20.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.056 0.836 . . . . 10.0 112.331 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.64 164.36 37.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.515 1.157 . . . . 10.0 110.473 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 85.9 m95 -73.46 153.68 40.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 168.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.29 156.08 32.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.942 2.097 . . . . 10.0 105.366 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.87 162.89 33.39 Favored Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.452 -0.78 . . . . 10.0 112.865 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.2 mt -106.94 118.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 101.612 -3.477 . . . . 10.0 101.612 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.38 127.54 16.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -162.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -101.14 37.88 1.67 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.847 -1.168 . . . . 10.0 107.847 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.96 -48.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.407 1.003 . . . . 10.0 111.847 167.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -64.68 146.91 54.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.771 0.714 . . . . 10.0 110.379 -169.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.95 37.21 1.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.453 1.501 . . . . 10.0 109.535 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 56.07 26.94 10.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.692 1.597 . . . . 10.0 112.702 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.248 0.982 0 N-CA-C 107.308 -1.367 . . . . 10.0 107.308 167.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.0 pt -60.67 160.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 122.08 0.943 . . . . 10.0 111.466 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -119.55 165.27 14.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.863 2.465 . . . . 10.0 106.523 163.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.09 135.77 54.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.031 -2.211 . . . . 10.0 105.031 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -138.38 142.89 34.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 -167.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -145.28 101.48 3.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -152.15 149.87 24.24 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 118.828 0.74 . . . . 10.0 109.871 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.06 -27.75 19.98 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.082 1.855 . . . . 10.0 113.366 -173.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -72.09 -25.28 61.69 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.17 35.47 26.8 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.792 -1.004 . . . . 10.0 115.099 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -58.7 98.99 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.114 1.366 . . . . 10.0 111.514 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.32 110.72 4.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.682 0.793 . . . . 10.0 108.862 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.98 -12.19 31.33 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.52 -66.05 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.14 2.576 . . . . 10.0 114.606 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 p -164.52 161.74 21.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.943 1.297 . . . . 10.0 110.745 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.4 177.73 10.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.452 1.501 . . . . 10.0 109.099 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.41 129.82 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 106.042 -1.836 . . . . 10.0 106.042 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.7 tp -155.67 143.72 19.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 46.11 47.7 12.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.585 1.554 . . . . 10.0 112.512 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.81 63.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.116 0.865 . . . . 10.0 113.612 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 m -134.94 147.85 49.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.32 1.448 . . . . 10.0 107.19 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -91.1 150.24 21.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.816 -0.809 . . . . 10.0 108.816 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -135.24 140.37 45.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.413 -1.699 . . . . 10.0 106.413 -171.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.5 158.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.424 1.09 . . . . 10.0 112.002 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.04 157.32 8.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.223 1.809 . . . . 10.0 112.458 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -139.17 -61.94 0.55 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 117.608 -1.187 . . . . 10.0 109.529 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 m -152.58 149.3 28.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.889 1.222 . . . . 10.0 111.215 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -148.11 156.07 42.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.872 0.869 . . . . 10.0 109.696 169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -155.5 161.01 41.01 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.033 1.333 . . . . 10.0 108.877 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.87 118.93 31.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.227 -1.397 . . . . 10.0 107.227 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.59 80.34 8.04 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -53.02 -26.71 16.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.944 1.297 . . . . 10.0 113.451 -175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 m -63.0 -21.2 65.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.453 1.101 . . . . 10.0 112.983 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.57 -12.44 6.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.696 1.198 . . . . 10.0 112.065 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.47 41.8 29.15 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.62 0.645 . . . . 10.0 111.739 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.2 164.91 30.77 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.926 0.863 . . . . 10.0 110.555 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -79.52 149.48 31.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.5 t -135.8 149.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.576 -2.009 . . . . 10.0 105.576 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.44 165.98 36.98 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.58 -0.7 . . . . 10.0 113.204 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 58.9 mt -110.73 120.21 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 101.489 -3.522 . . . . 10.0 101.489 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.76 139.02 26.15 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 -162.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -111.88 35.56 3.65 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 170.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.51 -44.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.485 1.039 . . . . 10.0 112.003 168.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -66.1 152.76 44.01 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.293 0.951 . . . . 10.0 110.816 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.81 38.15 0.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.967 1.307 . . . . 10.0 109.76 -167.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 65.86 -33.12 0.17 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.018 2.527 . . . . 10.0 114.491 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 tptt . . . . . 0 C--O 1.248 1.016 0 C-N-CA 124.83 1.252 . . . . 10.0 109.853 176.64 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.506 0.193 . . . . 10.0 110.961 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.2 165.71 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.566 0.698 . . . . 10.0 111.452 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -130.91 161.38 32.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.552 1.941 . . . . 10.0 106.832 167.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.76 134.78 51.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.579 -2.008 . . . . 10.0 105.579 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -140.48 148.25 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 -163.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -152.94 137.66 16.97 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.661 0.785 . . . . 10.0 109.911 171.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 m -161.03 153.04 16.65 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.043 1.337 . . . . 10.0 108.204 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.86 -28.17 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.885 1.723 . . . . 10.0 112.812 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -75.97 -16.56 59.97 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.86 1.059 . . . . 10.0 113.86 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.08 44.51 33.11 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.298 0.954 . . . . 10.0 112.787 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -65.81 78.04 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.848 1.259 . . . . 10.0 112.21 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -55.82 126.57 26.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.134 1.374 . . . . 10.0 109.712 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.57 -4.75 14.67 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.124 1.157 . . . . 10.0 114.124 -170.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.19 -68.4 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.271 2.628 . . . . 10.0 115.492 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.8 p -165.55 162.57 19.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.98 1.312 . . . . 10.0 110.508 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -158.74 174.49 14.95 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.296 1.438 . . . . 10.0 108.712 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.7 132.64 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.797 -1.927 . . . . 10.0 105.797 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.87 127.31 13.16 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.02 42.33 9.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.617 1.967 . . . . 10.0 112.695 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 1.28 57.15 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.27 0.938 . . . . 10.0 114.119 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -95.19 140.66 29.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.605 -1.628 . . . . 10.0 106.605 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.85 151.15 21.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -137.9 140.23 40.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.276 1.831 . . . . 10.0 106.358 -171.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 tt -153.39 159.83 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 119.617 1.099 . . . . 10.0 112.257 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.23 156.96 9.01 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.026 1.73 . . . . 10.0 112.371 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -138.17 -64.54 0.53 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 117.519 -1.229 . . . . 10.0 109.498 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -151.92 149.9 29.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.112 1.323 . . . . 10.0 111.112 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -147.56 157.24 43.48 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.789 0.836 . . . . 10.0 110.129 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -155.26 160.18 40.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.453 1.501 . . . . 10.0 108.774 173.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -92.76 122.05 34.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -89.58 79.48 6.85 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.755 -1.202 . . . . 10.0 107.755 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -52.13 -28.47 18.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.666 1.186 . . . . 10.0 113.235 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m -66.75 -19.98 65.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.353 1.061 . . . . 10.0 112.874 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -124.15 -17.04 6.31 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.635 1.174 . . . . 10.0 112.079 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.79 37.42 16.51 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.917 0.781 . . . . 10.0 112.508 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.46 163.06 37.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.316 1.058 . . . . 10.0 109.729 173.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.92 153.26 36.79 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 t -139.82 154.24 23.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.413 1.885 . . . . 10.0 105.972 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.19 165.17 37.04 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-O 121.998 0.777 . . . . 10.0 112.877 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.92 125.47 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 101.57 -3.492 . . . . 10.0 101.57 169.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.42 153.9 44.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.331 -0.618 . . . . 10.0 109.331 -166.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -124.72 31.47 5.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.827 -1.175 . . . . 10.0 107.827 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.61 -45.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 119.366 0.984 . . . . 10.0 112.156 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -64.61 148.77 50.2 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.855 0.752 . . . . 10.0 110.184 -170.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -140.78 39.07 1.82 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.261 1.024 . . . . 10.0 110.738 -168.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 58.53 43.34 19.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.411 1.484 . . . . 10.0 113.248 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.244 0.798 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 174.176 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.544 0.211 . . . . 10.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt -58.76 151.93 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.559 0.695 . . . . 10.0 110.979 171.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -110.69 162.93 14.25 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.242 1.817 . . . . 10.0 106.56 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.92 136.12 53.46 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.22 -2.141 . . . . 10.0 105.22 168.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.72 144.54 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 -164.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -145.54 106.81 4.18 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.147 1.379 . . . . 10.0 107.467 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -152.64 144.04 16.17 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 119.421 1.009 . . . . 10.0 110.027 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.8 -36.05 89.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.119 2.546 . . . . 10.0 114.6 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -73.83 -25.12 59.93 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.498 0.925 . . . . 10.0 113.498 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.0 28.8 26.1 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.603 -1.11 . . . . 10.0 115.644 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -52.01 112.44 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.244 1.417 . . . . 10.0 111.772 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -73.0 102.45 3.49 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.691 0.796 . . . . 10.0 108.974 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.12 -13.2 57.58 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.82 1.044 . . . . 10.0 113.82 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.85 -69.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.123 2.569 . . . . 10.0 114.481 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -165.16 164.16 20.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.848 1.259 . . . . 10.0 110.589 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -158.0 176.68 12.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.729 1.612 . . . . 10.0 108.669 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.75 135.92 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.04 128.79 12.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t0 45.64 44.25 10.09 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.104 1.762 . . . . 10.0 113.022 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.68 79.61 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.262 -0.744 . . . . 10.0 113.858 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -112.22 135.6 52.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -90.14 152.39 21.14 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.582 -0.896 . . . . 10.0 108.582 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -138.22 140.18 39.61 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 -171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.9 tt -153.89 157.24 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.562 1.074 . . . . 10.0 112.24 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.71 154.91 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.705 1.602 . . . . 10.0 112.223 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -135.28 -66.52 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.314 -1.326 . . . . 10.0 109.092 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 m -151.35 151.31 31.57 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.378 1.445 . . . . 10.0 111.352 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HE2' ' CZ3' ' A' ' 37' ' ' TRP . 21.2 ptmt -145.54 153.17 40.82 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 10.0 109.698 170.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -153.63 157.77 40.13 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.296 1.439 . . . . 10.0 108.865 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -91.7 123.97 35.49 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -93.63 86.3 5.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.653 0.74 . . . . 10.0 109.115 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 m -56.09 -17.1 6.16 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.673 1.189 . . . . 10.0 113.443 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.67 70.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.202 0.91 . . . . 10.0 111.633 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.46 -13.08 3.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.275 1.03 . . . . 10.0 112.308 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.7 43.82 8.16 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.775 0.716 . . . . 10.0 111.759 171.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -145.86 162.78 36.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.773 0.787 . . . . 10.0 109.883 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CZ3' ' HE2' ' A' ' 28' ' ' LYS . 80.2 m95 -75.51 152.89 37.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.385 0.612 . . . . 10.0 109.369 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.4 t -135.16 153.19 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.22 162.04 33.96 Favored Glycine 0 N--CA 1.45 -0.433 0 O-C-N 121.575 -0.703 . . . . 10.0 112.983 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -102.0 121.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 101.641 -3.466 . . . . 10.0 101.641 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 137.18 25.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.336 -0.987 . . . . 10.0 108.336 -165.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -108.69 33.38 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.897 -1.149 . . . . 10.0 107.897 172.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.59 -44.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.341 0.973 . . . . 10.0 112.313 170.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -66.07 153.07 43.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.991 0.814 . . . . 10.0 111.492 -168.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -148.35 34.53 0.8 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.496 1.518 . . . . 10.0 109.801 -167.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 69.83 -25.84 0.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.848 2.459 . . . . 10.0 114.406 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm . . . . . 0 C--O 1.247 0.958 0 C-N-CA 124.289 1.036 . . . . 10.0 109.999 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 119.523 -0.275 . . . . 10.0 110.512 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 pt -57.71 156.89 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.673 0.749 . . . . 10.0 110.968 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -122.22 159.21 27.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.316 2.246 . . . . 10.0 106.053 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.94 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.6 -2.0 . . . . 10.0 105.6 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.46 141.95 36.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -163.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -147.73 102.37 3.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.098 1.359 . . . . 10.0 107.912 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -153.19 150.13 23.17 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.687 0.676 . . . . 10.0 109.683 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.49 -26.58 28.72 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.28 1.987 . . . . 10.0 113.22 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -70.04 -33.18 71.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.756 0.707 . . . . 10.0 112.389 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.9 30.01 74.05 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.766 -1.019 . . . . 10.0 114.076 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -50.46 106.5 0.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.57 1.548 . . . . 10.0 112.06 -174.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -75.12 102.98 5.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -10.83 58.38 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.602 0.964 . . . . 10.0 113.602 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.05 -70.94 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.165 2.586 . . . . 10.0 114.489 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 p -163.92 162.78 23.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.969 1.308 . . . . 10.0 110.708 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -158.73 177.5 11.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.528 1.531 . . . . 10.0 109.026 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.16 129.83 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.974 -1.861 . . . . 10.0 105.974 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.2 tp -155.46 143.66 20.1 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.331 1.453 . . . . 10.0 107.271 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t0 45.61 47.41 11.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.487 1.515 . . . . 10.0 112.532 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.81 63.33 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.165 0.888 . . . . 10.0 113.698 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -134.93 148.44 50.05 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.337 1.455 . . . . 10.0 107.258 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -90.87 150.49 21.52 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -136.51 140.54 43.08 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.273 -1.751 . . . . 10.0 106.273 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.7 tt -155.77 159.23 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.59 1.086 . . . . 10.0 112.286 -165.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -55.36 154.51 6.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.018 1.727 . . . . 10.0 112.621 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -136.09 -59.18 0.75 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-O 117.578 -1.201 . . . . 10.0 109.133 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -161.57 159.89 28.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.282 1.401 . . . . 10.0 112.354 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -141.24 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.231 1.412 . . . . 10.0 108.643 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -150.71 158.6 44.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.99 1.316 . . . . 10.0 108.233 162.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -91.57 123.22 34.82 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.095 -1.446 . . . . 10.0 107.095 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -95.64 88.78 5.12 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -56.75 -15.72 5.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.894 1.278 . . . . 10.0 113.383 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -64.17 -24.58 67.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.361 0.982 . . . . 10.0 111.855 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -130.23 -12.42 4.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.579 1.152 . . . . 10.0 112.016 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 46.32 16.87 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.34 167.44 22.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.556 0.743 . . . . 10.0 110.48 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.83 150.05 28.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.44 152.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.501 -2.037 . . . . 10.0 105.501 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.2 37.57 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 121.358 -0.839 . . . . 10.0 112.914 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.92 126.45 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 102.107 -3.294 . . . . 10.0 102.107 167.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 136.17 23.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -104.17 31.49 4.55 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 p -153.79 -50.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.505 1.048 . . . . 10.0 111.705 169.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -67.54 148.27 51.69 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.831 0.741 . . . . 10.0 110.453 -170.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.09 47.4 0.77 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.848 1.259 . . . . 10.0 109.734 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 62.41 10.78 4.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.363 1.865 . . . . 10.0 113.977 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.248 1.019 0 C-N-CA 124.111 0.964 . . . . 10.0 108.576 174.285 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 119.471 -0.299 . . . . 10.0 110.842 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 pt -60.17 159.15 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.832 0.825 . . . . 10.0 111.312 174.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 159.32 27.25 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.247 2.219 . . . . 10.0 106.574 168.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -111.66 133.96 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.196 -2.15 . . . . 10.0 105.196 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.91 149.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -167.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.33 137.92 16.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 109.31 173.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -169.79 150.55 3.89 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 125.18 1.392 . . . . 10.0 107.603 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.27 -26.63 43.99 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.747 2.298 . . . . 10.0 113.194 166.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -63.83 -39.67 94.79 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.636 0.774 . . . . 10.0 112.226 -175.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.45 33.8 17.94 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.302 0.953 . . . . 10.0 114.001 -175.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -60.57 105.67 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.411 1.084 . . . . 10.0 111.08 -168.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.48 108.45 4.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.024 -0.732 . . . . 10.0 109.024 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.09 -10.63 38.29 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 -174.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.96 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.14 2.576 . . . . 10.0 114.582 -171.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -164.6 162.98 21.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.995 1.318 . . . . 10.0 110.314 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -157.75 176.97 11.89 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.527 1.531 . . . . 10.0 108.63 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.34 135.93 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 174.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -152.56 131.47 12.52 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.494 -1.298 . . . . 10.0 107.494 -174.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.0 t0 44.49 47.72 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.494 1.918 . . . . 10.0 113.021 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.29 75.85 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.797 0.713 . . . . 10.0 113.625 175.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.8 m -124.67 135.82 53.38 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -89.14 153.18 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 175.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.96 140.49 40.26 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.465 -1.68 . . . . 10.0 106.465 -172.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.08 157.23 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 119.379 0.991 . . . . 10.0 112.217 -167.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -57.1 154.27 10.23 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.781 1.633 . . . . 10.0 112.373 170.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -138.75 -55.82 0.62 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 117.516 -1.23 . . . . 10.0 109.914 165.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -159.82 153.36 22.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.519 1.509 . . . . 10.0 111.613 173.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -145.26 160.67 41.13 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.413 1.085 . . . . 10.0 108.615 161.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -152.51 162.48 41.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.701 1.6 . . . . 10.0 108.591 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -95.85 123.59 39.5 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -96.5 90.9 5.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.835 0.854 . . . . 10.0 108.718 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.71 -15.4 7.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.756 1.222 . . . . 10.0 113.416 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -63.78 -26.14 68.5 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.381 0.991 . . . . 10.0 111.576 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -129.95 -10.82 4.32 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.371 1.068 . . . . 10.0 112.114 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.7 46.36 18.68 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.794 -0.923 . . . . 10.0 110.794 175.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.96 164.78 31.85 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.953 0.901 . . . . 10.0 110.201 177.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -81.39 153.17 27.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.81 151.44 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 127.161 2.184 . . . . 10.0 105.194 176.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.93 173.22 39.95 Favored Glycine 0 C--N 1.334 0.418 0 O-C-N 120.904 -1.122 . . . . 10.0 113.973 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 54.1 mt -124.85 113.51 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 101.618 -3.475 . . . . 10.0 101.618 178.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.81 139.43 32.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.792 -1.188 . . . . 10.0 107.792 -158.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -108.99 30.75 6.26 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 173.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.67 -45.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.174 0.897 . . . . 10.0 112.1 171.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -65.99 154.05 40.48 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.985 0.811 . . . . 10.0 111.164 -169.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.47 31.59 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 10.0 110.103 -166.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 67.4 -23.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 127.983 2.513 . . . . 10.0 114.403 -175.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm . . . . . 0 C--O 1.251 1.17 0 C-N-CA 124.253 1.021 . . . . 10.0 110.187 178.708 . . . . . . . . 0 0 . 1 stop_ save_